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The potent cytotoxin ricin, obtained from the seeds of the castor
oil plant Ricinus communis, is composed of two polypeptide subunits 
linked by a single disulphide bond. The binding of this molecule to the 
surface of eukaryotic cells is mediated via the sugar-binding activity 
of the B subunit. The exact nature of the ricin receptor(s) on the cell 
surface is unclear, but is most probably some glycoprotein or glycolipld 
containing exposed galactosyl residues. The ricin molecule becomes 
internalized by the cell and, by an unclear mechanism, ricin A chain 
escapes its endocytic vesicle entering the cell cytoplasm where it 
enzymatically and irreversibly inhibits eukaryotic ribosomes, bringing 
about the cessation of protein synthesis.
The toxicity of ricin A chain-containing immunotoxins can in many 
model systems be enhanced by the subsequent addition of ricin B chain. 
This apparent ricin B chain-mediated potentiation of cytotoxicity 
suggests that this subunit has some role in the mechanlsm(s) 
facilitating the entry of ricin A chain into the cell cytosol.
The work presented in this thesis has attempted to examine the 
potential of ricin B chain as a carrier of proteins into cells other 
than ricin A chain. In this example ricin A chain has been replaced 
with the type I ribosome inactivating protein, gelonln.
Further to these studies, preliminary work considering the possible 
Importance of the hydrophobic C-terminus of ricin A chain in the 
translocation events, has been presented. To date this work has
ii
demonstrated that it is possible to delete at least 30 amino acid 
residues from the C-terminus of the A  chain and retain full ribosomal 
inactivation activity as judged by in vitro analysis. This truncated 
form of ricin A chain has been expressed in an E. coli expression system 
and a soluble and active recombinant protein has been partially 
purified. The implications of this work and possible future analysis of 
this mutant polypeptide have also been considered.
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1:1:1 Overview.
The protein rlcln Is an extremely potent cytotoxin occurring with a 
number of other seed storage proteins within protein body organelles found 
In the seeds of the castor oil plant Rlclnus communis (Tulley and Beevers, 
1976; Youle and Huang, 1976). The toxic and medical properties associated 
with the seeds of this plant have been realised since ancient times; their 
use being recorded In classical Greek and Sanskrit medicine. More 
recently, in the nineteenth century, Paul Ehrlich established some of the 
basic principles of immunology using crude rlcin preparations obtained from 
castor beans (Ehrlich, 1891). Ehrlich Is of course the originator of the 
term "magic bullet", a term used to describe reagents designed for the 
targeted destruction of diseased cells. Nowadays this term frequently 
describes the construction of rlcin-antlbody conjugates, commonly referred 
to as immunotoxins.
An historical perspective of the scientific work relating to ricln has 
been made by Balint (1974) in his extensive review. In summary, Stlllmark 
In 1887 was the first person to name the toxic component from the castor 
oil seed, rlcin. However, its activity had been noted as early as 1878 by 
Rltthausen and later confirmed by Dixon In 1887. The first detailed 
description of rlcin poisoning In man was published in 1899 by Muller.
Early purification procedures were improved by Osborne (1905) and later by 
Robert (1913) who introduced an ammonium sulphate precipitation stage. The 
major breakthrough however did not occur until 1965 when affinity 
chromatography using sepharose was first achieved by Dlrheimer. This 
technique now forms the basis for most present day methods of ricin 
purification.
Ricin is a potent toxin towards eukaryotic cells. It has been 
estimated that 1 Kg of the purified toxin would be lethal to 3.6 million 
people, which equates to a lethal dose of 0.27 mg per person, (Balint, 
1974). Sensitivity to the toxin varies from species to species; the horse 
and the guinea pig being the most sensitive. Indeed Ehrlich has calculated 
that a single gram of ricin would be enough to kill l.S million guinea 
pigs. At the other extreme, the domestic hen is the most resistant of the 
higher animals tested, and the frog apparently has an outstanding 
resistance to the toxin (Balint, 1974). Table 1:1 describes the 
sensitivity of different species to ricin intoxication (after Olsnes and 
Pihl, 1982).
Table 1:1
Animal Lethal dose 50%
Mice 2.7 ¿tg/Kg body weight
Rabbit *50 ng/Kg
Dog *1.25 pg/Kg
Human *0.15 /ig/Kg
*intravenous administration of abrin, a toxin closely related to ricin.
Inevitably throughout the ages ricin has been exploited for criminal 
purposes, with possibly the most famous case being the assassination of the 
Bulgarian expatriate Georgy Markov on Waterloo Bridge in London in 1978. 
Markov was shot in the 1 « 8  with what is believed to be a ricin impregnated 
pellet, fired from a modified umbrella.
The use of ricin for medicinal purposes is, thankfully, far more 
common. Recently, attention has focused on ricin and associated toxins for
their potential as specific anti-tumour agents whereby the toxins are 
targeted to cancerous cells by being coupled to a suitable cell binding 
monoclonal antibody. These so-called lmmunotoxlns have achieved reasonable 
efficacy in whole cell and animal model systems, but as yet only a limited 
response in clinical trials.
1  ; 1  ; 2 S t r w c of Risln-
Ricln is a glycosylated, heterodimerlc protein with an estimated 
molecular weight of 62,057 daltons (Olsnes and Fihl, 1982). It is composed 
of two subunits termed A chain and B chain. Both are N-glycosylated and 
have molecular weights of 30,625 daltons and 31,432 daltons respectively.
The complete amino acid sequence of ricin A chain (Funatsu et al., 1978) 
and ricin B chain (Funatsu et al., 1979) has been established by peptide 
analysis and also deduced from the nucleotide sequence of cDNA clones 
coding for preproricin (Lamb et al., 1985). These latter studies showed 
preproricln to be composed of a 35 amino acid N-terminal sequence preceding 
the A chain (267 amino acids), which is joined to the B chain (262 amino 
acids) by a 12 amino acid linker region. In the mature protein the signal 
sequence and linker are removed by specific processing enzymes. The two 
subunits are covalently linked by a single disulphide bond between cysteine 
residues at position 259 in the A chain and position 4 in the B chain.
However, it is apparent from X-ray crystallographic analysis of ricin that 
a more complex Interaction occurs between the two subunits (Montfort £_£ 
al.. 1987). In addition to the interchain disulphide bond, ricin B chain 
contains 4 intrachain disulphide bonds. In contrast ricin A  chain has no 
intrachain disulphide linkages. Both subunits possess two N-glycosylation 
sites, both of which are occupied in the B chain by high mannose type 
oligosaccharides (Foxwell et al., 1985). Ricin A chain may exist in two 
glycosylated forms, as the A, species with only one N-glycosylatlon site
3
4occupied with a complex oligosaccharide containing xylose and fucose, or as 
the A, species in which the second N-glycosylation site is also occupied.
A more detailed account of the oligosaccharide side chains of the ricin 
subunits is considered in the discussion section of Chapter 3.
1 ;1 ;3  p io io g ica i A c tiv it ie s , vt R ic in  subunjt$.
The structure and function of the respective subunits will be 
considered in more detail elsewhere. However, each subunit may be 
characterised through distinct biological activities. Ricin A chain, the 
effectomer, is known to enzymatically inactivate eukaryotic ribosomes 
resulting in a cessation of protein synthesis in the Intoxicated cell. 
However, to inactivate the ribosomes ricin A chain must first become 
internalized into the cell, and then translocated into the cell cytoplasm. 
The biological activities of ricin B chain are believed to facilitate these 
processes. Ricin B chain, the haptomer, has a well-defined sugar-binding 
or lectin activity, exhibiting a specificity for galactosyl residues. This 
activity of the B chain mediates the binding of the whole toxin to the 
surfaces of cells, probably to galactosyl residues which occur on exposed 
glycoproteins and glycolipids on the cell surface. No specific receptors 
have been identified for ricin, rather its binding appears to be 
opportunistic towards a range of cell-surface molecules. The number of 
binding sites is therefore enormous. He La cells for example, possess 3 x 
10T potential binding sites for ricin (Olsnes and Pihl, 1982). Together 
therefore, the two subunits constitute an extremely potent toxin which can 
bind, through the B chain, to any one of millions of sugar residues on a 
wide range of different cell types and become internalised resulting in the 
inactivation of susceptible ribosomes.
In addition to its sugar-binding role there exists indirect evidence 
that B chain has some role in promoting the entry of the A chain into the
5cytosol. This effect has been observed in studies in which the cytotoxic 
activities of ricin A chain-containing immunotoxins has been potentiated in 
the presence of ricin B chain (Youle and Neville, 1982; McIntosh et al.. 
1983). This effect is apparently not a result of the binding of ricin B 
chain to galactosyl residues on the cell surface because it has also been 
demonstrated in the presence of high lactose concentrations which would 
ensure blockage of the binding sites.
l i l i A  Th? C v to tp g U  <?f Rl<?ln.
The cytotoxic activity of ricin on eukaryotic cells may be considered 
in three stages. Stage I involves binding of the whole toxin to the cell 
surface. This is mediated through the sugar-binding sites of the B 
subunit. That ricin cytotoxicity can be abolished by the presence of free 
lactose (100 mM), suggests that (a) binding to the cell surface is a 
prerequisite for intoxication and (b) binding mediated through the lectin 
activity of ricin B chain represents the predominant means by which ricin 
interacts with (and ultimately kills) the cells. It remains unclear 
however, as to whether particular cell surface sugar residues on particular 
glycoproteins or glycolipids are more important than others with respect to 
the next stage, of toxin internalisation and ultimate delivery of ricin A 
chain into the cytosol. Studies by Simmons et al. (1986) have suggested 
that the mannose-rich oligosaccharide side chains of ricin may have some, 
possibly minor, role in the internalisation of ricin.
Stage II is concerned with the internalisation of ricin and 
translocation of ricin A chain into the cytosol. As it is of particular 
interest to the subject of this thesis, it has been considered in a 
separate section later in the Introduction.
Stage III involves the inactivation of eukaryotic ribosomes, leading 
to the inhibition of protein synthesis. This inhibition of protein
synthesis is brought about by the enzymatic inactivation of the large (60S) 
ribosomal subunit by ricin A chain (Olsnes and Pihl. 1976; Sperti et al. . 
1973). Cawley et al. (1978) have shown this inactivation to be catalytic 
in nature, requiring no cofactors. Kinetic experiments have indicated that 
a single ricin A chain molecule can inactivate salt-washed ribosomes at a 
rate of 1500 per minute (Km - 1-2 x 10*T M), (Olsnes Et ftl- , 1975). A 
more detailed account of ribosome inactivation has been given in the later 
section, Ricin A chain : Structure, Function and Evolution.
1  = 1:5 aiflimthaaia <?f
Ricin and the related castor bean lectin, RCA^, are synthesised 
simultaneously in the endosperm cells of maturing castor bean seeds 
(Gifford et al.. 1982). This synthesis occurs during and after testa 
formation when the organelles are being rapidly formed (Roberts and Lord, 
1981a). The structural and functional homology between the two lectin 
species would suggest a similar biosynthetic pathway, indeed it seems 
likely that duplication of an ancestral gene may have evolved into the 
genes encoding for these two lectins. Work by Butterworth and Lord (1983) 
has shown that both the A and B subunits of ricin and the A' and B' 
subunits of RCAj are derived from large precursors. The ricin precursor, 
preproricln, is composed of a 35 amino acid N-terminal signal peptide 
preceding the A chain (267 amino acids), which in turn is linked to the B 
chain (262 amino acids) by a 12 amino acid linker region (Lamb et al ■ , 
1985). The N-terminal signal peptide is cleaved during cotranslational 
translocation of the nascent precursor across the endoplasmic reticulum 
membranes at which stage core glycosylation occurs and the disulphide bonds 
are formed (Roberts and Lord, 1981b). The glycosylated precursor is 
then apparently directed via the Golgi to vesicles which fuse with the 
protein bodies. Transport is possibly directed by some kind of targeting
sequence. Within the protein bodies the precursor is processed to the 
mature form of ricin. Details surrounding these final processing events 
are presently being investigated.
The synthesis of ricin as a precursor molecule, its concomitant 
segregation within the endomembrane system and its transport to protein 
bodies prior to processing prevents enzymatic inactivation of castor bean 
endosperm ribosomes by ricin A chain. Thus if ever exposed to the 
ribosomes as a result of inefficient translocation, ricin A chain occurs as 
a precursor which is known to be biologically inactive (Lynne Roberts, 
Personal Communication).
1:2 = 1 The s tr v c w r * . EvglvUen tn4 Fwnctipp 9 f E lg in  g chain.
Ricin B chain is a lectin with an affinity for galactosyl residues. 
Earlier work by Zentz et al. (1978) and Houston and Dooley, (1982) 
established that ricin B chain binds two sugar molecules in a non- 
cooperative manner. These two authors disagree however as to the binding 
affinities of each of these sites; Zentz et al. . suggesting that the sugar­
binding domains can be differentiated as a low and a high affinity binding 
domain, whilst Houston and Dooley maintain that the binding affinities 
of each site are more or less equal.
Villafranca and Robertus (1981), have shown that ricin B chain is a 
gene duplication product, showing approximately 32% homology at the amino 
acid level between the two halves of the molecule. Each half of this 
molecule contains a sugar-binding domain. Work by Mise et al. (1986) , has 
implicated the amino acid residue tyrosine 248 in the "strong” galactose 
binding site, and an undetermined tryptophan residue in the weak site 
(Hatakeyama et al.. 1986). Each sugar-binding domain is proposed to 
contain two disulphide loops which show significant homology with residues 
168-22S of dlscoidln I, a galactose binding peptide from the slime mould
8Dlctvostellum dlscoideum (Robertus and Ready, 1984). These same authors 
have suggested that this peptide was an ancient galactose binding unit from 
which rlcln B chain has evolved. More recently X-ray crystallographic 
analysis, revealing the three-dimensional structure of ricln at a 
resolution of 2.8 A, has confirmed that rlcln B chlan Is composed of two 
globular regions, which although separate, share Identical folding 
topologies. Each will bind a lactose molecule (Montfort et al. . 1987). It 
Is Interesting to note however, that each sugar molecule binds to different 
sites within each domain.
A more detailed analysis of each domain, described by Rutenber et al. 
(1987), shows that each homologous domain can be divided into four peptide 
sub-domains. These authors have named these peptides A- , a-, fi- and y-sub- 
domalns. The A-peptide of domain 1 (peptide 1A, residues 1-16) is 
homologous to the A peptide of domains 2 (peptide 2A, residues 136-150). 
These two peptides are however not related to the other sub-domains within 
the molecule. At this point It Is interesting to note that the 1A sub- 
domain forms the N-terminal extension of ricln B chain which interacts with 
the carboxyl-terminal domain of ricin A chain (Montfort et al. ■ 1987). The 
remaining sub-domains, the a, fi and y peptides are homologous with each 
other. These sub-domains, which comprise the main body of each domain have 
undergone considerable divergence but, despite this they still demonstrate 
a statistically significant homology.
In the model presented by Rutenber et al. (1987) the two sugar-binding 
domains, which are linked by the 2A peptide, each bind a lactose molecule 
in a non-homologous fashion at the domain level. However, at the sub- 
domain level, the binding of lactose in each respective domain, to peptides 
la and 2y Is homologous (Rutenber et al.. 1987). At both binding sites (in 
sub-domains la and 2y) the lactose molecule is believed to lie In a pocket 
formed on one side by a kink In the peptide chain and on the other side an 
aromatic side chain. This kink formed by the residues Asp-Val-Arg is
9conserved in both sub-domains, and che aromatic side chains belong to 
tryptophan residue 37 in la and tyrosine residue 248 in 27 . These side 
chains however, serve only as a flat binding surface and apparently do not 
specifically interact with the sugar hydroxyl groups (Montfort et al ■ , 
1987). Specific non-covalent interactions in the fora of hydrogen bonds do 
occur between the sugar and amino acid residues Asn 46 and Asn 2SS. These 
binding residues are only conserved in the sub-domains which still bind the 
sugar and have therefore been considered as prime targets for modification 
in attempts to abolish the sugar-binding activity of ricin B chain. Other 
highly conserved residues are believed to fulfil structural roles.
Rutenber et al. (1987), speculate that ricin B chain has evolved from 
an ancient galactose-binding peptide of approximately 40 residues which 
resembles the la domain found presently in the molecule. They further 
speculate that the ancient molecule existed as a trimer and that from gene 
duplication and fusion a afii molecule resembling a modern day B chain 
domain evolved. Such a fusion is thought to have abolished binding in the 
P subunit, leaving only two binding sites in the a and 7  sub-domains. The 
addition of the A peptide is expected to have stabilized the structure to 
form a XafJ-y unit which by a further duplication event would form the 
structure (,XaP~i)3 , resembling modern ricin B chain. This final duplication 
event is thought to have blocked access of galactose to the 1A unit. Sub­
domain 2a appears to have also lost its binding residues at some point.
This leaves two sugar-binding domains, la and 2 7  which are 75 A apart. 
Rutenber et a l . (1987) speculate that the selection of two sugar-binding 
sites this distance apart reflects a requirement for cell surface binding 
and the triggering of endocytosis. The primitive "galactose-fold" 
speculated by these workers is consistent with structural analysis of the 
lectin discoidln I, extracted from the slime mould Dlstvostellum 
discoldeura. fueling the speculation that ricin B chain has evolved from a 
primitive sugar-binding protein (Robertus and Ready, 1984).
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Throughout this analysis of the structure and function of ricin B 
chain it is interesting to note that no obvious candidate for a membrane 
penetrating domain, such as those observed in diphtheria toxin (Greenfield 
et al. , 1987) and Pseudomonas aeruginosa exotoxin A (Allured et al. , 1986) 
has been identified. Despite this, ricin B chain apparently possesses some 
ability to potentiate the cytotoxic activity of certain ricin A chain- 
containing immunotoxins (Youle and Neville, 1982; McIntosh et al.. 1983). 
This activity, as mentioned earlier, is apparently independent of the 
sugar-binding activity of ricin B chain.
The possibility that ricin B chain interacts directly with lipid 
membranes has been examined by a number of workers (Ishida et al. . 1983; 
Utsumi et al.. 1984). In their experiments Ishida et al. . 1983 used the 
Newcastle Disease Virus (NDV) as the target membrane for ricin and ricin 
subunits. The membrane of NDV is rich in the ganglioside GMj which 
provides an avid binding site for ricin and ricin B chain. In the case of 
both whole ricin and ricin B chain, the presence of galactose significantly 
reduced membrane interaction. In contrast the binding of ricin A chain to 
the virus membrane envelope was unaffected by the presence of galactose. 
These workers conclude that both subunits of ricin have the inherent 
ability to penetrate the lipid bllayer.
In similar experiments Utsumi et al. (1984) considered the interaction 
of ricin and ricin subunits with dipalmitoylphosphatidylcholine (DPPC) 
vesicles. They observed no association between these vesicles and the 
unreduced toxin, but considerable interaction when the purified ricin 
subunits were presented to the vesicles separately. In fact, their 
experiments indicated that ricin B chain demonstrated the greater lipid- 
protein association of the 2 subunits. However, these same authors 
observed a significantly greater perturbation of the DPPC bilayer after 
incubations with ricin A chain as compared with either whole ricin or ricin 
B chain. They concluded that although both subunits are able to form
strong associations with lipid membranes, only ricin A chain was able to 
achieve full penetration. This finding is in agreement with the 
speculation that the hydrophobic C-terminal region of the A chain is 
important in membrane penetration and entry of ricin A chain into the cell, 
OJchlda et al.. 1980).
If, as has been suggested by these results, ricin B chain does not 
actively participate in membrane penetration, then the observed 
potentiation of A chain immunotoxins cytotoxic activity may be the result 
of some indirect or cooperative activity. Possibly ricin B chain acts to 
protect the A chain from proteolytic degradation, or perhaps being 
associated with ricin B chain acts to direct ricin A chain to an 
appropriate intracellular compartment for translocation into the cytosol. 
Observations by Montfort et a l . (1987) and Lewis and Youle, (1986) have 
suggested that the ricin subunits form an intimate association. In 
particular Montfort et al. (1987) have speculated from their analysis of 
the three-dimensional structure of ricin, that the carboxyl-terminus of 
ricin A chain inserts between the two sugar-binding domains of the B chain. 
Possibly this association acts to maintain the hydrophobic C-terminus of 
the A chain in a protected conformation until intracellular conditions are 
optimum in facilitating subunit dissociation and the subsequent exposure of 
this protected region. For the mean time these suggestions remain untested 
speculation.
1;2 ¡2 s*r*»?tvnrt. Function Evglutlw 9f R icin  A Chain-
The X-ray crystallographic analysis of ricin carried out by Montfort 
et al. (1987) has divided ricin A chain into three arbitary domains. The 
first, comprising 117 amino-terminal residues, forms a flat domain at the 
base of the A chain, dominated by a five-stranded /3-sheet structure. The 
second domain, comprising residues 118-210 is dominated by five a helices.
This domain is located above, and slightly to the left of the first domain. 
The third domain, comprising residues 211-267 forms a compact disc-like 
domain which, as well as interacting with the first two domains of the A 
chain, interacts with the ricin B chain. As mentioned in the previous 
section, this interaction results in the insertion of this C-terminal 
domain between the two sugar-binding domains of ricin B chain. The A chain 
is a more globular protein than the B chain. It is approximately 55 A 
long, 45 A wide and 35 A thick. Of this, the C-terminal disc-like domain 
comprises of a region 25-30 A across and 15-20 A thick. In addition to its 
strong interaction with ricin B chain, this C-terminal domain represents a 
significantly hydrophobic region of the molecule which has been implicated 
in membrane associations (Uchida et a l . . 1980).
Ricin A chain is an enzyme whose substrate is 28S rRNA. Recently, 
work by Endo et al. (1987) has demonstrated a specific N-glycosidase 
activity associated with the A chain. The location of the active site 
however, remains unclear. Montfort et al. (1987) have identified a 
putative active site within the A chain structure, but readily acknowledge 
the need to carry out further studies. Interestingly this cleft, formed at 
the interface between the three domains, would be exposed to the aqueous 
media in the unreduced holotoxin, suggesting that upon reduction and 
dissociation from the B chain, ricin A  chain undergoes some degree of 
conformational change to form the active molecule.
Ricin A chain inhibits protein synthesis by inactivating the function 
of the 60S subunit of eukaryotic ribosomes, (Sperti et al. . 1973). This 
activity appears to be confined to eukaryotic ribosomes only. Ribosomes 
extracted from prokaryotic sources are totally insensitive when incubated 
with concentrations of ricin that result in complete inhibition in 
eukaryotic systems (Greco et al.. 1974). Ribosomes extracted from higher 
plants have also been shown to be susceptible to ricin inactivation, 
although the concentration required to produce an IC40 in a cell-free
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translation system was some 23,000 times higher than the concentration 
giving the same effect on mammalian ribosomes, (Harley and Beevers, 1982). 
These findings are in agreement with the result described in Figure 5:7 in 
which ricin A chain raRNA translated in a wheatgerm in vitro system does not 
apparently inactivate the ribosomes in that system. In contrast, when the 
same RNA is translated in a rabbit reticulocyte lysate system complete 
ribosome inactivation occurs within the duration of the experiment (see 
Figure 5:8). In addition the ribosomes from the protozoan, Tetrahvmena 
pvrlformis have also been reported to be resistant to ricin (Wilde et al., 
1979).
As mentioned earlier in this chapter, a single molecule of ricin A 
chain can inactivate a large number of ribosomes. Olsnes et al. (1975), 
have estimated that a single A chain molecule can inactivate 1500 salt- 
washed ribosomes per minute, which translates to a Km value between 1-2 x 
10*T M. The use of salt-washed ribosomes in these kinetic studies is 
important, since pre-bound elongation-factor 2 (EF-2) which is removed in 
the salt wash, has been shown to protect ribosomes against ricin 
inactivation. This suggests that ricin A chain may bind at or very close 
to the normal EF-2 binding site. Protection of ribosomes is also seen with 
amino acyl-tRNA (Fernandez-Puentes et al.. 1976). Furthermore ricin A 
chain treated ribosomes are apparently unable to bind EF-1, thereby 
blocking the binding of amino acyl-tRNA. All this data suggests that the 
action of ricin A chain is to somehow modify the binding sites for these 
accessory factors on the ribosomes. It is possible that EF-2 may bind to 
the same site or a site close to the EF-1 binding site on the ribosome. 
Interestingly ricin A chain has been shown to demonstrate some amino acid 
homology with hamster EF-2. The deletion of a contiguous stretch of six 
homologous residues from the ricin A chain sequence results in a molecule 
which displays no activity when tested in a ricin A chain sensitive in 
vitro translation system (May et al.. 1988). It is unclear however as to
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whether this loss of activity has resulted from the inability of an 
otherwise active ricin A chain molecule to bind to the ribosomes, or the 
consequence of malfolding.
Evidence that ricin A chain might bring about ribosomal inactivation 
by inducing some subtle conformational change in the ribosome comes from 
the observations of Cawley et al. (1979) who were able to protect and even 
rescue ribosomes from the effects of ricin A chain. In their experiments, 
they found that high concentrations of Mg2+ ions reduced A chain 
inactivation and have speculated that this may be the result of an induced 
conformational change. More recently, work by Teroa et al. (1988) has 
demonstrated that the labelling of the ribosomal protein L-14 with either 
*H or 1 *C labelled N-ethylmaleimide was reduced after treatment of the 
ribosome with ricin. This result suggests that ricin may alter the 
conformation of the ribosome in the vicinity of that protein. The same 
authors have speculated that these conformational changes are related to 
the specific N-glycosidase activity which is characteristic of ricin A 
chain action on eukaryotic ribosomes.
This N-glycosidase activity, discovered by Endo et al. (1987) produces 
an apparently minor, but highly specific, modification of the 28S rRNA.
More precisely it catalyses the removal of an adenine residue from position 
4324 in a highly conserved region of rat liver 28S rRNA. The ribosomal RNA 
backbone is not cleaved by the action of the A chain, but the 
phosphodlester linkages on either side of this residue become 
hypersensitive to cleavage using reagents such as aniline at low pH. This 
ability to cleave ricin A chain modified rRNA using simple chemicals is 
exploited in the RNA modification assay described in Section 2:11. Endo 
has also demonstrated that ricin A chain can catalytically modify naked 
rRNA extracted from both eukaryotic and prokaryotic ribosomes. This 
suggests that susceptible prokaryotic rRNA is somehow protected by the 
structure of the prokaryotic ribosome. From these studies, Endo has been
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able to deduce che minimum requiremenc for che subscrace of ricin A chain 
Co be rRNA in a seem loop sCrucCure, having Che sequence GA GA within Che 
loop (Endo, Y., abstract from the International Symposium on immunotoxins, 
June 9-11, 1988, Sheraton University Centre, Durham, North Carolina,
U.S.A.).
Considered together, this data would support a model in which ricin A 
chain binds at or near to the binding site for EF-2 on the ribosome. Ricin 
A chain then catalyses the removal of the adenine residue at position 4324 
in the 28S rRNA. This adenine residue is located within a ribonucleotide 
sequence GA GA, situated in a stem/loop structure. This modification of 
28S rRNA has been associated with conformational changes in the 60S 
ribosomal subunit (Terao et a l . , 1988) which are thought to result in 
inactivation of the whole ribosome. Interestingly this region of 28SrRNA, 
modified by the action of ricin A chain, is highly conserved in the large 
rRNA of both prokaryotic and eukaryotic ribosomes. The observation by Endo 
(Symposium abstract) that prokaryotic rRNA, when purified from associated 
ribosomal proteins, is also modified by ricin A chain suggests that 
prokaryotic ribosomes form a conformation which somehow protects this 
susceptible region.
Although these recent developments have contributed considerably to 
our understanding of ribosomal Inactivation by ricin A chain, much work 
remains before the precise mechanism can be defined. Perhaps the greatest 
benefit to be gained from the efforts of Endo and co-workers is that it has 
focused the research on ricin A chain activity, which prior to this had 
consisted of an examination of a number of putative A chain associated 
phenomena. In order to avoid unnecessary confusion, these earlier 
observations which led to speculation regarding the mode of action of ricin 
A chain, such as dephosphorylation (Houston, 1978) or inhibition of 
ribosomal GTPase activity (Benson, 1977), have not been considered here.
Recently a number of authors have identified ribosomal RNA 
modification activity, identical to that found with ricin A chain, in a 
variety of other ribosome inactivating proteins, for example barley toxin, 
(Endo et al.. 1988(c)), viscumin, a type II RIP from mistletoe (Endo at 
al., 1988(a)) gelonin, saporin, momordin, pokeweed antiviral proteins (PAP, 
PAP-II and PAP-S) (Endo et al.. 1988(b)), recombinant ricin A chain, 
tritln, trichosanthin and dianthins (Stirpe et al., 1988) . All these RIPs 
come from plant sources although from species that are taxonomically 
unrelated. The source and data describing the toxicity of these and many 
other RIPs have been extensively reviewed by Stirpe and Barbieri (1986). 
This diversity of RIP sources suggests that these proteins, and indeed 
ricin A chain, may have evolved from some primitive common ancestor. 
Furthermore, the observation that the cytotoxln from the bacterium Shigella 
dvsenteriae (Shiga toxin) also catalytically inactivates ribosomes in a 
ricin A chain-like fashion supports this possibility (Endo and Tsurugi, 
1987). The biology and biochemistry of Shiga and Shiga-like toxins have 
been reviewed by O'Brien and Holmes (1987), and their nucleotide sequence 
determined and compared with ricin (Calderwood et al. , 1987). These 
workers conclude that the A subunit of Shiga-like toxin is homologous with 
the A chain of ricin. Analysis of the amino-terminal sequences of RIPs 
extracted from Phytolacca americana (PAP, PAPII, PAP-S), Phytolacca 
dodecandra (dodecandrin) and the A chains of ricin and modeccln, has 
indicated that all these proteins appear to be related (Ready et al.,
1984). These same authors suggest that these proteins have diverged from a 
common ancestor, in some cases fusing with the genes for sugar-binding 
proteins, the predecessor to the modern B chains (type II RIPs). In other 
cases they remain as single chain molecules (type I RIPs). This type of 
analysis, together with the discovery of a common rRNA modification 
activity and the widespread, divergent occurrence of these proteins goes a 
long way to supporting this hypothesis.
The occurrence of hydrophobic regions within the ricin A chain 
sequence, in particular the significance of the hydrophobic C-terminal 
portion of this molecule have been considered briefly in the previous 
section. The possibility that this region may be involved in membrane 
interactions and its association with ricin B chain are considered more 
fully in the discussion section of Chapters 5 and 6 .
1:3:1 In«?erp,aUsatlan-..»nd Intrac^Hy;»t TrgfflgfclhR of Ricin.
For ricin A chain to bring about cessation of protein synthesis in 
eukaryotic cells it must gain access to its intracellular target, the 60S 
ribosomal subunit located in the cell cytosol. Access to this environment 
requires that ricin is internalized by the cell and that ricin A chain at 
least, is able to translocate the intracellular membrane and enter the 
cytosol.
The binding of ricin to the cell surface is mediated via sugar-binding 
sites within the B chain. As mentioned earlier, ricin is able to bind to a 
variety of cell surface molecules bearing terminal galactosyl residues, 
although it is unclear as to whether all these binding events result in the 
internalization of the toxin. Methods for detecting ricin on the surface 
of exposed cells, such as the use of horse-radish peroxidase (hrp) 
conjugates, or the use of imrounoperoxidase cytochemistry, have indicated 
that ricin binds evenly over the cell surface, including regions of coated 
and uncoated pits. This is in contrast with similar studies carried out on 
transferrin-horse radish peroxidase complexes which are detected within or 
close to coated pit structures. This suggests that the receptors for 
transferrin are located only within this region (Sandvig et al.. 1987). 
Interestingly, Shigella toxin - hrp, a toxin with an apparently identical 
ribosome inactivating activity to ricin binds to cells in a similar manner 
to transferrin, i.e. around or within coated pits, (Sandvig et al.. in
preparation). It is important however, in any analysis of these protein 
labelling studies to determine the extent of any chemical modifications on 
the protein, induced by the presence of the label itself. For instance van 
Deurs et al. (1985) have reported that ricin-gold and polyvalent ricin-hrp 
could not be removed from the cell surface by lactose, whereas monovalent 
ricin-hrp could. If chemically altered, this begs the question - how 
physiological is the system under study? Such studies are further hampered 
by the apparently slow uptake of ricin by cells and the evidence that some 
internalized toxin becomes recycled to the cell surface (Sandvig and 
Olsnes, 1979). The apparent multiplicity of possible entry routes for 
bound ricin is a further indicator of the opportunistic nature of the cell 
binding step.
To date there is no firm understanding of the mechanism(s) by which 
ricin becomes internalized. Despite the limitations of the immunogold 
conjugate approach considered earlier, the association of ricin into coated 
pit regions, observed using this technique, suggests that at least some 
ricin becomes internalized by this route, i.e. the standard endocytic 
pathway. Equally this does not rule out the possibility of alternative, 
non-coated pit mediated endocytosis of ricin (van Deurs et al. . 1988, in 
press).
Regardless of whether ricin becomes internalized via coated or smooth 
pits the endosome represents the first clearly distinct intracellular 
compartment which it encounters. Thus, internalized ricin enters an acidic 
environment. However, unlike other receptor-ligand complexes, only about 
22% of ricin (initially bound at pH 7.0) was found to be released from its 
receptor at pH 5.0 (van Deurs, 1988, J. Cell Biol., in press). Studies by 
Sandvig and Olsnes (1979) and Sandvig et al. (1978) have indicated that the 
majority of toxin, which remains bound, becomes recycled to the cell 
surface. This recycling of the toxin apparently occurs via a fast and a 
slow route. In contrast to these findings no morphological evidence has
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been presented supporting these observations. Some evidence exists that a 
proportion of internalized ricin molecules are transferred to the lysosomes 
where they are slowly degraded (Sandvig and Olsnes, 1979). This slow 
degradation may possibly result from the reported resistance of ricin to 
proteolytic enzymes (Olsnes et al. , 1975) and if so would indicate that the 
ricin subunits had not become dissociated at this stage.
Unlike other toxins such as diphtheria toxin, modeccin and Pseudomonas 
aeruginosa exotoxln A, ricin and the related toxins abrin and viscumln do 
not require a low pH for translocation into the cytosol. Indeed if the pH 
of the intracellular vesicles is increased with 10 mM NH«C1 the cells 
become sensitised to ricin (Sandvig et al.. 1979), suggesting that ricin A 
chain translocation is not facilitated by low pH. Ca2+ ions appear to be 
important for ricin entry into the cytosol as their absence, or blockage of 
their transport, allows endocytosis but not translocation (Sandvig and 
Olsnes, 1982). Also the lag period observed after the initial uptake of 
ricin would suggest that translocation occurs from a compartment distal to 
the endosomes in the endocytlc pathway. Furthermore this observed lag 
period argues against the possibility that ricin achieves direct entry into 
the cell cytosol across the plasma membrane.
Gonatas et al. (1977) , were the first workers to show ricin-hrp 
conjugates associated with Golgi compartments in neuroblastoma cells and 
more recently Sandvig et al. (1986), have shown similar associations with 
Vero cells, the cell line used in the cytotoxicity assays described in this 
thesis. Experiments using secretory-Golgi pathway markers (van Deurs,
1988, J. Biol. Cell, in press) and immunoperoxldase cytochemistry studies 
have also demonstrated the presence of ricin in the Golgi compartments. 
However, as Indicated before, such conjugate studies are limited by the 
influence of the coupled marker on the route of internalization. Thus van 
Deurs et al. (1986), observed that although ricin and monovalent ricln-hrp 
reached Golgi compartments, ricin-Au and polyvalent rlcln-hrp did not. The
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observations by van Deurs et al. (1988, in press) that ricin toxicity can 
be virtually abolished in cells incubated at 18°C has been associated with 
the fact that no ricin can be detected in the Golgi compartments at this 
temperature. Further evidence implicating the Golgi compartments in ricin 
A chain translocation comes from the observations that cells are sensitised 
to ricin after treatment with 0.1 iM monensin, (Sandvig and Olsnes, 1979). 
Treatment of cells with monensin has been shown to induce morphological 
changes in the Golgi (Tartakoff and Vassalll, 1979), although the same 
treatment has no measurable effect on the pH of endosomes and lysosomes 
(Sandvig and Olsnes, 1979).
Possibly the most original method employed associating ricin with the 
Golgi comes from the work of Youle and Columbatti (1987), who took 
hybridoma cells, synthesising monoclonal antibodies capable of blocking 
ricin toxicity and exposed these cells to extracellularly applied ricin.
The ricin was internalized and yet these cells demonstrated a 50*300 fold 
resistance to ricin intoxication compared to control cells. As further 
controls, these workers eliminated the possibilities that either 
extracellular or surface bound antibodies acted to prevent ricin entry.
They therefore concluded that intracellular monoclonal antibody synthesised 
and assembled de novo, blocked ricin toxicity. Thus these Intracellular 
antibodies must meet the internalized ricin before it becomes translocated 
to the cytosol. This presumably occurs in the Golgi since this is a 
compartment common to both secretory and endocytic pathways. These 
observations suggest that ricin located within endosomes or lysosomes does 
not enter the cytosol. It is not clear at present whether ricin reaches 
the Golgi via the endosoraal route. Youle and Colurabattl (1987), suggest 
that ricin must reach the Golgi apparatus to find a neutral pH compartment 
from which it is able to enter the cytosol. In addition Youle and 
Columbatti (1987) have shown that a monoclonal antibody specific for a 
galactose binding site of ricin B chain also blocks the cytoplasmic entry
of ricin, suggesting that the sugar-binding activity of ricin is required 
Intracellularly, possibly for the translocation of ricin A chain into the 
cytosol. These authors speculate that if efficient cytoplasmic entry 
requires that ricin interacts, via its sugar-binding sites, with a specific 
intracellular "receptor", this might account for the enhancement of 
cytotoxicity observed when ricin B chain is added to ricin A chain 
containing immunotoxins (McIntosh £t_al., 1983). If correct, this 
mechanism will have important implications in the design of immunotoxins 
Incorporating ricin B chain with an abolished sugar-binding activity.
In conclusion therefore, it remains unclear as to how and from what 
compartment ricin A  chain is able to translocate into the cell cytoplasm.
Of all the possibilities considered there exists a body of evidence 
suggesting that cytosolic entry is achieved from part of the Golgi, 
possibly from within the trans-Golgi network (TGN).
1:4:1 A Comparison of Structure and Function between Ricin and Diphtheria 
Toxin.
Despite originating from quite different sources ricin and diphtheria 
toxin, from the bacterium Corvnebacterium dlphtherlae. show some striking 
similarities. These toxins have in common a dimeric polypeptide structure 
in which the two subunits are linked by a single disulphide bond.
(Although diphtheria toxin is made as a single polypeptide, it is 
invariably nicked by proteases to generate two subunits or fragments linked 
covalently by a disulphide bond) . In addition both toxins possess a cell 
surface binding capability and intoxicate susceptible eukaryotic cells by 
enzymatic Inactivation of the protein synthesis machinery. These 
respective activities reside on one or other of the distinct polypeptide 
subunits. In both toxins, the A subunit enters the cell cytosol and brings 
about the enzymatic inactivation of protein synthesis within that cell.
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The other subunit, the B subunit, Is responsible for binding the toxin to 
sites on the cell surface. In addition there Is evidence that the B 
subunit may function in the penetrative mechanism by which the enzymic A 
subunit enters the cell cytosol. With the B subunit of diphtheria toxin 
this role Is fairly well defined. Hydrophobic regions of diphtheria toxin 
fragment B are actively involved in the penetration of fragment A into and 
across the intracellular membrane barrier into the cytosol. A more 
detailed analysis of these events has been considered by Boquet et al.
(1976), Lambotte et a l . . 1980, and Sandvig and Olsnes, (1981). In contrast 
the B chain of ricin does not appear to interact with membranes in the same 
fashion although evidence exists suggesting ricin B chain may have some 
other role in promoting the entry of ricin A chain (Youle and Neville,
1982; McIntosh et al. . 1983). Indeed with respect to the interaction of 
hydrophobic regions of the toxin with membranes, the C-terminus of ricin A 
chain appears equally likely to fulfil or participate in the membrane 
penetration step (Utsunti et al.. 1984).
Despite these superficial similarities the more detailed comparison of 
the two toxins at the different stages of intoxication indicates that these 
two proteins demonstrate a parallel but never the less quite different 
series of activities.
1 ;A l 2 C e l l  S w rf«c t B in d in g
The lectin activity of ricin and the role of this activity during cell 
surface interactions and the intoxication process have been considered in 
detail earlier in this chapter. Briefly the lectin activity of ricin 
resides in the B subunit. Ricin B chain has a specificity for galactosyl 
residues and as a result is able to bind to a variety of cell surface 
markers, mostly cell surface glycoproteins or glycollpids. The binding of 
ricin to the cell surface is apparently a random event, and it is as yet
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unclear as to whether specific cell surface residues are more important 
than others as functional binding sites.
In contrast the binding of diphtheria toxin to the cell surface occurs 
only at a limited number of sites on the cell surface. As yet it is 
unclear as to the exact nature of the diphtheria toxin receptor. Evidence 
exists that the receptor is a glycoconjugate, as neuraminidase treated 
cells demonstrate increased binding (Sandvig et al.. 1978), whilst 
tunlcamycln treatment reduced binding (Hranitzky et al. . 1985). However, 
the possibility exists that these treatments may have induced cell surface 
alterations which may have in turn effected toxin binding. Other 
literature, associated with studies on the binding of diphtheria toxin to 
cell surfaces had been considered in a recent review by Olsnes and Sandvig 
(In: "Immunotoxins", A. E. Frankel, ed. , Martinus Nijhoff Publishing, 
Boston, 1988).
1;4;3 Endosytosis end I n tr a c e llu la r  Rpytlns-
A detailed consideration of the internalization and intracellular 
routing of ricin has been made in the previous section. Despite 
considerable efforts, the events culminating in the translocation of ricin 
A chain into the cytosol remain vague.
In conjugate studies similar to those carried out with ricin, labelled 
diphtheria toxin has been shown to bind to the entire surface of Vero cells 
and then to subsequently migrate to coated pits (Morris et al. . 1985). The 
toxin was then found to be internalized by coated vesicles. It became 
apparent from further experiments that toxin molecules internalized by this 
route resulted in intoxication of the cell, and if this specific 
internalization route was blocked, or diphtheria toxin was internalized 
from non-coated regions of the cell surface, then intoxication of the cells 
did not follow. Thus it would appear that receptor mediated endocytosis by
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coated pit pathway Is the major route by which diphtheria toxin is able to 
enter and subsequently intoxicate cells.
As before, studies relating to the translocation of ricin into the 
cytosol have been considered in the previous section. To date the exact 
mechanism and the roles, if any, of the ricin subunits during these events 
remains unclear.
With diphtheria toxin a critical step in cytosol penetration is the 
exposure of the receptor bound, internalized toxin to a pH of <5.3 (Draper 
and Simon, 1980; Sandvig and Olsnes, 1980). At pH 5.3 or lower a normally 
hidden hydrophobic domain of the B fragment becomes exposed and the toxin 
structure opens up (Blewitt et al. . 1985). As a result of this pH- 
facllitated exposure, the hydrophobic domain (and possibly other regions) 
become inserted into the membrane (Zalman and Wismlski, 1984; Hu and 
Holmes, 1984). This insertion then somehow facilitates the translocation 
of the A fragment into the cytosol. In contrast low pH does not facilitate 
the translocation of ricin A chain into the cytosol, nor is there evidence 
of any membrane penetrating mechanism analogous to that described for 
diphtheria toxin. A much fuller consideration of the transport of 
diphtheria toxin fragment A into the cytosol, including other conditions 
required for translocation are considered in the Olsnes and Sandvig review, 
mentioned earlier.
1:4:5 Enzymatic Inactivation of Protein Synthesis by Ricin and PlPhthtrU 
Toxin.
Despite the significant contribution of Endo and co-workers to our 
understanding of ricin A chain activity, the exact mechanism by which it
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catalyses ribosome inactivation remains to be fully characterised. The 
most recent studies attempting to clarify this mechanism have been 
considered earlier in Section 1:2:2.
The inhibition of protein synthesis, catalysed by the activity of 
fragment A of diphtheria toxin occur as a result of a quite different 
inhibitory mechanism. Diphtheria toxin, and also the 26 Kd fragment of 
pseudomonas exotoxin A (from Pseudomonas aeruginosa) catalyse the process 
by which NAD is cleaved to yield ADP-ribose which then becomes covalently 
linked to the soluble ribosomal cofactor, elongation factor 2 
(Pappenheimer, 1977). The process is known as ADP-ribosylation of 
elongation factor 2 (EF-2). The effect of this ADP-ribosylation is to 
severely reduce, but not completely abolish the normal activities of EF-2, 
i.e. GTP cleavage and peptide chain elongation. However these activities 
are so severely reduced that the cells are unable to maintain a level of 
protein synthesis adequate for survival.
Interestingly ADP-ribosylation occurs only at a particular amino acid, 
the diphthamide residue, of EF-2 (van Ness et a l . ■ 1980; Bodley et al. . 
1984). This particular amino acid is derived from a particular histidine 
residue in EF-2 which has been post-translationally modified so as to 
contain a 3-carboxyamido-3-(trimethyl-amino) propyl side chain (Hoehring 
Al., 1984),
The turnover number for diphtheria toxin fragment A has been 
calculated at 2000 ADP-ribosylated EF-2 molecules per minute (Moynihan and 
Pappenheimer, 1981), with a ■ 1.5 x 10 T M for elongation factor 2 
(Chung and Collier, 1977). This in effect means that in theory a single 
diphtheria toxin fragment A would be adequate to kill a cell (Yamaizumi £_t 
al. . 1978). Thus despite achieving their inhibitory activities by 
different mechanisms, both ricin and diphtheria toxin are potent inhibitors 
of protein synthesis.
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L i l i  C<?nclv<Ung P«ia»irks
The realisation that potent toxins such as ricin might be suitable 
effector molecules in therapeutic agents constructed to be targeted to 
specific cell types, has resulted in considerable interest in these 
molecules. In the main, these cytotoxic proteins have been modified so as 
to facilitate coupling to cell specific monoclonal antibodies. These so- 
called immunotoxins combine the antibody's cell binding specificity with 
the toxin's potent cytotoxic activity and have demonstrated encouraging 
efficacy when tested in in vitro model systems. To date however these 
molecules have only demonstrated a limited efficacy in the clinical 
environment, as mentioned in Section 1:1:1. A significant obstacle to the 
engineering of a truly effective immunotoxin is the non-specific way that 
ricin binds to eukaryotic cells, a function mediated by the B subunit (see 
Section 1:1:2). One strategy to overcome this non-specific cell binding 
activity has been to construct immunotoxins from ricin A chain only, either 
biochemically purified from whole ricin (Gilland et al.. 1980, Krolick ££ 
&1., 1980, Blythman et al.. 1981) or with recombinant ricin A chain 
(FitzGerald et al.. 1987; Bjorn and Groetsema, 1987). In many instances 
these ricin A chain containing-immunotoxins show cell specific cytotoxic 
activity, a property determined by the specificity of the monoclonal 
antibody. However, this cytotoxic activity is usually reduced in 
comparison with equivalent immunotoxins made with whole ricin (Youle and 
Neville, 1980). This suggests that the presence of ricin B chain somehow 
acts to enhance cytotoxicity. This ricin B chain potentiation is 
apparently not a result of the sugar-binding activity of ricin B chain as 
it can be demonstrated in the presence of high concentrations of free 
lactose (Youle and Neville, 1980).
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Currently a major research effort is being directed towards the design 
of immunotoxins possessing the potency of whole ricin in the absence of its 
characteristic, non-specific cell binding activity. As yet the precise 
role of ricin B chain (other than its sugar-binding activity) during the 
process of cellular intoxication is unclear. The work presented in this 
thesis has attempted to examine the function of ricin B chain by exploring 
the potential of using it as a carrier of a protein other than ricin A 
chain. In this case ricin A chain has been replaced with the type I 
ribosome inactivating protein (RIP), gelonin. In addition, the possible 
significance of regions of ricin A chain to the cytoplasmic entry process 
have been considered. Preliminary data presented here have demonstrated 
the maintenance of ribosome inactivating activity after the removal of 30 
amino acid residues from the C-terminus of the polypeptide.
Coincident with this recent drug development has been the application 
of a wide variety of biochemical techniques which have gone some way to 
improving the understanding of these cytotoxins at both a cellular and 
molecular level. Yet despite these recent advances much work remains 
before the biological processes involved during ricin-mediated cytotoxicity 
can be fully understood. It is probable that an increased understanding of 
these processes will promote the design of improved immunotoxins.
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2:0 Materials
Castor beans of mixed variety were obtained from Croda Premier Oils, 
Hull and Gelonin as a generous gift from the Institute of Cancer Research, 
or purchased from Pierce.
All chromatographic materials (Sepharose 4B, Sephacryl S-200, 
Polybuffer exchanger, polybuffer, PD10 columns, Blue sepharose. Cyanogen 
bromide activated Sepharose 4B) were obtained from Pharmacia fine 
chemicals. Galactose, N-acetylgalactosamine and aslalofetuin were obtained 
from Sigma.
SDS-PAGE reagents were supplied by BDH except for acrylamine (Fisons), 
and bis-acrylamide (Kodak). Reagents for silver staining SDS-PAGE were 
obtained from Fisons or BDH, silver nitrate was supplied by Johnson Matthey 
Chemicals.
Nitrocellulose for Western blotting was supplied by Hybond, the 
Biotin-streptavidin kit by Amersham and the colour developing substrates 
from Sigma.
Phenylhydrazine, Heparin and Haemin required for the preparation of 
rabbit reticulocyte lysate were obtained from Sigma, as were the amino 
acids, creatine phosphate, creatine phosphokinase and spermidine components 
of the translation reaction mixes. Hepes buffer was supplied by BDH. All 
nucleotides (e.g. ATP, GTP, rATP, rGTP, rUTP and rCTP were obtained from 
Boehringer Mannheim. Cap was supplied by Pharmacia.
Phenol, formamlde, formaldehyde, polyethylene glycol 6000 and caesium 
chloride were from Fisons, chloroform, Triton X100 and aniline (for RNA 
modification) from BDH and RNAase A, agarose, ethidlum bromide, amplcillln, 
lysozyme, IPTG and X-gal from Sigma.
For isolation of DNA fragments, DE81 paper was obtained from BDH and
low melting point agarose from BRL.
All components required for the maintenance of bacterial strains were 
supplied by Difco as was foetal calf serum required in eukaryotic cell 
media.
Restriction endonucleases were supplied from Amersham, BRL or NBL, TA 
DNA ligase, polynucleotide kinase, "Klenow fragment" of DNA polymerase I 
and SP6 RNA polymerase were obtained through Amersham and calf Intestinal 
alkaline phosphatase from Boehringer Mannheim.
The M13 cloning and sequencing kit came from Amersham as did all 
radionucleotides and radiolabelled amino acids.
Finally protein derivatlsation reagents, SPDP and 2-iminothiolane were 
obtained through Sigma, Ellman's reagent from Aldrich.
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2;1;1 PmrUimlpn of be»n Iccyfn?
(Nicholson and Blaustain, 1972)
The castor bean lectins, ricin and Riclnus communis agglutinin (RCA^) 
were purified from mixed varieties of Rlclnus communis seeds obtained from 
Croda Premier Oils, Hull, U.K.
Prior to grinding, whole seeds were washed, weighed and flash frozen 
in liquid nitrogen. The frozen seeds were then ground to a dry fine powder 
using an "atomix" blender and the powder resuspended in phosphate buffered 
saline (PBS) so as to form a light slurry. The slurry was stored at 4°C 
for 2-3 hours (with occasional stirring) before filtering through 6 layers 
of muslin to remove the larger debris. The filtrate from this step was 
centrifuged at 16,300 x g at 4°C for 10 minutes to pellet smaller debris. 
Floating fat, released from the seeds was removed at this stage and 
ammonium sulphate was added to the supernatant to 60% (w/v) at 4°C. 
Precipitated protein from this step was pelleted by centrifugation as 
before and the pellet resuspended in a small volume of PBS. The 
resuspended pellet was then extensively dialysed against PBS prior to 
loading onto an acid-treated Sepharose 4B column.
2:1:2 Affinity chromatography of castor bean lectin» using Seoharose 4B-
Sepharose 4B (Pharmacia) pre-treated with 1 Molar (M) proprionic acid 
contains within its matrix, exposed sugar residues to which both ricin and 
RCAj bind.
A column of Sepharose 4B (25 cm x 5 cm) was equilibrated in PBS at 
4°C. Proteins from the prepared castor bean seeds (see Section 2:1:1) were 
applied directly to the column which was then flushed with PBS until all 
unbound protein had been eluted. Ricin and RCA^ were eluted together by 
passing 100 mM galactose in PBS through the column. If necessary the
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lectin preparación was concentrated using an Amicon stirred cell 
ultraflltratlon system.
2:i;3 $gpar»uon 9f W n  Iggylps using gel fiKrgtipn apgn
g^phacryl S-20Q.
Separation of the two lectins, rlcln (60 Kllodaltons, Kd) and RCA^
(120 Kd) , was achieved using gel filtration upon a Sephacryl S-200 
(Pharmacia) column (80 cm x 3 cm) .
The column was equilibrated with PBS at 4°C and the sample (volume <
10 ml) was applied. To achieve good separation of the two lectin species 
the column was run overnight at a flow rate of 0.7 ml min’1 . Fractions of 
approximately 10 ml were collected. Those fractions from each peak were 
pooled and concentrated where appropriate.
2; 2i.l Pvrifi<?*ti<?n <?f rlcln gvrtnmitg-
Ricin is composed of two dissimilar subunits, ricin A chain and ricin 
B chain. The two subunits, which have separate and distinct functions (see 
Section 1:1) are joined covalently by a single disulphide linkage. To 
successfully purify these subunits this disulphide linkage must be cleaved.
2;2;2 Rsduqttgn 9f lntsrch»ln ton«-
Ricin was incubated with 5% (v/v) 2-mercaptoethanol for 24-48 hours at 
4 C in the presence of 100 mM lactose or galactose. The presence of the 
sugar helps prevent the denaturation and aggregation of the liberated B 
chain. (Olsnes and Pihl (1973)).
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2:2:3 S e p » m l 9 n  p£ rcftwid rig In snbunlts vslng chr9ro»t9f9S98ing-
The technique of chromatofocusing separates proteins on the basis of 
their differing isoelectric points (pis). The widely differing pis of the 
ricin subunits makes chromatofocusing a particularly powerful purification 
method. A sample of reduced ricin will contain both free subunits and a 
small proportion of non-reduced holotoxin. Using a chromatofocusing system 
with a pH range of 7-4, all three species can be resolved into separate 
peaks eluting from the column in order of their pis viz: A chain pi - 7.5, 
whole ricin pi — 7.1 and B chain pi - 4.8.
A column of polybuffex; exchanger (Pharmacia) (30 cm x 2 cm) was 
equilibrated in 25 mM degassed, Imidazole buffer (HC1) pH 7.4 at 4°C. The 
sample of reduced ricin was applied to the column and its components eluted 
according to their pis using polybuffer 7-4 (Pharmacia) (HC1) pH 4.0. The 
addition of the polybuffer creates a pH gradient upon the column which 
facilitates the separation of proteins according to their pis.
Optimum resolution of protein components was achieved by running the 
column overnight at a flow rate of approximately 1 ml min 1 . The eluting 
polybuffer 7-4 was made up with 100 mM lactose (see Section 2:2:2). 
Fractions from respective peaks were pooled and concentrated as appropriate 
after dialysis to remove polybuffer components.
2:2:4 rvrlfl9*tl9 n 9 f rigln A gfoln by.affinity 9hr9i m 9grgphY vsing 
•»l8l9f$tuln-
By treating the glycoprotein fetuin with neuraminidase it is possible 
to cleave terminal sialic acid residues from the oligosaccharide side 
chains creating a molecule with oligosaccharides terminating in galactose 
(Sandvlg et al.. (1978)). Asialofetuln is a suitable binding substrate for 
ricin B chain (K^ approximately 8 x 10* M 1 - 4.2 x 10* M 1 (Sandvig ££
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&1. , 1976; Baenzlger, J. U. and Flete, D., 1979). Asialofetuln (Sigma) was 
immobilized by covalent linkage to cyanogen bromide activated sepharose 
(Sigma), thus forming a column matrix.
Ricin A chain, greatly purified by chromatofocusing was passed through 
the asialofetuin column (22 cm x 0.5 cm) and the column washed with PBS 
until all unbound material (ricin A chain) had eluted. The process was 
repeated, providing a source of highly purified A chain. Any contaminating 
B chain or unreduced holotoxin remained bound tightly to the column and 
could not be subsequently eluted. The unbound material consisting of 
highly purified ricin A chain was pooled and concentrated where 
appropriate.
2 :2 ;? storage of ricin and ricin subunits.
Whole ricin may be stored at -20°C for considerable periods of time 
without significant loss of biological activity. This activity may become 
reduced upon frequent freezing and thawing.
Purified ricin subunits are considerably less stable than whole ricin. 
Purified subunits were therefore never frozen but stored, filter sterile, 
at 4°C in the presence of 10-50 mM DTT. 100 mM lactose was also included
in ricin B chain samples.
2;3;1 Sodimw «fodacYl sulphate - pplvagryUmite &al_9l9ctr<?ph<?]rs.si£ 
ISPS-fASE)
(Laemmli, U. K., 1970).
Mini gal gystan»-
Two clean glass plates (one notched to receive a gel comb) were 
combined with suitable plastic spacers to form a mould for a polyacrylamide
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slab gel. The complete mould was placed Into a plastic trough containing 
melted 1% (w/v) Agarose (Sigma) which once set acted as a plug.
A 15% (w/v) polyacrylamide gel solution was prepared according to the 
recipe below.
R<??olviri&_gel.
Final Cgncgntrgtjpn
Acrylamide/Bis-acrylamide (30%/0.8% (w/v)) 1 0  ml 15%/0.4%
3 M Tris HCl pH 8 . 8 2.5 ml 375 mM
H20 7.25 ml -
10% (w/v) SDS 0 . 2  ml 0 .1 0 %
1 0 % (w/v) ammonium persulphate 83 0.04%
TEMED 8.3 Ml
This solution was poured into the frame up to a level just below the 
position of the well forming comb. The resolving gel was overlaid with 
water saturated isobutanol and allowed to polymerise. Following 
polymerisation the isobutanol was removed by rinsing with Ha0 and a 
stacking gel solution poured into the remaining space. A clean plastic 
well-former was inserted and the gel allowed to polymerise around it.
S.E.fls.king-fcel recipe-
Final Concentrâtign
Acrylamide/Bis-acrylamide 30%/0.8% (w/v) 2 ml 6%/0.16%
0.5 M Tris HCl pH 6 . 8 2.5 ml 125 mM
Ha0 5.0 ml -
10% (w/v) SDS 0 . 1  ml 0 . 1  %
10% APS 50 /il 0.05%
TEMED 7.5 Ml
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After complete polymerisation the comb was gently removed and any 
unpolymerised acrylamide solution washed from the wells. The gel was 
removed from the plastic trough, taking care to ensure the agarose plug 
remained in position and the gel was assembled into a gel tank. 500 ml of 
lx running buffer (25 mM Tris HC1 pH 8 .8 , 200 mM Glycine, 0.01% (w/v) SDS) 
was required to fill both upper and lower tank reservoirs. Samples for 
electrophoresis were prepared by diluting with an equal volume of 2x sample 
buffer, boiling for 2-3 minutes, and then loaded onto the gel. 
Electrophoresis was carried out at 26 mA constant current for 2-2H hours.
0.5 M Tris HC1 pH 6 . 8 2.5 125 mM
H,0 0.5 -
Glycerol 2 . 0 2 0 % (v/v)
10% (w/v) SDS 4.0 0.4% w/v
2 -mereaptoe thano1 1 . 0 1 0 % (v/v)
Bromophenol blue a few grains to colour -
2; 3; 2 H<?n-reducing dens w r in g  ge l?-
As in Section 2:3:1 except that the reducing gel sample buffer was 
replaced with a non-reducing buffer in which the reducing agent (2 - 
mercaptoethanol) was replaced with water.
2; 3;3 Sodium. dpflasYl-.»ulpftif. FolYacrylemlde gel clectrophoreel?.
29 cm a 29 cm system-
The larger gel system has two principle advantages over the mini gel 
system (Section 2:3:1). Firstly, larger sample volumes may be loaded and
secondly greater resolution of protein bands may be achieved by 
electrophoresing proteins over a greater distance. It is, in contrast, 
less convenient and more time consuming.
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Resolving gel
30% Acrylamide 0.3% Bis- 
Acrylamide (w/v)
3 M Tris-HCl pH 8 . 8  
H,0
10% (w/v) SDS 
10% (w/v) APS 
TEMED
Units in mis unless otherwise stated
Starting gel-
10% Acrylamide 0.5% Bis-acrylamide
0.5 M Tris HC1 pH 6 . 8
H,0
10% (w/v) SDS 
10% (w/v) APS 
TEMED
Sample buffer as in Sections 2:3:1 
Gel running buffer as in Section 2
1 0 % 1 2 % 15% 2 0 %
16 2 0 24 32
6 6 6 6
25.4 21.4 17.4 9.4
0.48 0.48 0.48 0.48
2 0 0  pi 2 0 0 pi 2 0 0  pi 2 0 0  pi
2 0  pi 2 0 pi 2 0  pi 2 0  pi
(w/v) 5
2.4
2.4 
0 . 1
1 0 0  pi 
5 pi
and 2:3:2.
3:1.
Gels were elecCrophoresed overnight at 8 mA for 15% resolving gel and 
for 6 - 8  hours; at 19 mA for 10% gels.
l l A Acrylamide gel staining techniques.
2:4:1 Silver staining polyacrylamide protein gels.
(Merrll et a l . , 1981)
Prior to staining, polyacrylamide gels were washed several times with 
50% methanol to remove residual glycine absorbed from the gel running 
buffer during electrophoreals. To stain the gel, 0.8 g of silver nitrate 
was dissolved In 4 mis H20. This solution was added dropwlse with rapid 
stirring to a solution of 21 mis 0.36% (w/v) NaOH and 1.4 ml 14.8 M 
ammonium hydroxide. The mixture was made up to 100 mis with distilled H 20 
and applied directly to the gel for 15 minutes with constant shaking.
After 15 minutes the gel was washed extensively with distilled H20 to 
remove any excess silver Ions before developing the staining reaction with 
0.025% citric acid solution containing 0.25-0.5 ml 38% (v/v) formaldehyde 
solution. Bands develop between 5-10 minutes depending on the protein 
loadings of the gel. The reaction was stopped by placing the gel Into 
destain solution comprising 10% Acetic acid, 45% methanol.
2:4:2 Coomassle Blue staining.
Stain g<?lMtl9n-
0.5% (w/v) Coomassle Blue (Sigma) in 10% Acetic acid
45% Methanol
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Immediately after electrophoresis gels were removed Into the stain 
solution for 15-30 minutes with shaking.
Following staining the gels were removed Into a destaln solution of 
10% Acetic acid and 45% methanol. Gels were destalned until the background 
became clear.
2:4:3 Drying of SDS-PAGE gels.
Polyacrylamide gels were dried onto 3 MM filter paper using a vacuum 
drier. A piece of 3 MM paper cut to the size of the gel was placed In 
position on the drier. The. paper was soaked with H 30, and the gel placed 
upon the paper. Cling-film was placed over the gel, and a piece of card 
laid on top to prevent the gel from cracking. With the gel in position, 
vacuum and heat were applied for one hour. The dried gel was removed and 
stored flat.
2:4:4 Fluorograohy and autoradiography.
Radioactively labelled proteins were visualised by fluorography and 
autoradiography.
Gels containing radiolabelled proteins were washed extensively In 
destain solution (10% Acetic acid, 45% methanol) to (a) fix the proteins in 
the gel and (b) flush out any excess label not Incorporated into the 
protein. Once fixed, the gel was placed In "Amplify" (Amersham) for 30 
minutes and then dried as described in Section 3:4:4. Finally, the dried 
gel was affixed Into a light-proof cassette and exposed to X-ray film 
(FIJI).
Films were developed under dark-room conditions using LX24 developer, 
(Kodak) and fixed with Unlfix (Kodak), both diluted 1:4 with H 30.
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2:5 Sample preparation for SDS-PAGE.
2:5:1 Trichloroacetic acid protein precipitation.
To reduce sample volumes for convenient loading onto SDS-PAGE gels 
proteins were precipitated by adding trichloroacetic acid (TCA) at a final 
concentration of 10% (w/v). Samples were stood on ice for 30 minutes and 
precipitated proteins pelleted by a 15 minute spin at 13,000 rpm in a 
microcentrifuge. The supernatant was carefully discarded and the pellet 
washed in 100% acetone. The sample was recentrifuged, the acetone removed, 
and the pellet resuspended in sample buffer prior to loading onto the gel, 
as in Section 2:3:1.
2  : ?. = 2  Acetpp? protein palpitation-
Protein samples for precipitation were mixed with an equal volume of 
cold 100% acetone and stored at -20°C for a minimum of 2 hours. The 
precipitated proteins were then pelleted at 13,000 rpm for 15 minutes in a 
microfuge and all traces of acetone removed. The pellet was resuspended in 
sample buffer.
2 ; 5 ; 3  Trggtsm snt o f  p m * I n »  * l t h  End<? g-N -a ce ty igiyio o sa ffin d asg . H
(Endo H).
(Foxwell et al.. 1985; Foxwell et al.. 1987)
Proteins for Endo H treatment were TCA precipitated (see Section 
2:5:1) and resuspended in 10 /«I of 0.1 M sodium citrate buffer pH 5.6, 
containing 1% (w/v) SDS and 1 mM Phenylmethylsulphonylfluoride (PMSF). The 
samples were boiled for 2 minutes and then the SDS diluted 10 fold by 
adding Sodium citrate buffer pH 5.6, minus SDS. Each 100 pi sample was
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divided into two, one remaining untreated the other incubated with 2.5 mU 
of Endo H (Miles Scientific). Samples were incubated at room temperature 
overnight and analysed by SDS-PAGE.
ill Western blotting,.
2:6:1 Biotln-streptavidin method.
Proteins initially separated by SDS-PAGE were transfered onto 
nitrocellulose paper using the Bio-Rad transblotting apparatus. Transfer 
was achieved by sandwiching the polyacrylamide gel next to the 
nitrocellulose paper such that when an electrical current was applied, 
proteins would migrate from the gel and bind in the same relative positions 
upon the nitrocellulose paper. The transfer buffer was 20 mM Tris-HCl, 200 
mM Glycine, 20% methanol pH 8.3 and blotting was carried out at 60 volts 
for 2 hours or 30 volts overnight.
Following blotting the gel and nitrocellulose sandwich was separated. 
The gel was placed into 50% methanol prior to silver staining (see Section 
2:4:1), whilst the nitrocellulose filter was placed into PBS containing 1% 
"Marvel" milk product. Three 10 minute washes in the "Marvel" solution was 
adequate to prevent non-specific binding of antibodies to the filter. The 
filter was then probed with specific antibodies (a polyclonal preparation 
prepared from rabbit serum) raised against target proteins, for 2-4 hours 
at room temperature or overnight at 4°C. Following incubation the antibody 
solution was removed and stored at -20°C. The filter was washed 5 times in 
blocking solution and then Incubated with a 1:300 dilution of blotinylated- 
protein A  (Amersham) for 1 hour at room temperature. The filter was then 
washed as before and further incubated with a 1:300 dilution of 
Streptavidin-horseradlsh peroxidase complex (Amersham) for 30 minutes at 
room temperature. The filter was washed a further 5 times in blocking
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solution prior to development.
2 ;$ ;2 P svglgplng u sin g  tain s s u b s i s t s  (PAP1-
Following washing with blocking solution the filter was given a 
further two washes in PBS, before a final wash in 50 mM Tris-HCl pH 7.4, 
0.9% (w/v) NaCl. For small filters, 10 mis of the final wash buffer was 
retained, into which 6 mg of DAB and 15 pi of 20% (v/v) hydrogen peroxide 
was added. The filter was developed in this solution which was scaled up 
approximately for larger filters. The reaction was stopped by air drying 
the filter.
2-Liil Peyslpplng **slng » ChlprO-l-NapthPl (4(?Uil.
The filter was washed as described above except that the final wash 
was 0.5 mM Tris-HCl pH 7.4, 125 mM NaCl in a final volume of 50 mis. 30 mg 
of 4C1N was dissolved in 10 mis methanol together with 20 pi of 20% (v/v) 
hydrogen peroxide. The 4C1N solution was added to the final wash to 
develop the filter. The reaction was stopped by air drying the filter.
i ll Electroelution.
2:7:1 fxgegr#tlvS SPS-PAQE-
Separated proteins were extracted from polyacrylamide gels by excising 
the appropriate gel bands and electroeluting the protein from the 
acrylamide into solution.
SDS-PACE gels were prepared as Section 2:3:3 using a large single well 
forming comb. The gel was run as normal and then the edge of the wells 
trimmed and silver stained according to Section 2:4:1. Following staining,
the edge strips were used to identify the position of the appropriate band 
in the unstained region which was then excised from the gel prior to 
electroelution.
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2:7:2 EUgtrgglutlop exci?$j p m *  In-
Strips of polyacrylamide gel containing the excised protein were 
placed into glass rods sealed at one end with an agarose plug. Sealed 
dialysis tubing containing a small volume of running buffer was placed over 
the end of each tube and the glass rods positioned so as to span the upper 
and lower buffer reservoir tanks of the electroelution equipment.
Electrical connections were made so that the lower tank became the positive 
terminal and the protein was electroeluted overnight at 70 volts constant 
voltage. Immediately before collecting the sample from the dialysis tubing 
the direction of electrical current was reversed for 2 minutes to liberate 
any material adhering to the sides of the dialysis tubing. The collected 
samples was analysed by SDS-PAGE.
2: 8: i  s p m m c o p lc  ds-i.ennlnsEign ,<?f p m *  in cp n c e n tm lg n -
Extinction coefficients for 1 mg/ml solutions at 280 nra wavelength
Rlcln ( 1  .j/.l) -  e ‘ * 0 - 1.14
A chain 0.7
B chain 1.49
Gelonln 0.68
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2:9 Biological Activity Assay Techniques.
2:9:1 Cell cytotoxicity assay.
Vero (African Green Monkey Kidney) Cells at 1 x 10* cells/ml were 
seeded (100 pl/well) into 96 well microtitre plates (Costar). The cells, 
growing in Glasgow's minimal essential media (GMEM), non-essential amino 
acids (NEAA) plus 5% (v/v) foetal calf serum (FCS), CDifco) and 4 mM 
glutamine were maintained at 37°C with 5% C02 . Cells were allowed to form 
a stable monolayer before the media was removed, and replaced with 1 0 0  pi 
of toxin dilution in sterile PBS. The toxin was added directly onto 
the cells for 1  hour, then diluted by the addition of 1 0 0  pi of fresh media 
and incubated overnight. Following intoxication, the media bathing the cells 
was removed and replaced with 100 pi of sterile PBS containing (1 pCl/100 
pi) [*‘S] methionine 30 TBq/mmol (Amersham) for 2 hours at 37°C, 5% C02 . 
Finally all label was removed, the cells washed twice with 5% (w/v) TCA and 
then dissolved in fresh 1 M KOH (200 pl/well). After 1-2 hours to dissolve 
the cells, the contents of each well were removed and counted in a liquid 
scintillation system in an LKB rackbeta 2010. Results were expressed as a 
percentage of no toxin controls. All assays were carried out in tripicate.
2:9:2 Toxin preparation for cell cytotoxicity assay.
Stock solutions of proteins used in the cytotoxicity assay were 
diluted with sterile PBS to give a range of toxin concentrations from 1 x 
10" 1 1  M to l x  1 0 - 6  M
Subunit reassociation experiments involving the mixing of ricln B 
chain with either purified native ricin A chain or chemically derivatised 
(see Section 2:12) gelonin (a type I ribosome inactivating protein (RIP) 
were carried out as follows:-
Ricin A chain/gelonln dilutions were made in sterile PBS from 2 x 
10-H  M to 2 x 10 ’ 5 M. Each dilution was then mixed with an equal volume of 
2 x 10*B M ricin B chain, and the mixture dialysed overnight against PBS at 
4°C to remove any reducing agent or lactose from the preparation.
Following dialysis, samples were applied to cells as outlined in the 
previous section.
2:10 Cell-free toxicity assay.
2: 10;1 fg g p ftx g tlo n  r a b b it  r c t U 'i le s Y .s s  ly s a t e -
(Pelham and Jackson, 1976; Allen and Schweet, 1962; Clemens, 1984)
Rabbits were injected subcutaneously with 1.0 ml of 2.5% (v/v) 
phenylhydrazine (Sigma) daily for 5 days to induce anaemia. The rabbits 
were rested for 1 day and then bled by cardiac puncture. The blood was 
stored on ice in tubes containing heparin and then centrifuged at 2,500 x g 
for 15 minutes to pellet the cells. The plasma supernatant was discarded 
and the cells resuspended in washing buffer (0.13 M NaCl, 0.5 mM KC1, 7.5 
mM MgCl2) to a volume equal to the discarded plasma volume. The washing 
step was repeated a further two times and the cells then lysed by adding 
four times the packed call volume of 2 mM MgCl3 and stirring for 10 minutes 
on ice. One packed cell volume of 1.5 M sucrose containing 0.15 M KC1 was 
added and stirring on ice continued for a further 10 minutes. The lysate 
solution was centrifuged at 15,000 x g for 10 minutes at 4°C. The 
supernatant from this step (the reticulocyte lysate) was aliquoted into 1  
ml samples and stored in liquid nitrogen.
2;19;2 Preparation of reaction mix.
(Clemens, M. J., 1984).
L-amino acid mixtures
1 mM stock solutions of the following amino acids were prepared.
Anijno soifl.
Alanine Histidine hydrate HC1 Tryptophan
Arganlne HC1 Isoleucine Tyrosine
Aspartic acid . Leucine*
Lysine HC1 Valine
Asparagine hydrate Methionine Hydroxypro line
Cysteine Phenylalanine
Glycine Proline
Glutamic acid Serine
Glutamine Threonine
A 100 ml solution of 1 mM amino acids was prepared, neutralized to pH 
7.4 (NaOH) and stored at -70°C.
*When using [1 4 C] leucine as a radiolabel an amino acid mix minus non- 
labelled leucine was used. Uhen [*6S] Methionine was the radiolabelled 
amino acid the mix was prepared to Include leucine, but non-labelled 
methionine was omitted.
S topic Solution A-
40 mM Magnesium acetate. 2 M Ammonium acetate, 200 mM Tris HC1 pH 7.4
Stoçk §<?lvti9n B Cmgte vp irgzen) •
ATP 3.5 H30 (Sigma) 4.7 x 10' 8 M
GTP 3.0 H30 (Sigma) 4.5 x 10'» M
rabbit reticulocyte assay mixture was made up at follows
Amino acid mixture 1 ml 
Solution A 1 ml 
Solution B 0.1 ml 
Creatine phosphate S H30 (Sigma) 103 mg 
Creatine kinase (Sigma) 1 mg 
H 20 510 /tl
* a[l4C] leucine 11 GBq/mmol (Amersham) 600 /il
* For [,sS] methionine 30 TBq/mmol add 10 /id (1 /il) per sample, fresh.
2; 19.; 2 C g ll- fr g *  t o x ic it y  using n9n-nuc.igagg tr a a ta d  a fc h ls
reticulocyte lysate.
The biological activity of free ricin A chain and other type I 
ribosome inactivating proteins (RIPs) was determined using a cell-free 
toxicity assay as follows:
A 20 ng/ml stock solution of the toxin was made in PBS/Bovine serum 
albumin (BSA) (2 mg/ml). Serial dilutions of 20. 10, 5, 2.5, 1.25 and 
0.625 ng/ml were made giving final concentrations of 8 , 4, 2, 1, 0.5 and 
0.25 ng/ml in the total reaction mix.
25 /<1 aliquots of each toxin dilution were prepared in triplicate, 
including 3 x 25 /il H30 controls for background radioactivity and 3 x 25 /il 
H30 controls for 100% incorporation (no toxin controls). 12.5 /il of assay
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mixture was added to each tube and allowed to equilibrate at 28°C. 1.0 ml
of 0.1 M KOH was added to the three zero control tubes and then 2S pi of 
rabbit reticulocyte added to each tube at 15 second intervals. After 10 
minutes the reaction was stopped by the addition of 1 ml 0.1 M  KOH to each 
tube. 2 drops of 20% (v/v) H 20 2 was added to each to bleach the 
reticulocyte mixture followed by 1  ml of 2 0 % (w/v) trichloroacetic acid.
The solution was mixed thoroughly and stood at 4 C for a minimum of 1 hour 
to precipitate any synthesized protein.
Precipitates were filtered onto Vhatman glass microfibre filters grade 
GF/C (BDH) presoaked in H 20. The filters were washed three times with 5% 
(w/v) TCA, dried and then counted using an LKB rackbeta liquid 
scintillation counter.
Results were corrected to background and expressed as a percentage of 
the 1 0 0 % incorporation controls.
2:11 R 1 W 1 9 M 1  RKA Rgdlf jgatlon •
(Endo et al., 1987)
2 ;1 1 ; 1  aLjatauaatlfi glhaaiati wlsh_£ggln-
Rabbit reticulocyte lysate was prepared as described in Section 
2:10:1. 30 ^1 of non-nuclease treated lysate was mixed with 30 pi of toxin
dilution and Incubated at 30°C for 30 minutes. After incubation, lysate 
samples were diluted by the addition of A0 pi Kirby buffer (see Section 
2:11:2), mixed and the total RNA extracted by two rounds of phenol/ 
chloroform extraction. Phenol/chloroform extractions were carried out as 
follows: to the 100 pi sample, 50 pi of TE saturated phenol and 50 pi of 
chloroform were added. The solution was mixed, and the two phases 
separated by a brief centrifugation (2-3 minutes at 13,000 rpm in the bench 
centrifuge). The upper (aqueous) layer was removed and the procedure
repeated. RNA obtained from the aqueous phase of the second extraction was 
precipitated at -20°C by the addition of 0.1 x volume of 7 M Ammonium 
acetate and two volumes ethanol. RNA was pelleted by centrifugation (15 
minutes at 13,000 rpm), rinsed in 70% ethanol, dried and resuspended in 10 
pi sterile H 20.
2 ¡11 ¡2 K irb y  b u i l t r -
Kirby buffer (Parish and Kirby, 1966) was added to aid the 
dissociation of RNA from protein thereby improving RNA yields.
1.2 g of 4 aminosalicylic acid (BDH) dissolved in 5 ml H30 was mixed 
with 40 mM KC1, 10 mM Tris HC1 pH 7.6 The cloudy
solution formed was cleared by adding a few drops of phenol and the
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solution made up to 70 ml with H 20.
RNA samples prepared in Section 2:11:1 were diluted 1 in 500 with H 20 
and their absorbance measured at a wavelength of 260 nm.
Concentration of RNA (pg/ml) -
0D?,n x Extinction coefficient x dilution factor 260 1 0 0 0
260 1000
OD260 x 2 0
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2;11;4 o f  F.NA with » n jiin e .
4 pg of RNA was incubated with 20 pi aniline pH 4.5 at 60°C for 3 
minutes. Immediately after Incubation the samples were precipitated, in 
ethanol as described in 2 :1 1 :1 , rinsed, dried and then resuspended in 2 0 pi 
of RNA sample buffer. Samples were heated to 65°C for 5 minutes, cooled on 
ice, mixed with 4 pi of dye and electrophoresed.
2:11;? ElfigtLgphoresjs of RNA sample?.
1 x TEP - 36 mM Tris, 30 mM. NaH2P04 (2H30), 2 mM EDTA pH 8.0
RNA sample buffer - 60% formamide (deionized)
0.1% TEP
1.2% (w/v) Agarose formamide gel buffer 50% (v/v) formamide (deionized)
0.1% (v/v) TEP
Running buffer 0.1% (v/v) TEP
The 50% formamide - 1.2% (w/v) agarose gel was prepared using RNAase 
free gel former and comb. Once set, the gel was positioned into the gel 
tank and running buffer added level with but not over the gel. 2 0 pi of 
RNA sample buffer was placed into each well, then the samples loaded. The 
gel was electrophoresed at 20 mA constant current for 2-3 hours. Following 
electrophoresis the gel was stained with ethidium bromide for 15 minutes 
then destained in water prior to photography.
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2 l12 Pmpln-prptpin ç<?nlvg»yl<?n m i n a  htmgfrlfvnctlgml *hl9l l ln^rr
(Carlsson et al.. 1978; Thorpe and Ross, 1982; Cumber et al.. 1985)
2 :1 2 : 1 p m  »In <terivgtls»Uon vglng P-sugçlnlmWvl-3-(2-PYTldvl4UM9)
PTPPEl<?n»*9 (?PPP) •
Heteroblfunctional thiol linkers were used to introduce reactive thiol 
groups into proteins facilitating the formation of protein conjugates by 
disulphide exchange.
Protein for derivatisation was equilibrated in 50 mM boric acid, 290 
mM NaCl buffer-NaOH pH 9.0.and adjusted to a concentration of 10 mg/ml. A 
pH of 9.0 favours the reaction of SPDP with amino side chains over the N- 
terminus of the protein. To introduce 1-1.5 SPDP residues/molecule of 
protein, SPDP was added in a 2.5 molar excess over the protein molarity.
Molecular weight SPDP - 314.2
Amount of protein (me) x molar excess SPDP _ ABBMPfc Pf SPPP
Molecular weight of protein Molecular weight SPDP
The appropriate amount of SPDP was dissolved in dry dime thy 1 formamide, 
(10 pi per ml of protein solution) and added to the protein solution. The 
reaction took place at room temperature for 1 hour with stirring. Free 
SPDP was separated from derivatised protein using a PD10, G25M pre-poured 
column (Pharmacia) equilibrated in PBS. 500 pi fractions collected from 
the column were monitored at 280 nm and fractions containing the 
derivatised protein (first peak) were pooled.
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2:12:2 Determination of the extent of derlvatlsation with SPDP.
Protein - NHa N-O-CO-(CHa)a-S-S
-* Protein - NH-CO-(CHa)a-S-S
+ N-hydroxysucclnimide 
The extent of derlvatlsation of a protein with SPDP can be measured by 
determining the release of S-pyrldyl groups from the derlvatlsed protein In 
the presence of a reducing-agent such as dlthlothreitol (Sigma).
500 pi of derlvatlsed protein (°D2 8 0  > 0.2 0D units) was placed into a 
1 ml cuvette. The optical density (O.D.) was measured at 450 nm to give a 
base-line zero, 343 nm to measure the release of free S-pyridyl groups and 
280 nm to measure protein absorbance. Once the readings became steady 50 
1*1 of 100 mM dithiothreltol (DTT) was added to the cuvette. The base-line 
was rezeroed at 450 no and the absorbance at 343 nm and 280 nm measured.
The release of S-pyridyl groups was calculated as below
[S-pyrldyl] - Volume gfliPBlfi-.^  PTT x Volume sample
Chonge In QD243
Extinction coefficient 
of S-pyrldyl
(A) M
Molar extinction coefficient of S-pyrldyl groups at 343 nm - 8.08 x 10s
The OD2 8 0 of the derivatised protein will have been Increased by the 
presence of S-pyridyl groups. Therefore the correct 0D2gQ was obtained by:
(A)M x molar extinction coefficient of S-pyrldyl at 280 nm
and substractlng this amount from the OD280 m**sured before the addition of
DTT.
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The concentration of protein was determined by:
,_. „ f _ , . correct 0D_o_(B) M - [Protein] - 280
Extinction coefficient for protein at 280 run x 
molecular weight of protein
To determine the ratio of S-pyridyl groups to protein divide the value (A)M 
by the value B(M).
The appropriately derivatlsed protein was concentrated to 5-10 mg/ml 
using an Amicon stirred cell ultrafiltration system with a YM2 membrane 
(Amlcon).
2:12:3 v?ln& 2-lmlnp*hlPl»n9 (Sjgmg).
An alternative method of Introducing reactive thiol groups into 
proteins is to use 2-iminothlolane hydrochlorate (2-IT) .
As with derivatisation with SPDP the protein sample was equilibrated 
in a borate buffer NaOH pH 9.0 and adjusted to a concentration of 10 mg/ml. 
To introduce a single 2-IT group into each protein molecule, 2-IT was 
reacted in a 1 0  fold molar excess over the protein concentration, 
calculated as below:
Amount of protein (nig) x molar excess _ AffPVnt pf 2-IT (mg)
Molecular weight of protein Molecular weight of 2-IT
The 2-IT was dissolved in borate buffer pH 9.0 and the concentration 
adjusted so as to deliver the correct amount in 25 /il/ml of protein. The 
solution was reacted at room temperature for 1 hr. The reaction was 
stopped by adding 0.1 x volume of borate buffer containing 2.2 M glycine
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and reacting for a further hour at room temperature. The derivatised 
protein was then treated for a further hour with 5'5' Dithiobis-(2- 
nitrobenzoic acid), Ellman’s reagent (Aldrich). Ellman's reagent was added 
50 pl/ml to give a final concentration of 2 mM. The addition of Ellman's 
was accompanied by the appearance of a bright yellow colour indicating the 
release of the 4 Ellman's group (see reaction).
After the hour incubation with Ellman's reagent the derivatised 
protein was separated from unbound 2-IT using a PD10 column as described in 
Section 2:12:1.
Protein - NH2 + «to, - c
S- CH2
2-lffliTK>thi9lghe
II
Protein - N - C - CH2 - CH2 - CH2 - SH
H
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The -SH group from the 2-IT is now activated by the addition of 
Ellman's reagent.
Derivatised protein containing the protected thiol group from 2-IT.
2:12:4 Determination of derlvatlsatlon with 2-lminothlolajg■
(Ellman et al., 1959)
The extent of derivatisation with 2-IT can be determined by following
with a reducing agent such as dithiothreltol.
A 500 pi sample (OD^gQ > 0 . 2  units) was placed in a 1 ml quartz 
cuvette. The absorbance was determined at 600 run, base-line zero, 412 nm, 
absorbance of h Ellman’s and 280 nm absorbance of protein. Once the 
readings remained steady 50 pi of 100 mM DTT was added, the sample re base­
lined at 600 run and the change in absorbance recorded at 412 run and 280 nm.
II
Protein - N - C - CHa - CHa - CHa - SH
H
tl ilease of h Ellman's following the reaction of the derivatised protein
The extent of derivatisation was calculated as follows
[h Ellman's] -
[Protein] -
volwne <?L s.m sls + PIT x
Volume of sample
Change in OP . 
Extinction coefficient 
for H Ellman's
- <A)M
^ 2 8 0 tU71 a^itian,.gi.j?ii
Extinction coefficient at 280 nm x Molecular weight * (B) 
of protein of protein
The loading of 2-IT was determined by A/B.
If necessary the derivatised protein was concentrated and then stored 
filter sterile at 4°C.
2:13 Preparation of polyclonal antibodies raised against ricln subunits.
Highly purified ricin subunit preparations were used as antigens to 
raise antibodies in rabbits.
2:13:1 innvcvlvm prspgrativn-
Prior to injection collect pre-immune serum.
50 pg of protein (in PBS) was mixed with 0.5 ml Freund's Complete 
Adjuvant (FCA) until the preparation became white and viscous. The 
innoculum was taken up in a 1  ml syringe and injected subcutaneously into 
New Zealand white rabbits. The rabbits were rested for two weeks and then 
given a booster injection of 100 pg protein in 0.5 ml Freund's Incomplete 
Adjuvant (FICA). After a further two weeks rest blood samples were 
collected by ear bleeds and the rabbit given a second booster injection.
56
2:13:2 Etaam&lflQ a t  HitllAEl-
Collected blood was "ringed” (detached from the edges of the glass 
collecting bottle) and allowed to form a clot overnight at 4°C. The sample 
was centrifuged at 6000 rpm in a benchtop centrifuge for 15 minutes and the 
serum collected. The volume of serum was measured, and ammonium sulphate 
added to form a 50% (w/v) saturated solution. Precipitated material was 
pelleted (12,000 rpm in the 8 x 50 rotor for 20 minutes) and then resuspend 
in PBS to a volume equal to half the original serum volume. The sample was 
dialysed against PBS and then divided into 500 /il aliquots for storage at - 
20°C.
2:14:1 Growth and maintenance of Escherichia coll strains.
Stock strains of E. coli were plated on L-agar media (1% (w/v) 
tryptone, 0.5% (w/v) yeast extract, 1.5% (w/v) Agar, 85 mM NaCl) and stored 
at 4°C.
Liquid cultures of E. coli were grown in L-Broth (1% (w/v) tryptone, 
0.5% (w/v) yeast extract, 170 mM NaCl). Liquid cultures were maintained at 
37°C in orbital shakers at 200 rpm. Cells containing plasmids conferring 
antibiotic resistance were grown in, or plated on, media containing the 
appropriate, antibiotic. Cells with plasmid conferred ampiclllin resistance 
were grown in the presence of 0 . 1  mg/ml ampicillln.
sc.
2 ; A? ; ? 125I IrttlllM ?i pricing
Proteins requiring an 125I label were treated as follows:
An aliquot, 0.5 - 1.0 mCi (5 - 10 pi) of Na125I was diluted with 10 
pi 25 mM phosphate buffer pH 7.5.
Approximately 5 pg (10 pi) of protein was rapidly mixed with 50 pg 
(10 pi) of chloramine T solution and 120 pg (100 pi) of sodium 
metabisuphite solution (1.2 mg/ml). All solutions were made up with 
phosphate buffer as described earlier. The volume of this solution was 
made up to 1 ml with Hal solution (2.0 mg/ml). The Nal solution 
contained the Ha12^I component so that a measure of the total 
radioactivity in a known volume ( 1  ml) could be determined.
Labelled protein was separated from unreacted Hal using a prepacked PD10 
(G25F) column. Fractions from this column containing the labelled 
protein were pooled and samples removed for counting.
An index of 125I cpm/mg protein was determined.
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2 ; 14; 2 BecESJlfll..§trff ins •
(Carter et al., 1985)
Strain Genotype
BMH 71.18 K12 A(lac-pro) supE
thi/F' pro A'B' laq Iq 
lac Z AMI5
BMH 71.18
Mut L
As BMH 71.18 but 
Mut L :: TnlO
The above bacterial strains must be grown on minimal glucose plates. 
Mut L (Repair -) strains mutate at high frequency and should therefore be 
stored in glycerol at -20°C.
frepffrfftlpn 9f ppmpstsnt ceil».
E. coll cells were grown in a 50 ml culture of L-Broth at 37 C and 200 
rpm to an optical density of 0.48-0.5 units at 550 nm. At this density the 
expotentlally growing cells were removed from Incubation and placed on Ice. 
Cells were centrifuged a 3000 x g for 10 minutes, the supernatant carefully 
removed and the pellet gently resuspended in 25 ml (0.5 volume) of ice cold 
50 mM CaCl,. The suspension was stood on Ice for 30 minutes and the cells 
repelleted as before. The pelleted cells from this centrifugation step 
were resuspended In 2.5 ml (0.05 volume) and stood on ice for a further 30 
minutes after which the cells were Judged as competent.
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2 ; 16:1 Tr»nsfprffig*l9n <?£ <?<?;npet<?nt cell?-
100 pi of competent cells were mixed with dilutions of the DNA and 
stood on ice for 30*45 minutes. The cells were heat-shocked at 42°C for 
90-120 seconds and then diluted to 1 ml with L-Broth. Cells were incubated 
for 1 hour at 37°C, pelleted by a brief centrifugation in a bench top 
microcentrifuge and then resuspended in 100 /¿I L-Broth prior to plating on 
appropriate L-agar plates for overnight incubation at 37°C.
2:17 E xtractio n  and p u r ific a tio n  o f pla?ml<j DNA.
2;17;1 Mini preparation •?( plasmid p n a u?ihg_the, M i n t  mgthfrd- 
(Holmes and Quigley, 1981)
5 ml aliquots of L-Broth containing 0.1 mg/ml ampleillin were 
innoculated with individual colonies selected from L-Amp plates of 
transformed E. coll. The cultures were grown overnight at 37°C and 200 rpm 
and then harvested by centrifugation at 2 0 0 0 rpm in a bench top centrifuge. 
Cell pellets were resuspended in 180 pi of 20% (w/v) Sucrose, 100 mM Trls 
HC1 pH 8.0, 50 mM EDTA (SET) buffer and mixed with 180 pi of 4 mg/ml 
solution of lysozyme made up in the same buffer. Cells plus lysozyme were 
stood at room temperature for 5 minutes then mixed with 300 pi of 10% (v/v) 
Triton X-100 and boiled for 2 minutes before immediately returning to ice. 
The boiling and snap cooling acts to denature the chromosomal DNA which 
does not reanneal correctly, whereas the two DNA strands of the much 
smaller plasmid DNA correctly reanneals. The lysed bacterial cells were 
then centrifuged for 15 minutes in a microcentrifuge (13,000 rpm) and the 
pellet discarded. The supernatant was mixed with 300 pi of 7.5 M ammonium 
acetate and stood on ice for 2 0  minutes to precipitate any soluble protein, 
which was pelleted by bench top centrifugation as before. Finally, 630 pi
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of propan-2-ol was added to the supernatant and the DNA precipitated by 
incubating the mixture at -20°C for 10 minutes.
The precipitated DNA was pelleted in a microcentrifuge for 10 minutes 
at 13,000 rpm, rinsed using 70% (v/v) ethanol, dried under vacuum and 
dissolved in 60 /il 10 mM Tris (HC1) pH 7.2, 10 mM EDTA pH 7.2 (TE) buffer.
2; 17; 2 Hint pr$pfrir»t;ipn o f pta$mi<j pna u$ln& the Alfcsline method.
(Birnboim and Doly, 1979)
Cells were grown and harvested as in Section 2:17:1. The pellet of 
cells from each 5 ml culture was resuspended in 100 /il of 20% (w/v) 
glucose, 100 mM Tris HC1 pH 8.0, 50 mM EDTA (GET) buffer and then mixed 
with 100 /il of 5 mg/ml lysozyme made up in the same buffer. After 5 
minutes at room temperature, 2 0 0  /il of lysis solution (1 .0 % (w/v) sodium 
dodecyl sulphate, 250 mM NaOH) was added and the mixture incubated on ice 
for a further 5 minutes. 150 /il of 3M sodium acetate (HAc) pH 4.8 was 
added, the solution vortexed, and stood on ice for 5 minutes after which it 
was centrifuged at 13,000 rpm for 10 minutes in a microcentrifuge. The 
supernatant was removed and extracted with TE saturated phenol/chloroform 
(50:50). The volume of the upper aqueous layer was measured and 0.1 volume 
of 7.5 M ammonium acetate and two volumes of 100% ethanol were added. The 
DNA was precipitated at -20°C for 30 minutes, then pelleted in a mlcrofuge 
for 10 minutes, rinsed in 70% (v/v) ethanol, dried briefly and dissolved in 
50 /il TE.
2:17:3 U w c f f l »  p r w r atlgn <?f P M  ygln&..ths...t>pmng nsthgd.
(Holmes and Quigley, 1981)
400 ml cultures were lnnoculated with transformed E. coll cells and 
grown overnight at 37°C and 200 rpm. Cells were pelleted by centrifugation
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(4000 x g for 5 minutes at 4°C) and resuspended in 7.2 ml SET, to which an 
equal volume of 4 mg/ml lysozyme was added. After 5 minutes at room 
temperture, 12 ml of 10% (v/v) Triton X-100 was added, and the mixture 
heated over a bunsen flame until the cell suspension became viscous. The 
lysed cells were immediately cooled on ice then transferred to 40 ml 
plastic Oakridge tubes. Cell debris and insoluble proteins were removed by 
centrifugation (48,000 x g for 25 minutes at 4°C), the supernatant removed 
and mixed with a 0.5 volume of 7.5 M ammonium acetate on ice for 20 minutes 
to precipitate soluble proteins. The precipitated proteins were removed by 
centrifugation (27,000 x g for 10 minutes at 4°C) and the supernatant mixed 
with 0.7 volume of propan-2-ol at -20°C for 10 minutes. Precipitated DNA 
was recovered by centrifugation (27,000 x g for 10 minutes) and the pellet 
drained.
2;17;4 Equilibrium density gradient centrifugation (Caesium Chloride 
Cgntrlfyggtlgp)•
The drained DNA pellet (from 2:17:3) was resuspended in EDTA TE buffer 
(10 mM Tris pH 8.0, 0.1 mM EDTA), mixed with 4.3 g CsCl and 0.5 ml (5 
mg/ml) ethidlum bromide. The dissolved solution was transferred to a 5 ml 
clearseal Beckman centrifugation tube, heat sealed and then centrifuged in 
a Beckman ultracentrifuge using a Vti 65.1 rotor for 7 hours at 55,000 rpm 
at 18°C. After ultracentrifugation the tubes were carefully removed, and 
the lower of the two horizontal bands apparent on the gradient removed 
using a hypodermic needle and syringe. The lower band represents plasmid 
DNA whilst the upper is chromosomal DNA.
The collected plasmid DNA was repeatedly mixed with an equal volume of 
lsobutanol saturated with TE buffer containing excess CsCl, until all 
traces of ethldium bromide had been removed from the upper aqueous layer. 
The CsCl present was diluted by the addition of 4 volumes of TE and the DNA
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precipitated by the addition of 0.1 volume of 3 M sodium acetate pH 6.0 and 
two volumes at 100% ethanol at -20°C for 30 minutes. Precipitated DNA was 
collected by centrifugation (27,000 x g for 10 minutes at 4°C, rinsed in 
70% (v/v) ethanol and dissolved in 400 pi TE buffer.
2:18 Preparation of DNA from the single-s trended, I>NA bacteriophage M13- 
(Schrier and Cortese, 1979; Messing, 1983)
M13 is a filamentous, single-stranded bacteriophage ('phage) whose 
life cycle can be exploited for the production of single-stranded DNA 
template (Schrier and Corte.se, (1979)).
The 'phage invades the host cell (E. coli F') via the F pillus. Once 
inside, the single-stranded DNA (of the uncoated 'phage particle) acts as a 
template for the synthesis of a complementary strand to produce the so- 
called replicative form (RF) which is double-stranded. DNA replication, 
exploiting the host cells replicative apparatus, produces a population of 
daughter RF molecules, (up to 100+ per cell) until a point is reached when 
replication becomes asymmetric such that new single-stranded DNA is 
synthesised. This occurs by the rolling circle method of replication. The 
DNA is packaged in viral coat proteins and mature phage particles are 
extruded from the host cell without causing cell lysis. Some 200 'phage 
particles per cell, per generation can be harvested as a source of pure 
single-stranded DNA.
The RF form of M13 being double-stranded is susceptible to enzymic 
manipulation and may therefore be used as a cloning vector. The Messing 
series of M13 rap vectors (Messing, J., 1983) have been specially modified 
to fulfil the role of cloning vehicle. They possess a cluster of 
convenient cloning sites (referred to as the polylinker or multiple cloning 
region) and a system allowing selection of recombinant over non-recombinant 
clones. This selection is based on the presence or absence of the enzyme
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ß-galactosidase. E. coll host cells infected with non-recombinant M13 
(from the Messing series) will in the presence of IPTG (the lac operon 
inducer) produce a functional ß -galactosidase which will hydrolyse the 
substrate X-gal to produce a blue dye and therefore blue plaques.
Insertion of foreign DNA into the vector inteferes with ^-galactosidase 
production which under selection conditions produces colourless plaques.
2:18:1 frgpar»yj<?n pf sjnglg-ssr»n<te<j M13 PPA-
The fact that double-stranded M13 DNA can also exist as single- 
stranded DNA depending on the natural infective cycle is important for two 
techniques where single-stranded DNA templates are required viz : dideoxy 
chain termination DNA sequencing (Sanger et al., 1977) and site directed 
mutagenesis (Hutchinson et al., 1978). Single-stranded M13 DNA was 
prepared as follows.
An appropriate volume of L-Broth was innoculated with a droplet of a 
host cell strain (E. coli F') and then aliquoted in 3 ml volumes into 
sterile narrow-necked universal bottles. Each aliquot was then infected 
with 'phage taken from plaques (areas of reduced growth rather than lysed 
cells) on B-agar (0.8% (w/v) bactotyptone, 100 mM NaCl, 2.0% (w/v) 
bactoagar) plates, see Section 2:23:5. The cultures were incubated at 37°C 
and 300 rpm for good aeration for 5W-6 hours. After incubation, 1.5 ml of 
culture was centrifuged for 5 minutes in a microcentrifuge to pellet the 
E. coll cells. The supernatant (containing the extruded virus) was then 
mixed with 200 pi 20% (w/v) polyethylene glycol (PEG)/2.5M NaCl and allowed 
to stand at room temperature for 20 minutes to precipitate the 'phage. The 
PEC/salt precipitate was pelleted for 10 minutes in a microcentrifuge and 
then all traces of the PEC/salt solution removed. The 'phage pellet was 
resuspended in 100 pi TE by vortexing and the protein coats were removed by 
phenol extraction. 100 pi TE saturated phenol was added to the solution,
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vortexed and centrifuged. The aqueous layer was removed and extracted 
again this time using TE saturated phenol/chloroform (50:50). The last 
traces of phenol were removed from the second aqueous phase by adding 0.5 
ml of ether. DNA in the final aqueous layer (i.e. the lower layer of the 
ether extraction) was precipitated by adding 0.1 x volume salt (3M Sodium 
acetate pH 6.0) and two volumes of 100% ethanol. The precipitated DNA was 
harvested by centrifugation, rinsed, dried and redlssolved in 20 /¿I TE.
2:18:2 fr«p«mlon Of RF DMA fEPB M13-
10 ml phage cultures were prepared by innoculatlng L-Broth with a drop 
of a suitable culture of host E. coll and by infecting these cells with M13 
mp 'phage picked from plaques on a B-agar plates (see Section 2:18:1).
These cultures were grown overnight at 37 C, 200 rpm.
40 ml aliquots of sterile L-Broth were innoculated with a drop from a 
host E. coll culture and grown to a density of 0.5-0 . 6  OD units at 550 nm. 
These cultures were then infected with 100 pi of an appropriate 'phage 
overnight culture and incubated at 37°C for 4 hours at 300 rpm. Cells were 
harvested by centrifugation (3000 x g at 4°C for 10 minutes) and 
resuspended in 1.9 mis SET buffer. Fresh lysozyme (40 mg/ml) was added to 
a final concentration of 2 mg/ml and the solution stood on ice for exactly 
15 minutes. Two volumes (4 mis) of freshly prepared lysis solution (0.2 M 
NaOH, 1% (w/v) SDS) was added and the mixture stood on ice for 10 minutes.
A half volume (3 mis) of 3M sodium acetate HAc pH 4.8 was then added and 
the mixture returned to ice for a further 15 minutes. The dense 
precipitate formed during this procedure was centrifuged at 27,000 x g for 
15 minutes at 4°C and discard ed. The supernatant was retained and 
incubated with 5 pi RNAase A (10 mg/ml) for 15 minutes at 37°C. The 
preparation was extracted using TE saturated phenol/chloroform (50:50) 
twice and the DNA precipitated by adding 0.6 volume of Isopropanol. The
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precipitated DNA was harvested by centrifugation (27,000 x g at 4°C for 10 
minutes) and the pellet redissolved in 2 mis of 6.5% (w/v) PEG/0.4 M NaCl 
on ice for one hour. The DNA was pelleted in a bench-top microcentrifuge 
for 1 0  minutes, the supernatant removed and the pellet rinsed, dried and 
redissolved in 40 /il TE buffer.
2 = 19:1 <?f rs.striçtl9h çndpnvglçase?.
Restriction enzymes were used according to the manufacturer's 
instructions. lOx core buffer (BRL) was used where possible, otherwise 
buffers were prepared from sterile stocks.
Stock restriction endonuclease buffer (10 mM Tris HCl pH 7.4, 10 mM 
MgCl2 , and 100 /ig/ml Bovine serum albumin (BSA)) varied only in the NaCl 
concentration from 0 mM to 150 mM NaCl in 50 mM divisions. Incubations 
were carried out for 60 minutes at the optimum temperature for each enzyme, 
mostly 37°C. DNA concentrations varied from 10-100 ng//il.
Digestion products were analysed as 1% (v/v) agarose gels containing 1 
/ig/ml ethidlum bromide. Gels were made in Tris-Acetate-EDTA (TAE) running 
buffer (40 mM Tris HAc pH 8.2, 20 mM sodium acetate, 1 mM EDTA) and 
electrophoresed at 75-100 volts (constant voltage). Stained DNA was 
visualised under ultraviolet (u.v.) light and photographed using polaroid 
667 film.
Any alteration to this protocol will be referred to in the appropriate
results section.
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2:20 lialatlan at BBA fragments-
2:20:1 Isolation of DWA fragments using low melting point m i 8 U -
Plasmid DNA, previously digested with appropriate restriction enzymes 
(see Section 2:19:1) was electrophoresed in 1% (w/v) low melting point 
agarose made up in TAE buffer. DNA was electrophoresed until stained 
fragments could be distinguished from each other under u.v. light and then 
the required fragment was excised from the gel, taking care to remove any 
excess agarose. The agarose slice containing the DNA fragment (typical 
volume approximately 50 pi) was placed into 150 pi of TE buffer at 65°C, a 
temperature at which low melting point (LMP) agarose dissolves. The 
solubilised DNA was extracted twice with TE saturated phenol (no 
chloroform) and the DNA from the second aqueous phase precipitated in 
ethanol, collected, rinsed and dried as described before. The dried DNA 
pellet was dissolved in 5 pi TE buffer.
2;2Ql2 I s o U U on <?f  PEA.ft«gg?nts v?ln&._DE81^g»per.
Digested plasmid DNA was electrophoresed on 1% (w/v) agarose gels. At 
a position in front of the required fragment, a piece of DE81 paper 
(Vhatman) was inserted into the gel. The surface of the gel was dried as 
much as possible and the DNA fragment electrophoresed onto the paper, which 
was then removed and incubated for 2 hours at 37°C with 400 pi of 1.5 M 
NaCl in TE buffer. The paper was pelleted (5 minutes in the 
microcentrifuge) and the DNA precipitated by adding 1 ml of 100» ethanol to 
the supernatant and incubating at -20°C as described earlier. The 
precipitated DNA was collected as normal and redlssolved in 10 pi TE
buffer.
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DE81 paper was prepared by soaking in 2.S M NaCl, washing extensively 
with Ha0 and then storing in 1 dM EOTA pH 8.0 at 4°C.
2:21:1 LigHlgq 9f_.PPA lElgMntl-
Plasmid or 'phage DNA and isolated DNA fragments were ligated for 2 
hours at room temperature (or 15°C overnight) in 50 mM Tris HC1 pH 7.5, 5 
mM MgClj, 5mM DTT, 10 mM ATP (ligase buffer) with 0.1-0.3 units//il of T4 
ONA ligase (2.5 u//*l) . Between 0.1 and 0.3 units of T4 DNA ligase was 
adequate to catalyse the reaction of 10-100 ng of total DNA.
After ligation competent E. coll cells of an appropriate strain were 
transformed as in Section 2:16:1.
2;22; 1 pf U n w i n d  PPA with Alkaline Phggphfftffss-
Treatment of linearized vector with alkaline phosphate (calf 
intestinal) removes 5'-terminal phosphate groups thus preventing 
recircularisation of the vector during ligation. The addition of non- 
phosphatased insert provides one 5' terminal phosphate on one end of each 
strand between vector and insert. The unligated nick at the opposite end 
of each strand is repaired by host cell repair mechanisms following 
transformation into E. coll.
The phosphatase reaction was carried out as follows:-
Restricted vector (approximately 500 ng total DNA) was redlssolved 
after ethanol precipitation in 50 mM Tris HC1 pH 9.0, 1 mM MgCla, 0.1 mM 
ZnCla, 1 mM spermidine plus 50 mM glycine pH 9.4 and Incubated with 1 unit 
of calf intestinal alkaline phosphatase (CIP). The reaction mix was 
incubated for 15 minutes at 37°C followed by 15 minutes at 56°C. A further 
1 unit of CIP was added and the two stage incubation repeated.
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The reaction was stopped by dilution with 20 pi H a0 and addition of 5 
pi 10 x TNE (100 mM Trls HC1 pH 8.0, 1 M NaCl, 10 mM EDTA) , followed by 
heating at 6 8°C for IS minutes. Finally the phosphatased DNA was extracted 
twice with phenol/chloroform (50:50) precipitated in ethanol and collected 
as described earlier.
h 2 1  QlU9nv»?UoU<te
(Hutchinson et al.. 1978; Carter et al.. 1985)
A BamHI fragment encoding the complete ricin A chain was gel purified 
from pRICA (O'Hare et a l . . -1987) and ligated into M13mpl9 restricted with 
BamHI (see Figure 2:1).
The construction of the BamHI fragment encoding ricin A  chain has been 
described elsewhere (O'Hare et al.. 1987), but briefly it consists of a 
remnant of the pUC18 polylinker encoding a region of 5 amino acid residues, 
a short stretch from the ricin leader sequence encoding the last four 
residues of the signal peptide, the complete A chain encoding sequence (for 
267 residues) the linker region encoding twelve residues and the first 5 
codons of ricin B chain to the BamHI site at base position -«-852 (base 
numbering as described by Lamb et al. . 1985). A translation stop codon 
immediately after the A  chain encoding sequence was introduced by 
oligonucleotide site-directed mutagenesis (O'Hare et al.. 1987).
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FUurt 111
g»g«PI fvaR°»?nt encoding r ic in  A s la in  fron pMSA
♦..a
A CHAIN | LINKER \ 3'
BamHI
Polylinker derived 
from vector DNA
i : z i
BamHI Xhol
Base numbering after Lamb et al. (1985).
2:23:1 Thtt B M t w n l C  9lU9nvcl99tlds•
The non-phosphorylated oligonucleotide was synthesised using an 
Applied Blosystems 380B DNA synthesiser and purified by High Pressure 
Liquid Chromatography (HPLC) . It Is complementary to bases 703-723 of the 
published rlcin cDNA sequence (Lamb et al. , 1985) and carries a two base 
mismatch at positions 713 and 714 Indicated by the asterisks below;
CGT AAT GGT TCC AAA TTC AGT - 3* Non-template DMA
703 723 strand.
GCA TTA CCA ACT TTT AAG TCA - 5' Mutagenic
** oligonucleotide
The two base mismatch encodes for a translation stop codon (TCA) at
nucleotides 712-714.
2:23:2 Oligonucleotide phosphorylation.
The purfled oligonucleotide was diluted to 50 ng/pl with 50 mM Trls 
HC1 pH 8.0, 10 mM MgCl3 (Kinase buffer) in the presence of 5 mM 
dithiothreitol and 1 mM adenosine triphosphate and incubated with 5 units 
of polynucleotide kinase (Amersham) for 30 minutes at 37°C. The reaction 
was stopped by incubating at 65°C for 5 minutes. The reaction was scaled 
up as necessary.
2:23:3 Priming of single-stranded M13 template using mutagenic
9Ug9nu<?le9ti4e (Annealing,gg»ç£i9nl-
Successful mutagenesis was achieved by reacting the mutagenic 
oligonucleotide with the M13mpl9 template in the ratio 0.821.0.
400 ng of phosphorylated mutagenic oligonucleotide was reacted with 
525 ng of single-stranded M13mpl9 ricin A chain template (prepared as in 
Section 2:17:1), in 10 mM Tris HCl pH 8.0, 10 mM MgCla buffer by heating at 
80°C and then gradually cooling to room temperature. Heating the DNA at 
80°C serves to denature the template DNA, opening up the structure so that 
the oligonucleotide can anneal in the correct place during the cooling 
step.
2:23:4 Preparation of double-stranded DNA in vitro (Extension reaction)•
An extension reaction mixture containing 0.5 mM rATP, 0.5 mM 
deoxynucleotide triphosphates, 10 mM DTT, 1.0 unit of the Klenow fragment 
of DNA polymerase I 1.0 u/pl (Amersham) and 6 units of T4 DNA ligase 
(Amersham) was incubated with 10 pi (approximately 1 pg total DNA) of the 
annealing reaction at 15°C overnight. The reaction mix was diluted ten­
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fold with TE buffer and stored at -20°C.
2:23:5 Tren?f<?nagtlgD 9f I L H  m l  L__E- coll.
71.18 mut L cells are an E. coll F' strain susceptible to Infection 
with M13 'phage, and deficient in their DNA repair functions. These cells 
will therefore become Infected with M13 'phage, but not correct the two 
base mismatch introduced into the rlcin A chain encoding sequence by the 
mutagenic oligonucleotide (see Section 2:23:1).
71.18 mut L cells were rendered competent as described in Section 
2:15:1 and mixed with dilutions from the annealing/extension reaction (e.g. 
200 /¿I cells plus 0.005, 0.05, 0.1 and 0.2 volumes of the reaction mix).
The cells were stood on ice for 30*45 minutes, heat shocked for 90 seconds 
and then plated onto B-agar plates as follows:-
3 ml aliquots of B top agar (0.8% (w/v) bactotryptone, 0.6% (w/v) 
bactoagar 100 mM NaCl) were prepared at 42°C and mixed with 40 pi 100 mM 
isopropyl-^-D - thio-galactopyranoside (IPTG, (Sigma)) and 20 pi 2% (w/v) 5- 
bromo-4*chloro-3-indoyl-/9-galactoside (x gal) (see Section 2:18). 100 pi
of expotentially growing 71.18 cells (not deficient in mismatch repair were 
added to each aliquot as cells to provide the bacterial lawn. The 200 pi 
aliquots of transformed competent cells were then added, mixed and quickly 
plated out evenly on top of dry B-agar plates. Once the B top agar mixture 
had set the plates were incubated overnight at 37°C.
All plaques (areas of retarded cell growth rather than of cell lysis) 
should be clear for clones of recombinant M13 'phage.
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2:23:6 Colony hybridisation using mutagenic oligonucleotide.
(Wallace et al.. 1980)
Since no attempt was made to purify closed circular double-stranded 
M13 from excess single-stranded template after the in vitro steps, it 
cannot be assumed that all the plaques obtained contain 'phage carrying 
the desired mutation. It is therefore necessary to screen the clones.
This is achieved using the mutagenic oligonucleotide as a probe. This will 
anneal perfectly to DNA carrying the desired mutation, but imperfectly 
(i.e. incompletely) to DNA which remains wild type.
Individual plaques from the transformation step (Section 2:23:5) were 
toothpicked in duplicate onto L-agar plates in a pre-determined grid 
formation, and incubated overnight at 37°C so that the plaques can grow as 
infected colonies. One plate, serving as the master copy was stored at 
4°C, whilst the second was used for colony hybridisation.
Nitrocellulose filters, 0.45 pM, 82 mm diameter (Schleicher and 
Schuell) were placed onto the surface at the L-agar plates and firmly 
pressed into place in order to lift the colonies evenly. Individual 
colonies, now transferred onto nitrocellulose, were lysed, and the DNA 
denatured, by placing the filters, colonies uppermost, onto 3 MM sheets 
soaked in 0.5 M NaOH. Each filter was given 3 x 1  minute exposures to the 
lysis solution after which the colonies should glisten indicating 
successful lysis. The pH was neutralised by 2 x 1 minute incubations on 3 
MM filter paper soaked in 1 M Tris HC1 pH 7.4 and the denatured DNA was 
fixed to the nitrocellulose by incubating as before with 0.5 M Trls HC1 pH 
7.4, 1.5 M NaCl for 5 minutes. After fixing the DNA filters were air dried 
and then baked in vacus for 1 hour at 80°C.
The mutagenic oligonucleotide, phosphorylated using Adenosine 5'- 
[7 *aP] triphosphate (Amersham) served as a probe for correctly mutated 
template. Phosphorylation was carried out as detailed in Section 2:23:2,
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replacing Che 1 mM ATP with radioactively labelled ATP (approximately 30 
¡iCi. [7 saP] ATP 185 TBq/mmol). AfCer reacting for 30 minutes at 37°C the 
reaction was stopped and the labelled oligonucleotide diluted with 3 ml 6 x 
SSC (3 M NaCl 300 mM sodium citrate). The probe was filtered through a 0.2 
/¿M millipore filter into a 30 ml petri dish and stored at -20°C.
The filter was pre-wet in 6 x SSC and prehybridized at 67°C for 5 
minutes in 10 x Denharts (2% w/v BSA 2% (w/v) Ficoll 2% PVP) 6 X  SSC and 
0.2% (w/v) SDS to prevent non-specific binding of the probe. The filter 
was rinsed in 6 x SSC and then placed colony-side down into the probe 
solution for 1 hour at room temperature. After incubation the filter was 
removed and washed 3 times -at room temperature in 6 x SSC, dried and then 
exposed to X-ray film for 1-2 hours. The probe solution was refiltered and 
stored at -20°C.
Applying the Wallace rules to the oligonucleotide (Wallace et al. , 
1980) (where 2°C is added for each A and T, and 4°C for each G and C) the 
dissociation temperature (Td) of the mutagenic oligonucleotide to the 
mutated DNA template was calculated. The filter was washed in again in 6 x 
SSC at a temperature 5°C below the Td. Washing was carried out for 3 x 1  
minute periods, the filter dried and re-exposed to X-ray film.
Finally the washing procedure was repeated at the Td and the filter 
re-exposed. Any probe still bound should only be annealed to mutated 
template DNA. The series of autoradiographs (representing room 
temperature, Td-5°C and Td washes in 6 x SSC) give a graduating indication 
of those colonies carrying the directed mutation over those which remain 
wild type.
2 ;2?i? rUqv$ purification-
Putative positive colonies (i.e. those binding probe at the Td) were 
identified on the master plate and individually toothpicked into separate
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1 ml aliquots of L-Broth. The culture was diluted 1000 fold and 1 pi from 
this dilution used to lnnoculate 200 pi of expotentially growing 71.18 
feeder cells. These cells were then mixed with soft agar and plated on B 
agar as in Section 2:23:5.
2 ;24 Piflgpxv chain t im in g s  ig n  PNA sequencing-
(Sanger et al■, 1977)
The "Klenow fragment" of E. coll DNA polymerase I will accurately 
synthesise complementary DNA strands to single-stranded DNA templates 
(obtained as in Section 2:18:1) when provided with a primer possessing a 
3'-hydroxyl group and all four nucleoside triphosphates (dNTPs).
Dideoxynucleoside triphosphates (ddNTPs) can also be incorporated into 
the growing complementary strand by DNA polymerase I activity, but, because 
dideoxynucleoside triphosphates lack the 3'-hydroxyl group required for 
formation of the next phosphodlester bond, the DNA chain terminates after 
incorporation of a ddNTP.
To determine the sequence of a single-stranded template four separate 
reactions are carried out. Each reaction is supplied with all four dNTPs, 
but only one ddNTP, for instance ddATP. As the enzyme moves along the 
template synthesising the complementary strand it will insert either dATP 
or ddATP at the appropriate position. If dATP is Incorporated synthesis 
continues, but if ddATP is incorporated chain termination will result. By 
controlling the ratio of dNTP/ddNTP the incorporation of the ddNTP and 
therefore chain termination will occur randomly, resulting in a population 
of DNA fragments of different lengths.
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2:24:1 Dldeoxv chain termination DNA sequencing - The annealing reaction. 
(Amersham Ml3 sequencing handbook)
Single-stranded M13mpl9 template containing the BamHI fragment 
encoding ricin A chain (see Section 2:23) was obtained as outlined in 
Section 2:18:1.
The M13 universal primer is a single-stranded synthetic 
oligonucleotide: -
S' G T A A A A C G A C G G C C A G T  3'
The 17 mer is complementary to a sequence of + strand M13 DNA just 
down stream from the multiple cloning site present in all M13 mp vectors.
Annealing of single-stranded template to the M13 primer was carried 
out as described in the Amersham sequencing handbook, except that the 
reaction mixture was heated to 100 C for 5 minutes and then allowed to cool 
to room temperature. The rapid heating followed by the slow cooling opens 
up the M13 DNA allowing the M13 primer access to its complementary 
sequence.
2:24:2 Dldeoxv cheln tennlnatlon_I>NA sequencing - The sequencing reaction-
All reagents required for the sequencing reaction were obtained in kit 
form from Amersham. Adenosine 5'-7 [35s] thlotrlphosphate(22 TBq/mmol)used 
as radlolabelled nucleotide in the reactions was also obtained from 
Amersham.
Deoxy- and dldeoxynucleoside triphosphate working solutions were made 
up according to the Amersham handbook from the stock solutions provided in
the Amersham Kit.
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To the hybridisation nix (described in Section 2:24:1), 1 unit of 
"Klenov fragment” of DNA polymerase \ , 2 $i\ 7 ['*S] ATP and 1 pi of 100 mM 
DTT (final concentration 5 mM) were added. 3.5 pi of this reaction mix was 
incubated with 2 pi of each dNTP/ddNTP mix for 20 minutes at 30°C. 1 pi of
0.5 mM dATP was added as chase and the reaction incubated for a further 20 
minutes at 30°C.
4 pi of formamlde dye mix (0.1% w/v Xylene cyanol FF, 0.1% (w/v) 
bromophenol blue, 20 mM Na3 EDTA) was added to each reaction and then 
heated to 100°C for 5 minutes immediately before electrophoresis (see 
Section 2:24:3). The reaction mixes were loaded in a standard order, G, A, 
T, C on the polyacylamide gels.
Zilhsl Ctl
Samples from the sequencing reaction mixes were electrophoresed on 20 
x 40 x 0.04 cm polyacrylamide slab gels for 1H-2 hours at 40 watts. The 
electrophoresis gel plates, spacers and comb were extensively cleaned and 
allowed to dry before assembly. The gel was poured, taking care to avoid 
the creation of air bubbles within the gel and allowed to polymerise for at 
least 1 hour. A slot was formed in the * • 1 to accept the "sharks tooth" 
comb (0.4 mm thick, 5.7 mm point to point, BRL) prior to polymerisation.
Buffer gradient gels (Biggin et al. , 1983) were used to analyse the 
sequence of the mutagenised rlcln A chain clone as they produce more highly 
defined, evenly spaced band patterns than conventional gels.
Stock solutions for gradient gels were prepared as described in the 
Amersham sequencing handbook, the gradient being formed by mixing the two 
stock solutions in a 25 ml pipette by gently introducing air bubbles at the 
bottom. The gels were poured as described above.
Once polymerised the gels were assembled onto the tank apparatus. The 
slot made to accept the comb was rinsed to remove any unpolymerised
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acrylamide, and the comb placed in position. To warm the gel, and maintain 
a denaturing environment the gel was pre-run at 40 watts for 20-30 minutes 
in 90 mM Tris HC1 pH 8.3 890 mM boric acid 1 mM Na, EDTA 2Ha0 (TBE) running 
buffer. Finally the wells formed by the comb were rinsed and the samples 
loaded.
2;24;4 fpnwmlfo hafffii gygjltnt gels.
To achieve a more denaturing environment and to eliminate the 
formation of secondary structures within the DNA sequence 25% (v/v) 
formamide buffer gradient gels were used. As with standard gradient gels 
two solutions of different ionic strength were mixed as described in the 
previous section.
Stgck flcrylanite gglvtlpn
o.sx
40% acrylamide (19:1 acrylamide : bisacrylamide) 15 ml 6% (v/v)
10 x TBE 5 ml 5% (v/v)
Urea 46 g 46% (W/V)
Formamide (deionized) 25 ml 25% (v/v)
made up to 100 ml with H30 and filtered through a 0.45 /iM mlllipore filter 
and stored at 4°C in the dark.
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2.5X
40% acrylamide (19:1 acrylamide : blsacrylamide) 15 ml 6% (V/v)
10 x TBE 25 ml 25% (v/v)
Urea 46 S 46% (w/v)
Formamide 25 ml 25% (v/v)
Sucrose 5 S 5% (V/v)
bromophenol blue 5 mg To colour
made up Co 100 ml with H 20, filter and stored as above. 60 /*1 of 10% (w/v) 
APS and S ¿¿1 TEMED were added per 10 ml acrylamide solution. The gel was 
prepared and electrophoresed as described in Section 2:24:3.
2=24;? Autoradiography.
Following electrophoresis the gel was dismantled and (while still 
fixed to one gel plate) fixed in 5% (v/v) methanol, 5% (v/v) acetic acid 
for 20 minutes at room temperature. The gel was then mounted onto 3 MM 
filter paper (Whatman cut to size)and dried on a heated, vacuum block for 
40 minutes. The dried gels were exposed to X-ray film overnight and 
developed as described in Section 2:4:4.
2:25 in  atoflL Jaam ifiClatiflB -in d  Tr»n?lgti9n ,qf....th&..»qv»«=ay%4 x i d n  A <?h»ln Cipne (A
To establish the efficiency of the premature stop codon Introduced 
into the A chain sequence by site-directed mutagenesis and to ensure the 
fidelity of the retrieved A chain sequence (see Section 2:23:1), the 
mutated A chain sequence was ligated into an SP6 promoter driven, in vitro 
transcription vector, pSP64ABam.
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2i21.il Çlpning Ant? p S f from ttl2mpl9 •
RF DNA from M13mpl9 containing Che ricin A chain sequence, A stop, was 
prepared as detailed in Section 2:18:2. A fragment cut from the RF 
preparation with EcoRI and Belli was isolated from a low melting point 
agarose gel (see Section 2:20:1) and ligated (see Section 2:21:1) into the 
large EcoRI-Belli fragment from pUC8RA isolated in an identical manner.
The resulting plasmid formed had the S' end of the original ricin A chain 
cDNA up to the Bylll site at position 589 and the 3' end derived from 
M13mpl9 ricin A stop (Figure 2:2).
The Integrity of the ricin A stop clone in pUC8 was established by 
limited restriction enzyme mapping (see Section 2:19:1) and a BamHI 
fragment of 893 base pairs isolated from this plasmid and ligated into 
BamHI restricted, phosphatased (see Section 2:21:2) pSP64ABam (see Figure 
2:3).
Mini prep DNA was prepared as in Section 2:17:1 and correctly 
orientated fragments identified by restriction enzyme mapping. A large 
scale preparation of a correctly orientated BamHI fragment in the SP6 
vector (pSP64ABam A stop) was made.
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2 ¡2 Cloning-ef BeLII/EsoBI A stop fragment from M13otd19 RA stop 
Into p UC8 RA.
c
pUC8 RA stop was differentiated from pUC8 RA by restriction endonuclease 
mapping using Sj m I. PstI and Sail . pUC8 RA stop was linearized with Smal. 
but remained uncut when incubated with either PstI or Sail .
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U urt 2 i 3 Signing gf BamHl fr«gn«nt from p u c s r a  ,rnn into PsP64AB«mHT
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2:25:2 In vitro transcription of pSP64ABam A stop.
(Krieg and Melton, 1986)
The plasmid pSP64ABam contains a BamHI cloning site downstream from 
the bacteriophage SP6 promoter site. Between these two regions exists a 
sequence of 5' untranslated Xenoous 0 glob in, an inframe translation start 
codon (ATG) and 8 codons of 0 globin (see Figure 2:4).
To act as a template for run-off RNA transcripts, pSP64ABam A stop was 
linearized by Konl restriction endonuclease digestion (see Section 2:19:1). 
The digested DNA was extracted with TE saturated phenol/chloroform (50:50) 
and precipitated in ethanol as described in Section 2:18:1. Approximately 
2 Mg of linearized DNA was used in the transcription reaction as follows:-
2 i*l of (1 pg/pl) linearized DNA was incubated with 12 pi 
transcription premix (40 mM Tris HC1 pH 7.5, 6 mM, MgCla , 2 mM Spermidine, 
10 mM DTT, 500 pM rATP, rCTP, rUTP, 50 pH rGTP (New England Nucleotides 
(NEN), 100 pg/ml BSA (nuclease free BRL), 1 unit/pl ribonuclease inhibitor 
(Promega) plus 2 pi of 100 unlts/pl SP6 RNA polymerase (Amersham) . To 
produce capped transcripts (for increased translational activity and 
greater stability) 10 pi of G(5')ppp(5*)G (monomethyl cap) was added to a 
final concentration of 500 pM (Pharmacia). The reaction mix was incubated 
at 40°C for 30 minutes and then a further 30 minutes after the addition of 
2 pi 8 mM GTP (final concentration 0.7 mM). Reaction products were stored 
in liquid nitrogen.
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Z lssua. Z -1* A sto £
2:25:3 Translation of SP6 transcripts in a wheatgerm lvsate system.
Uheatgerm lysate was prepared as described by (Roberts and Paterson, 
1973) and (Anderson et al. . 1983).
1 pi of transcription reaction mix containing newly transcribed RNA 
(Section 2:25:2) was Incubated at 30 C for 1 hour with 3.75 pi wheatgerm 
lysate, 2.35 pi translation premix, 1 pi of [9SS] methionine 30 TBq/mmol 
(10 pCi/pl) made up to 12.5 pi with H 30. The wheatgerm translation premix 
was composed of 20 mM Hepes KOH pH 7.6 , 1 mM ATP, 8 raM creatine phosphate, 
40 pg/ml creatine phosphokinase 30 pg/ml spermidine pH 7.0, 2 mM DTT, 20 pM 
GTP, 25 pM amino acid mix (from 5 mM stock excluding methionine), 2.S mM 
magnesium acetate, 120 mM potassium acetate, final concentration (Anderson 
et al.. 1983).
2 pi aliquots were spotted onto Whatman No. 1 (1 cm3) paper and 
prepared for liquid scintillation as described in Section 20:10:3.
Products from the wheatgerm lysate translation were separated by SDS-PAGE 
(see Section 2:3:1) and visualised by fluorography and autoradiography (see
Section 2:4:4).
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2:25;4» Translation of SP6 transcript? In a rabbit reticulocyte lysate 
system.
(Jagus, 1987; Jackson et al.. 1979)
Rabbit reticulocyte lysate was prepared as described in Section 
2:10:1. Prior to translation, endogenous mRNA (mainly a and globin) was 
removed from the lysate by incubation with Ca2+*dependent endonuclease 
(Jackson et al. . 1976). Briefly to each 1 ml of lysate 10 pi of 100 mM 
CaCl3, 20 pi of 1 mM haemin hydrochloride (Sigma) and 10 pi of 200 units/ml 
creatine phosphokinase were added. Nuclease SI Ca2+ dependent from 
Staphylococcus aureus (Boehringer Mannheim) was added at an optimal 
concentration (usually between 25-100 unlts/ml) determined by assaying 
batch activity. The mixture was incubated at 20°C for 15 minutes and the 
nuclease then inactivated by the addition of 10 pi of 200 mM EGTA to 
chelate Ca2+.
1.5 pi of transcribed RNA (see Section 2:25:2) was Incubated for 30 
minutes at 37°C with 2.5 mM Trls HC1 pH 7.4, 3 mM Magnesium acetate, 250 mM 
potassium acetate, 150 pM amino acid mix (minus methionine), 10 mM 
phosphocreatlne, 80 mU of creatine phosphokinase, 0.02 mM haemin with 1.2 
pi |**S] methionine 30 TBq/mmol (10 pCl/pl), 0.625 pi wheatgerm tRNA and 
12.5 pi of mRNA dependent lysate (MDL) per reaction. In practise, a 
"master mix" of the above components was prepared and aliquoted for each 
separate translation reaction.
Products were analysed by SDS-PAGE or by scintillation counting as 
described in the previous section.
2:23:5 TgxicltY tnalvil» 9t rabbit railcvlgcvta translation produs.ta.
The biological activity of translated rlcln A chain transcripts with 
respect to their ribosome inactivating activity could be assayed using a
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rabble reticulocyte lysate system as described In Section 2:25:4.
Ribosomes from rabbit reticulocytes are sensitive to inactivation by 
ricin A chain, therefore such a system will only support a limited amount 
of translation before the product concentration reaches a level where it 
inhibits protein synthesis. This feature can be exploited in the analysis 
of any mutated ricin A chains by firstly translating A chain mRNA for 30 
minutes (as described in Section 2:25:4) and then adding a second mRNA for 
a non-inhibitory protein such as preproalpha factor (a yeast mating factor) 
or chicken lysozyme. If the first ricin A chain mRNA is translated to form 
biologically active protein then the second mRNA will not be translated. 
However, if the A chain mRNA translates to form a non-toxic protein then 
the second mRNA will be translated (May et al. , 1988 submitted to EMBO 
Journal).
Translation conditions are described in Section 2:25:4. After 30 
minutes translation with ricin A chain transcipts, the second mRNA encoding 
preproalpha factor was added and the system incubated for a further 30 
minutes. A control using chicken lysozyme mRNA as the first transcript 
followed by preproalpha factor was introduced to show inhibition was 
specific to ricin A  chain activity. Products from the translation 
reactions were analysed by SDS-PAGE as described previously.
2:26 EM>r9?>lgn Qt trvncm d ricin  A ch»ln in E*ch«lch U  co ll-
2:26:1 Construction of PDS5/3 A stop.
A BamHI fragment excised and isolated from pUC8 RA stop was ligated 
into the E. coll expression vector pDS5/3 as follows:-
10 pg of pUC8 RA stop was incubated for 1 hour at 37°C with the 
restriction endonuclease BamHI (see Section 2:19:1). An 893 base pair 
fragment was isolated from low melting point agarose (see Section 2:20:1)
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*nd ligaced (see Sección 2:21:1) into a BamHI rescricced. phospnacased (see 
Sección 2:22:1) preparación of che E. coli expression veccor pDS5/3 (O'Hare 
¿c al.. 1987; Scueber ec al.. 1984). Correccly oriencaced fragmencs were 
idencified by rescriccion mapping.
The veccor pDS5/3 concains a scrong coliphage T5 promoter fused co che 
E. coli lac operacor wich a ribosome binding sice (RBS) and iniciación 
codon immediacely upstream from a unique BamHI cloning sice (Scueber et 
di., 1984).
Figure 2:5 p DS5/3 A stop.
B B
rbs ribosome binding sice
ori origin of replicacion
C, terminator signal (rmB operon of E. coll)
to terminator signal (phage A)
PN25 fusion of coliphage T5 promoter wich lac operacor of E. coll
dnfr dihydrofolate reductase gene
Cat Chloroamphenicol acetyl transferase gene
bla 0 lactamase gene
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2:26:2 Transformation and Induction of expressed A stop.
BMH 71.18 E. coll cells were made competent as described In Section 
2:15:1, and transformed with dilutions from the ligated reaction between 
pDS5/3 and the BamHI fragment from pUC8 RA stop, described In Section 
2:26:1. Transformed cells were plated on L-amp plates containing 0.1 mg/ml 
amplelllln and Incubated overnight at 37°C.
Small colonies were selected, and mini prep DNA prepared as described 
in Section 2:17:2. Correctly orientated fragments were identified by 
restriction endonuclease mapping and a large-scale plasmid preparation made 
as described In Section 2:17:3.
DNA from the large-scale prep was used to transform competent BMH 
71.18 cells and from transformed colonies, 10 ml overnight cultures of L- 
Broth (+ 0.1 mg/ml ampiclllln) were prepared. Controls of cells 
transformed with full-length recombinant A chain (O'Hare et al. , 1987) and 
pDS5/3 vector only were also prepared. From each overnight culture 100 pi 
cells were used to innoculate 10 mis of fresh L-Broth (+ amplelllln) to 
which 20 pi of 1 M  IPTC (In TE buffer) was added (2 mM final concentration) 
and then Incubated at 30°C for 5 hours. Following Incubation, 100 pi 
aliquots were removed from each sample and analysed on 15% (w/v) SDS-PAGE 
under reducing conditions (see Section 2:3:1) and Western blotted (see 
Section 2:6:1) probing with polyclonal antibodies raised In rabbits against 
ricln A chain.
Note: All procedures relating to the expression of ricln A chain In 
E. coll were carried out under Category III containment conditions.
2:26:3 Scaled-up expression of truncated A chain and sample preparation.
500 ml cultures of L-Broth containing 0.1 mg/ml ampiclllln, 1 mM IPTC 
were Incubated with transformed cells containing pDS5/3 A stop and grown at
30°C, 200 rpm for 8 hours. Cells were harvested by centrifugation at 5000 
rpm for 5 minutes using the 6 x 300 ml MSE 21 rotor at 4°C, and the pellets 
resuspended In 20-30 ml sterile PBS at 4°C. The cell suspension was 
divided into 0.75 ml aliquots containing 20 pg lysozyme and 10 pg PMSF.
Each aliquot was sonicated on ice for three 20 seconds intervals and cell 
debris pelleted by centrifugation at 13,000 rpm in a microcentrifuge for 30 
minutes at 4°C. The supernatant from this step was carefully decanted and 
immediately dialysed against 25 mM ethanolamine HAc pH 9.6 in preparation 
for chromatofocusing.
2 <?f-trangatcQ A chain yglng chrom^ gfgsyglim-
Material prepared in Section 2:26:3 was separated using a 
chromatofocusing system, pH range 9-6. Polybuffer exchanger 9-4 
(Pharmacia) was equilibrated with 25 mM ethanolamine HAc pH 9.6 buffer at 
4°C. Soluble E. coli proteins prepared as described above were applied to 
the chromatofocus ing coluxn (30 cm x 2 cm) and then sequentially eluted 
with polybuffer 96 HAc pH 6.0, overnight at a flow rate 0.8 ml min'1 . Once 
the eluent reached a pH of 6.0 the column was washed with 1 M NaCl to elute 
any protein still bound. Fractions were analysed by SDS-PAGE and Western 
blotting.
2l2$¡5 Determination of rlcln A chain-specific activity in chromatofocused 
fractions.
Fractions from the chromatofocusing step Judged to contain the 
expressed truncated ricin A chain were analysed for specific rlcln A chain 
activity on RNA extracted from rabbit reticulocytes. The assay for ricin- 
specific modification of rlbosomal RNA was carried out as described in 
Section 2:11, using 20 and 30 pi aliquots of chromatofocused fractions as
che coxin dilution. Rlcin A chain specific modificación was caken as 
indicative of soluble biologically-active recombinant truncated ricln A 
chain.
2:26:6 Use of Blue Sephsrose affinity chromatography, to purify truncated A 
chain.
Chromatofocused fractions containing the expressed truncated ricln A 
chain were dialysed against 50 mM sodium phosphate buffer pH 7.5. Blue 
Sepharose CL- 6B (Pharmacia) was swollen in the same buffer and poured to 
form a 0.5 x 24 cm column. . The sample was applied and the column washed 
with 50 mM sodium phosphate buffer pH 7.4 until all unbound material had 
eluted. The column was washed with one bed volume of 50 mM sodium 
phosphate buffer and bound protein then eluted with 0.5 M NaCl in the same 
buffer. The column flow rate was 0.15 ml min'* and 1 ml fractions were 
monitored at ^ g Q  no (Knowles and Thorpe, 1987). Fractions from both bound 
and unbound material were analysed for ricin A chain specific activity by 
the ribosomal RNA modification assay detailed in Section 2:11.
Blue Sepharose CL-6B is the dye, Cibacron Blue F^G-A, covalently bound 
to Sepharose CL-6B (2 /¿mole dye ml'* swollen gel). The structure of 
Cibacron Blue F^G-A is such that it acts as a dinucleotide analogue binding 
number of enzymes with a requirement for adenylyl-containing substances.
It is via this type of Interaction that ricln A chain is thought to bind to 
the dye (Appukuttan and Bachhawat, 1979).
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3 :1 :1  q£. L s c U n s  fr9ro R lc ln v ?  gojm vn t? seeds-
The lecCins Ricln (RCAj j ) and Rlcinus communis agglutinin (RCAj) were 
purified from the seeds of the castor oil plant, Ricinus communis. Both 
ricin and RCAj are found amongst the matrix proteins of protein bodies in 
the seed endosperm tissue (Youle and Huang, 1976; Tulley and Beevers,
1976), and are easily separated from other seed proteins by affinity 
chromatography using acid-treated sepharose 4B, as described in Sections 
2:1:1 and 2:1:2. By binding to exposed /9 galactose residues in the 
sepharose column matrix, both ricin and RCA^ are retained whilst all other 
proteins pass straight through the column. Ricin and then RCA^ were 
sequentially eluted using PBS buffer containing 5 mM N-acetylgalactosamine 
and 100 mM galactose respectively (Nicholson et al.. 1974). Figure 3:1 
shows the protein elution profile from a typical lectin preparation.
An alternative and the preferred method for separating the two lectins 
from each other was to elute both together from the sepharose column, using 
PBS buffer containing 100 mM galactose and then to separate ricin from RCA^ 
by gel filtration upon a Sephacryl S-200 column as described in Section 
2:1:3. A typical Sephacryl S>200 elution profile is shown in Figure 3:2, 
the large RCAj (120 Kd) eluting first, followed by ricin (60 Kd) . Material 
from each peak was analysed by SDS-PAGE under reducing conditions as shown 
in Figure 3:3. Under these conditions, ricin appears as two bands and RCAj 
as three bands, (corresponding to the mobilities of their respective 
subunit components), enabling RCA^free ricin to be readily identified.
The subunit composition of these two lectins is considered in more detail 
in Section 3:3.
Purified ricin was tested for its ability to inhibit protein synthesis 
in eukaryotic cells, as described in Sections 2:9:1. Figure 3:4 describes 
the inhibitory effect of ricin dilutions upon the ability of Vero cells to 
Incorporate [**SJ methionine into TCA preclpltatable proteins. The data
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Figure 3; 1 Protein elution profile ; Rlclnus comnunls lectin preparation 
bv affinity chromatography using Sephare^AB ■
Figure 3:1 shows the isolscion of Rlcinus communis lectins from other 
seed storage proteins by affinity chromatography using Sepharose 4B, as 
described in Section 2:1:2. The elution of protein from the column was 
monitored by measuring the absorbance at 280 nm.
Peak I. represents material not binding to the sepharose column.
Peak II. represents material eluting with PBS buffer containing 5 mM 
galactosamine, predominantly ricin (60 Kd). 
represents material eluting with PBS buffer containing 100 
mM galactose, predominantly RCA^ (120 Kd).
Peak III.
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Figure 3: 1 Protein elution profile : Rlclnus coamunlB lectin 
preparation by affinity chromatography on a Sepharose 4B column.
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Figure 3:2 Protein elution profile : Separatlon__of..Ricinus SfflBmmll 
lectins bv gel filtration using « Sephacrvl S-20Q column-
Figure 3:2 shows the separation of Ricinus communis lectins by gel 
filtration, using a sephacryl S-200 column as described in Section 2:1:3.
Starting material, a mixture of ricin (60 Kd; and RCA^ (120 Kd) was 
applied to the column and the distinct lectin species sequentially eluted 
with PBS. The eluting protein was monitored by measuring the absorbance at 
280 nm.
Peak I represents material eluting first from the column, composed of 
the larger 120 Kd K C A J .
Peak II represents material eluting in the second peak from the 
column, composed of the smaller 60 Kd ricin.
nFigure 3: 2 Protein elution profile ; Separation of Rlclnua co— unis 
lectins by gel filtration using a Sephacryl S-200 column.
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Finura 3: 3 SDS-PAGE analysts of fraction» taken fron 
Sephacrvl S-aOQ pel filtration.
Sllvar-stalnad 808-PA8E analysis, undsr reducing conditions of 
soloctsd fractions fron tha Saphscryl 8-200 gol filtration atop.
fron peak Z (aas figura &  2) .Tracks 8-7 ragrasant coluan fractions 
28,30 and 32 fron poak ZZ (aas figura 3:2) .Track 8 is a purifisd 
ricin control.
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Figure 3; 4 Cytotoxicity assay : Inhibition of protein synthesis by 
purified rlcln concentrations.
Fleur* 3c 4 ahem th* Inhibitory *f fact of Mho la rlcln dilution* 
upon protaln aynthaala In Vara call* mm Judpad by tha incorporation 
of SB-8 eathlonln*.
Raaulta ara axpraaaad aa I Inhibition calculated free no-toxln
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have been expressed as percentage inhibition compared to the incorporation 
into no-toxin control. The concentration of ricin producing a 50% 
inhibition, (the inhibitory concentration 50% or I.C.so) was calculated at 
5 x 10* 1 2  M (0.31 ng/ml) , in close agreement with published figures (Stirpe 
and Barbieri, 1986).
h i  Purification of ricin subunits.
3:2:1 Chromatofocusing-and SDS-PAGE analysis.
As a prerequisite for'studying the properties of ricin subunits, a 
stringent purification and testing protocol was required. Earlier 
references to subunit purification (discussed in Section 3:3) describes 
methodology which achieves only partial purification of the subunits from 
one another. The protocol which consistently produced a high degree of 
subunit purification has been described in Sections 2:2:1 - 2:2:5, the key 
technique being the use of chromatofocusing which exploits the large 
differential in the pis of the subunit components (Olsnes and Pihl, 1982). 
Once optimised, it was possible, using a chromatofocus Ing system with a pH 
range from 7-4 to separate A chain (pi - 7.5), unreduced holotoxln (pi — 
7.1) and B chain (pi - 4.8) to homogeneity as judged b y  silver staining of 
polyacrylamide gels. Figure 3:5 shows a typical elution profile of 
chromatofocused ricin subunits, in which ricin A chain passes straight 
through the column without binding, followed by a small amount of unreduced 
holotoxin, (which elutes when the pH of the column equals 7.1) and then 
much later, ricin B chain, (which elutes at a column pH of 4.8). Silver 
stained SDS-PACE analysis of B chain purified by this method is shown in 
Figure 3:6. Track 1 of this figure contains a sample of ricin, 
electrophoresed alongside two tracks containing chromatofocused ricin B 
chain (tracks 2 and 3), under reducing, denaturing conditions. This figure
Figure 3:5 Protein elution profile : Purification of rlcin AubunitS-bv
chromatofocusIna.
Figure 3:5 shows the separation of reduced rlcin subunits by 
chromatofocusing. Starting material, consisting of a preparation of ricin 
reduced by incubation with 2-mercaptoethanol (see Section 2:2:2) was 
applied to the chromato focus ing column pre-equilibrated to pH 7.4 with 25 
mM imidazole buffer. The elution of the respective polypeptides was 
monitored by measuring the absorbance of each fraction at 280 nm.
Proteins eluted according to their pis as the polybuffer 7-4 (HC1) pH 
4.0 was applied, developing a pH gradient across the column, as indicated 
on the figure.
Peak I represents material not binding to the column, predominantly 
ricin A chain with a pi of 7.5. The high OD2i0na of this peak is the 
result of the 2 -mercaptoethanol which elutes from the column at this point.
Peak II represents material eluting from the column when the pH 
reaches 7.1, predominantly unreduced ricin with a pi of 7.1.
Peak III represents material eluting from the column when the pH 
reaches 4.8, predominantly ricin B chain with a pi of 4.8.
A pH meter was used to measure the pH of each fraction.
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Figure 3:5 Protein elution profile : Purification of rlcln subunits 
by chroMtofocuslng.
OP^BOno, <» 1 0 )
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Figure 3;6 SDS-PA6E analysis of chromatofocueed 
ricin B chain.
Sllvar-etalnad BOS-PABE analyele of ricin B chain 
purified by chroaetofocualnp.Track a and 3 ropraoant O.aBup and 
O.Sug aaaplaa of chroaatofocuaad ricin B chain raapactlvaly. 
Track l la a o.aug aaapla of purified ricin.
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demonstrates the high degree of B chain purity obtained after the single 
chromatofocusing step, as no contaminating ricin A chain can be detected in 
tracks 2 and 3.
To determine the purity of the chromatofocused ricin A chain by SDS- 
PAGE analysis it was necessary to pre-incubate the samples with 
endoglucosaminidase H (endo H) as described in Section 2:5:3. This step 
was introduced to differentiate between ricin B chain and "heavy" ricin A 
chain, (Aa), which has two oligonucleotide side chains and which 
electrophoreses with the same mobility as B chain on SDS-PAGE under 
reducing conditions. B chain contains two oligosaccharide side chains, 
both of which are removed By endo H treatment, resulting in proteins with 
increased electrophoretic mobility, corresponding to either a single or a 
double deglycosylation event. The oligosaccharide side chains of A chain 
(either A t or A2) however, are unaffected by endo H treatment. Thus, the 
presence of any contaminating B chain "hidden" by the "heavy" A chain will 
be revealed upon endo H treatment and subsequent SDS-PAGE analysis. Figure 
3:7 shows a sample of chromatofocused A chain before (track 3) and after 
(track 4) endo H treatment. No B chain contamination is apparent in this 
analysis. On the same figure, control tracks of chromatofocused B chain, 
before (track 1) and after (track 2), and ricin, before (track 5) and after 
(track 6 ), endo H treatment demonstrate the deglycosylation activity of the 
endo H used. The deglycosylation of ricin subunits is discussed in more 
detail in Section 3:3.
3:2:2 A <;h»ln wlfUttlwi = R?m9v»l cgntgnlnlhg P ch»ln fry « m n U Yghr9w g*Q fti:gplig •
Chromatofocused ricin A chain was further purified by the removal of 
any remaining ricin B chain contamination, using affinity chromatography on 
aslalofetuln columns as described in Section 2:2:4. Ricin A chain,
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Figure 3: 7 S0S-PA6E analysis of endo H treated rlcln and 
rlcin subunits.
1 2 3 4 5 6
811var-etalned 80B-PA8E analysis of ondo H t r u U d  picln and 
rlcln aubunlts under reducing condition«.
Track« 1 and 2 r«prao«nt untreated and treated chrooatofocueed 
rlcln B chain eaopleo respectlvaly.
Tracke S and 4 reprooont untreated and treated chronetofocuoed 
rlcln A chain ea^lM*
Tracke B and 8 represent untreated and treated ehela rlcln
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purified by chromaCofocusing, was able to pass straight through the column, 
whilst any contaminating B chain or unreduced holotoxin in the preparation 
bound almost irreversibly to the column and could not be eluted with 100 mM 
galactose buffer. Since chromatofocused rlcin A chain after silver stained 
SDS-PAGE analysis was apparently free from contaminating B chain, post- 
asialofetuin treated ricin A chain was analysed for increased purity in 
cytotoxicity and cell-free assays (see Sections 2:9 and 2:10 respectively).
3:2:3 Analyst? 9f purified »ubunltt-
Purified rlcln subunits were analysed for their ability to inhibit 
protein synthesis in eukaryotic cells. In theory, completely pure subunits 
should be non-toxic to cells; A chain, because it lacks the binding and 
putative translocating functions of the B chain, and B chain because it 
lacks the ribosome-inactivating activity of the A chain. In practise, 
however, some toxicity was detectable when higher concentrations of 
subunits were applied to cells, which may be accounted for by slight 
contamination by the other subunit (thus reconstituting holotoxin activity) 
or by some innate toxicity associated with higher protein concentrations,
i.e. not ricin-specific toxicity. These possibilities have been further 
tested with preparations of B chain as described later in Section 3:2:5.
Figure 3:8 shows the percentage Inhibition of protein synthesis (as 
judged by (*6S) methionine incorporation) at the different stages of ricin 
A chain purification. After chromatofocusing the IC , 0 of approximately 7.0 
x 1 0 * 9 M (0 . 2 1  /ig/ml) is increased almost ten-fold by the subsequent 
asialofetuin step, to a value of approximately 5 x 10** M (1.5 /ig/ml), and 
highly purified ricin A  chain is shown to be non-toxic to cells at a 
concentration of 1 x 10** M (0.3 pg/ml). The decrease in toxicity after 
the asialofetuin treatment suggests that contaminating B chain or holotoxin 
has been removed by this step.
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Figure 3:9 shows the inhibition of protein synthesis resulting from 
the application of ricin B chain dilutions from 1 x 10" 1 1  M - 1 x 10** M 
onto Vero cells. The IC60 for chromatofocused ricin B chain was calculated 
at approximately 3 x 10’T M (9.6 /¿g/ml) and B chain was non-toxic to these 
cells at concentrations up to 1 x 10 * M.
To show that the respective biological functions of each subunit had 
not been significantly impaired during purification, purified ricin A and B 
chains were reassociated as described in Section 2:9:2 (after Olsnes 
al., 1974) and then tested for their ability to inhibit protein synthesis 
in a standard cytotoxicity assay. Figure 3:10 shows the result from such 
an assay, in which the toxicity of purified A chain at the normally non­
toxic concentration of 1  x 1 0 '* M is increased by the presence of 1  x 1 0 '®
M B chain to give a 40% inhibition of protein synthesis. Above this 
concentration A chain itself is toxic, but this result demonstrates that 
both subunits are able to recombine to form an active toxin and is in 
agreement with the findings of other workers (McIntosh et al., 1988; Olsnes 
et al.. 1974). Reassociated subunits were however, never as active as the 
same concentration of holotoxin on cells (also in agreement with the 
findings of McIntosh et al.. 1988; and Olsnes et al.. 1974). This might be 
the result of some denaturation during the purification process, or the 
result of inappropriate association. To examine the latter, samples of 
purified B chain, purified A chain and a sample of reassociated material (1 
x 10’* M A chain + 1 x 10*® M B chain) were electrophoresed under non- 
reducing conditions on SDS-PAGE (see Figure 3:11). Track 1 of this figure 
shows ricin electrophoresed under non-reducing conditions with a mobility 
corresponding to 62 Kd protein. Tracks 2-4 show samples from the different 
stages of ricin A chain purification which are identical by SDS-PAGE 
analysis. The majority of the protein electrophoreses as the A, and A 2 
monomers, but some material forms an approximately 62 Kd homodlmer. Tracks 
5 and 6 represent ricin B chain preparations, and again the majority of
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Figure 3:8 Cytotoxicity assay : Inhibition of protein synthesis by 
rlcln A chain at different etagee of purification.
1X10-11 1X10 “10 1X10-9 1X10 “8 1X10 "7 1X10 “9
Toxln Concentration (H)
Fleur« ace ahowa tha lnhlbltory affect ef purlfied ricin A Chain 
upon protaln aynthaala ln Varo celle, «a Judoad by tha 
Incorporation of 36-8 æthlonlna.
o— a rapraaants ricin A chaln purlfied by chro— tofocualne only 
• ° rapraaanta ricin A chaln purlfied by chroeatofocualng and
aalalofatuln traataant.
Aeaulta ara expreaaed aa 8 Inhibition calculatad froa no-toxln
control valu««.
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Figure 3:9 Cytotoxicity assay : Inhibition of protein synthesis by 
purified rlcln B chain.
Toxin Concentration (M)
Fleur« ft 9 shows the inhibitory «ffect of purified rlcln B chain 
upon proto In oynthooio In Voro colls, as Judged by tho 
Incorporation of SB-8 aathlonlns.
Results ora expressed ae S inhibition calculated free no-toxin 
control values.
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Figure 3; 10 Cytotoxicity a w y  ; Inhibition of prof In synthes 1« 
by reaeeoclated rlcln subunit».
Toxin Concentration (M)
Fleur* *  10 ahou* th* inhibitory affect of raa— oclatad rlcln 
subunits upon protein ayntheala In Vara calls, aa Judged by th* 
Incorporation of SB-8 sathlonlna.
Rlcln B chain at a final concentration of IX10”® N «as 
roaaaoelated with rlcln A chain concentrations free 1X10-11H - 
1X10 and applied to th* call*.
Not* : Acre** th* cancantratlon rang* ahown hare both purified 
rlcln aubunlta ara non-toxic to Vara calls.
Raoulta ara axpraaaad aa I Inhibition calculated fro* no-toxln 
control value*.
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Figure 3:11 SDS-PA6E analysis of rlcln. purified rlcln subunits 
and rea980clated rlcln subunite under denaturing, non-reducing 
conditions
811vsr-otainod 8DB-PA8E analysis under non-reducing conditions.
Track 1 shows a saapla of whola ricin. Tracks 2-4 show saaplas of 
chroaatofocusad ricin A chain, poat-aolalofatuin trsatsd A chain 
and post- antibody affinity purlflad ricin A chain raapactlvaly.
Tracks 8 and 8 show saaplos of chrooatofocuaad ricin B chain and 
poat-antlbody affinity purlfisd rlcln B chain.
Track 7 shows a saapls froo tha roasooclatlon of oquloolar 
aaounts of rlcln subunits.
Tracks 8 and 8 show saaplas of purified ricin A chain and purlflad 
ricin 8 chain which wars a lift froo tha Iaparlsl Cancer Research 
Fund, drug tar gat ting laboratory .Those saaplas wars purlflad by the 
nsthod of Fulton l«88.
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protein exists in a monomeric form, but protein corresponding to the 
position of homodimers is clearly evident, which is in contrast to the 
findings of Olsnes et al. (1974) and Golmacher et al. (1987) who in their 
respective experiments did not observe homodimer formation. In track 7, 
which contains the reassociated A and B chains, an increase in the amount 
of material electrophoresing with a mobility corresponding to non-reduced 
ricin is increased, but a large proportion of material electrophoreses as 
subunit monomers. This apparently low efficiency of covalent reassociation 
may explain the reduced toxicity observed in Figure 3:10, but it should be 
realised that the data from track 7 in Figure 3:11 only shows material 
which has reassociated via-a reducible linkage and that other Interactions 
between the subunits may have been disrupted during sample preparation.
The clear evidence of the formation of homodimers in both A and B chain 
preparations may also account for some loss of activity, with such material 
being unavailable to form holotoxin.
The observation from this data is that purified ricin subunits can be 
reassociated to form active holotoxin. The biological activity of the 
reconstituted holotoxin was shown to be less, compared to non-reduced 
holotoxin, which probably reflects Inefficient covalent reassociation 
rather than denaturation of subunits. Therefore, ricin B chain, which is 
able to form heterodimers with ricin A  chain, has apparently retained both 
its binding and putative internalization activity.
3:2:4 Cell-free Assay: Analysis of purified subunits.
Subunit dilutions (1 x 10* 1 1  - l x  10*T M) were tested for their 
inhibitory effect on the translation of endogenous a and 0 globin mRNAs in 
a rabbit reticulocyte lysate system, as described in Section 2:10. Figure 
3:12 shows a representation of the results from such an assay in which the 
IC, 0 for purified ricin A chain is shown to be approximately 2.5 x 10 1 1  M
no
Figure a- 12 Cell-free aaaay : Inhibition of protein synthesis by 
purified rlcln subunits.
1X10"“  1X10 "10 1X10 “9 1X10-« 1X10"7 1X10 -*
Toxin Concentration (H)
Fleurs 3c 12 ahowa tha Inhibition of protoln aynthaola In a rabbit 
ratlculocyta lyaata call-fraa tranalatlon ayataa aftar lncubatlona 
with concan trot Iona of purlflad rlcln aubunlta. aa Judged by tha 
Incorporation of SB-S eothlonlna.
°--- a  rapraaanta tha affact of rlcln A chain concantratlona upon
protoln aynthaala In tha ayataa.
o— o  rapraaonta tha affoct of purlflad rlcln B chain 
concantratlona upon proto In aynthaala In tha ayataa.
Roaulta aro axpraoaod aa » Inhibition calculator froa no-toxin
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(0.8 ng/ml). This Indicates that ricin A chain, purified by the methods 
described earlier and used in the reassociation experiments, has retained 
virtually full activity compared with the published IC, 0 value for ricin A 
chain of 1 x 10’ 1 0 M (Stirpe and Barbieri, 1986) in similar cell-free 
translation systems.
In contrast, ricin B chain purified by chromatofocusing and tested in 
the same system has an IC6 0 of approximately 8 x 10 * M (0.27 /¿g/ml), as 
also shown in Figure 3:12. To determine whether the toxicity observed at 
the higher concentrations of B chain tested (10 • and 10 7 M) , was a result 
of contamination with ricin A chain, or the result of some other effect 
associated with ricin B chain by itself, similar dilutions of B chain (l.e. 
1 x 10* 1 1  M - 1 x 10 • M) were tested on ribosomes, obtained from the 
rabbit reticulocyte lysate. These dilutions were tested for their ability 
to produce a ricin A chain-specific modification of 28S ribosomal RNA 
(after Endo et al., 1987).
3:2:5 A minutt fil glfcfltfl—  aafllfilna tsiixlsx at pvrlfl94 rl&la B chain-
Dilutions of purified ricin B chain from 1 x 10* 1 1  M  - 1 x 10*• M were 
incubated with aliquots of rabbit reticulocyte lysate, the RNA from these 
extracted, and analysed for the characteristic ricin A chain catalysed 
modification of 28S ribosomal RNA, (see Section 2:11).
Figure 3:13 shows the formamide gel of treated RNA extracted from each 
rabbit reticulocyte lysate incubation. Tracks 1 and 2 show ricin A chain 
treated RNA incubated with and without aniline respectively, whilst tracks 
3 and 4 show the RNA extracted from ribosomes treated with buffer alone 
and then with and without aniline respectively. These four control lanes 
demonstrate that the characteristic 550 base RNA fragment indicated by the 
arrow in lane 1 is both ricin A  chain specific and is only apparent after A 
chain modified RNA has been Incubated with aniline. A more detailed
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Flflura 3; 13 RNA Modification assay : Analysis of ricin B chain 
dilutions for ricin A chain specific activity.
Foraaalda pal of IMA o m p Im  axtracted froa rabbit rotlculocyto 
lyaato Incubations.
Tracto 1 and 2 ahora ricln A chain traatod RNA lncubatsd with 
and without anilina roapactlvoly.
Tracks a and 4 ahora RNA oxtractod froa ratlculocyta lyaata 
traatad with buffor only and than Incuba tad with and without 
anilina roapactlvoly.
Tracto »-10 show RNA extractad froa rotlculocyto lysataa 
Incubated with purified ricln B chain dilutions of lxio-" M to 
1x10"** N. All MIA saaplsa In tracks B-10 racalvad aubsaquant 
anilina troataant.
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analysis of the specific N-glycosidase activity of rlcin A chain has been 
considered in the Introduction section of this thesis. Tracks 5-10 of 
Figure 3:13 shows the RNA extracted from reticulocyte lysates incubated 
with dilutions of purified rlcin B chain from 1 x  10 ' M  • 1 x 10 1 1  M 
respectively. All the RNA samples in tracks 5-10 have been subsequently 
treated with aniline, but only at the highest B chain concentration (i.e. 1  
x 10*• M) is the rlcln A chain specific RNA fragment apparent. This result 
indicates two important points; firstly that purified ricin B chain does 
have slight contamination with ricin A chain which can be detected only at 
a concentration of 1 x 10 6 M or higher, (but importantly, not at 
concentrations of 1  x 1 0 'T .M or lower), and secondly, that the toxicity 
observed with ricin B chain concentrations of 1 x 10’T M and 1 x 10** M in 
the cell-free assay analysis (shown in Figure 3.12) is unlikely to be 
caused by contaminating ricin A chain since no evidence of the specific A 
chain modification can be detected at these concentrations in the ribosome 
RNA modification assay (Figure 3:13, tracks 6 and 7). Therefore, it may be 
concluded from this data that the toxicity observed with purified ricin B 
chain preparations at concentrations of 1  x 1 0 "T M and below in both 
cytotoxicity and cell-free assay systems is unlikely to be the result of 
ricin A chain contamination, but rather a result of some other inhibitory 
effect of ricin B chain alone on these systems.
3:2:6 Qvmlf tl9n...gf ..tl.cln A chain ccntemlnatlcn in the rig in B chain 
preparation-
The specific RNA modifications observed at a B chain concentration of 
1 x 10** M (Figure 3:13, track 5) is assumed to indicate ricin A chain 
contamination. After a further 10 fold dilution (l.e. a B chain 
concentration of 1 x 10 7 M) , the modification of the ribosomal RNA was no 
longer detected. In order to quantify the extent of A chain contamination
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In the purified B chain preparation, dilutions of rlcln A chain were tested 
for their ability to modify ribosomal RNA, until the lowest concentration 
of A chain producing the characteristic RNA fragment had been determined.
It is important to stress here, that the experimental conditions and all 
reagents used in this analysis were the same as for the assay described in 
Section 3:2:5.
Figure 3:14 shows the RNA from rabbit reticulocyte lysate samples 
treated with ricin A  chain dilutions. Tracks 9 and 10 show a control of 
ricin A chain treated lysate, with and without aniline treatment 
respectively. The RNA fragment released by treatment of ribosomes with A 
chain and aniline (indicated by the arrow) is apparent in track 9. Tracks 
1-8 represent RNA extracted from ribosomes treated with 10 fold dilutions 
of ricin A chain from concentrations of 0.1 ng/pl (3 ng total protein) to 1 
x 10’ 6 pg//il (3 x 10 ' 4 pg total protein). The last dilution at which the A 
chain specific modification can be detected is at 1 pg//*l (track 3). This 
dilution is equal to 30 pg of A chain. Therefore, from this data, a 
concentration of 1 x 10** M ricin B chain representing 0.96 /¿g of total 
protein is contaminated with approximately 30 pg of A chain. This 
represents purified B chain with only a 0.003% contamination after a single 
step purification from whole ricin.
hi  B l a a m l e a *
3:3:1 Purification of rlcln.
The aim of the chromatographic procedures detailed in Sections 3:1:1 
to 3:2:6 was to establish a means of obtaining large quantities of highly 
purified, biologically active ricin subunits. The starting material for 
subunit purification, rlcln, was purified together with Rlclnus communis 
agglutinin (RCAj) from the other seed proteins by utilising the sugar
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binding activity of the two lectins, i.e. their affinity for p galactose 
residues exposed during the treatment of sepharose 4B beads with 1 M 
proprionic acid. The two lectins were eluted together from the sepharose 
column using 100 mM galactose in PBS, and then separated from each other by 
gel filtration on a Sephacryl S-200 column after the method of Nicholson 
and Blaustein (1972). The observation that ricin can be eluted from the 
sepharose column using 5 mM N-acetylgalactosamine (in PBS), without eluting 
RCA^ (Nicholson et al., 1974) provided a method by which ricin could be 
purified to homogeneity from seed material using a single chromatographic 
step. However, because ricin prepared by this method tended to vary with 
respect to contamination with RCA^, the standard method described above was 
generally employed. Olsnes and Pihl (1973b) report the use of ion-exchange 
chromatography for separation of the two lectins, but this technique has 
not been widely employed and it was not necessary to include this method in 
the purification of ricin described in this chapter.
Purified ricin and RCA^ were analysed by SDS-PAGE under reducing 
conditions as shown in Figure 3:3, and seen to electrophorese as two and 
three protein bands respectively under these conditions. The lower band of 
the reduced ricin sample is composed of the A x species of ricin A chain, 
which only contains one N-linked oligosaccharide side chain, and which has 
a molecular weight of 30,625 daltons. The upper band is composed of both 
ricin B chain and the A 2 species of ricin A chain, which both contain two 
N-linked oligosaccharides, and which has a molecular weight of 31,423 
daltons (Olsnes and Pihl, 1982). When RCA^ is electrophoresed on SDS-PACE 
under reducing conditions it forms a pattern of three bands which have been 
identified by Cawley et al. (1978) as RCAj B chain, and the two forms of 
RCA^ A chain. In order of increasing mobility, these bands have 
approximate molecular weights of 37 Kd, 33 Kd and 30 Kd respectively 
(Cawley et al.. 1978).
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Lord and Harley (1985) have reported that RCAj B chain contains a 
fucosylated oligosaccharide side chain, which Is not present on ricln B 
chain, and which accounts for the difference In molecular weight between 
the two. Roberts et al. (1985) report that the creation of a third 
possible N-glycosylatlon site In RCA^ has resulted from changes In amino 
acid residues of the B chain. Residue 79, which Is aspartic acid In rlcln 
B chain, Is asparagine In RCA^ B chain, and amino acid residue 81, which Is 
asparagine In rlcln B chain. Is changed to serine In the RCA^ B chain.
This results In the sequence Asn-Cys-Ser in RCA^ B chain which conforms to 
the required Asn-X-Ser/Thr amino acid sequence required as a signal for N- 
glycosylation, where X can be any amino acid except proline. Therefore 
analysis of fractions eluted from the Sephacryl S-200 column on SDS-PAGE 
under reducing conditions readily identifies RCA^-free ricln by the 
expected size differences of the glycoslated subunits (Figure 3:3).
h h l  Pvr I f  U n io n  ..g f .th g  l i t l n  a ih a a ija -
The preparation of purified ricin subunits may be considered in three 
stages, I. the reduction of the interchain disulphide bond, II. the 
physical separation of the subunits and III. the analysis of subunit 
purity.
3.; 3-i.2.;.l Reduction g f  th? lnm <?h»ln d lsv lp h ld ? frond-
Step I . Reduction of the Interchain disulphide bond was achieved by 
incubating whole ricin with 5% (v/v) 2-mercaptoethanol at 4°C for 48 hours 
in the presence of 100 mM galactose. The use of the apparently high 
concentration of reducing agent is in agreement with the analysis of Lappi 
et al. (1978) who compared a number of regimes for reducing the interchain 
disulphide bond of rlcln and concluded that 2-mercaptoethanol was required
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at relatively high concentrations for complete reduction. Despite 
incubating ricin under these conditions, some unreduced material was always 
detected during chromatofocusing. The presence of galactose during the 
reduction of the holotoxin helped to reduce the precipitation of the 
liberated B chain (Olsnes and Pihl, 1973), and therefore 100 mM lactose was 
included in all buffers prepared for the separation of the two subunits.
3 :3 :2; 2 gepagfttlgn  o f tfr? rifcln sybuniUS-
Step II. Separation of the reduced subunits was achieved mainly by 
the use of chromatofocusing, a technique which utilises the differences in 
the pis of the constituent proteins to achieve separation. By using a 
chromatofocusing system with a pH range of 7 to 4, the system was optimized 
for obtaining highly purified ricin B chain in a single step procedure. At 
the same time ricin A chain was obtained and judged pure by SDS-PAGE 
analysis (see Figure 3:7). The purity of this ricin A chain fraction could 
be further increased by removing any remaining B chain or unreduced 
holotoxin by affinity chromatography using an asialofetuin column. 
Production could be easily scaled up, e.g. 100 mgs of reduced ricin 
typically yielded approximately 20 mgs of highly purified B chain.
A consistent problem encountered when handling ricin B chain during 
any procedure was the lability of the polypeptide. This probably accounts 
for much of the material lost during chromatofocusing. To minimise such 
losses, B chain was maintained, whenever possible, in a reducing 
environment in the presence of lactose or galactose, at a protein 
concentration no higher than 1 mg/ml (see Section 2:2:5). Aliquots of B 
chain were filter sterilized and stored at 4°C. Subunit samples were never
frozen.
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3: 3:2:3 ; 1 Analysis of subunit purity bv SDS-PACE.
Step III. Analysis of the purity of the separated subunits began with 
SDS-PAGE analysis under reducing conditions. For ricin B chain, SDS-PAGE 
analysis was a straightforward examination of silver stained gels for the 
presence of any contaminating A chain present in samples from the 
chromatofocusing step, as described in Section 3:2:1 and shown in Figure 
3:6. The analysis of chromatofocused A chain however, required the samples 
to be pre-incubated with endo H as described in Section 2:5:3. The 
differential sensitivity of ricin B chain and ricin A chain 
oligosaccharides to endoglycosidases has been used as a means of 
differentiating between ricin B chain and the A 3 species of ricin A chain, 
which electrophorese with the same mobility on SDS-PAGE (see Section 
3:2:1). Analysis of the carbohydrate content of the isolated subunits and 
studies on the susceptibility of these oligosaccharides to cleavage with 
endo H, F, D or a mannosidase (Foxwell et al. , 1985) have indicated the 
existence of two high mannose oligosaccharides on the B chain. Treatment 
of ricin B chain with endo H under non-denaturing conditions resulted in 
the removal of a single oligosaccharide, the second being removed by endo H 
only after dénaturation of the protein (Butterworth and Lord, 1983; Foxwell 
et al. . 1985). This finding suggests that in one of the high mannose 
oligosaccharides the glycosidic bond of the N,N'-dlacetylchltobiose core 
structure adjacent to the asparagine residue and cleaved by endo H 
(Tarentino and Maley, 1974) is protected by the polypeptide structure, only 
becoming susceptible to cleavage when the polypeptide is denatured. In 
Figure 3:7 all ricin subunits treated with endo H were denatured with SDS. 
Track 2 shows the B chain control demonstrating the characteristic two 
stage deglycosylation of B chain after dénaturation and endo H treatment.
The A, species of ricin A chain contains a single carbohydrate side 
chain containing (ClcNac), (Xyl), (Fuc), (Man), 4 which is not susceptible
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to endo H cleavage (Foxvell et a l .. 1985). It also lacks the trlmannosldlc 
core and therefore does not bind to concanavalln A  (ConA) . The second 
oligosaccharide side-chain of the A 2 species (which accounts for Its 
reduced mobility on SDS-PAGE) does however bind to ConA (ConA(+)). If this 
ConA(+) material (predominantly A 2) Is separated from the non-blndlng 
ConA(-) material (predominantly A,) then It (A2 chain) is apparently 
susceptible to endo H cleavage, comigrating with the A t-chain. In 
unfractionated ricln A chain preparations however, both A, and A2-chains 
were unaffected by endo H, even in the presence of SDS (Foxwell et al. ■ 
1985). This is in agreement with the data shown in Figure 3:7 (tracks 3 
and 4). Foxwell et al. (1985), offer no explanation of this observation, 
but did note a slight decrease in the intensity of the A 2 band when 
unseparated A chain was endo H created. The resistance of the A, chain 
oligosaccharide to deglycosylation is due to the presence of an internal 
fucose residue which prevents the enzyme from gaining access to the 
glycosidlc bond between the innermost N-acetylglucosamlnes which is the 
bond cleaved by endo H. Analysis of the carbohydrate content of the A2 
chain indicates a slight increase in the amount of Xylose and fucose 
(compared to analysis of the A^ chain), but is not sufficient for these 
sugars to necessarily be included in the second oligosaccharide side chain 
(Foxwell et al. . 1985). The basis of endo H resistance of the second 
oligosaccharide side-chain of the A 2 species is therefore unclear, but is 
apparently dependent upon the presence of the A, chain.
3;3 ;2 ;3 ;2  E lgin  A chain In a g T W 9 K lcitx -« i» » T -
As, after the chromatofocuslng step, no contamination of the purified 
subunits could be detected by analysis of silver stained gels (see Figures 
3:6 and 3:7), further analysis of purity was carried out indirectly by 
examining the inhibition or protein synthesis in cytotoxicity assays.
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Analysis of purified A chain by this method (Figure 3:8) demonstrates an 
almost ten fold increase in the ICS0 (and therefore an increase in purity) 
of chromatofocused A chain after subsequent treatment using an asialofetuin 
column. As asialofetuin strongly binds both B chain and holotoxin this 
enhanced purification is presumably the result of removal of this type of 
contaminating material. From this data, the ICS0 of post-aslalofetuin 
treated A chain is calculated at approximately 5 x 10’“ M  (1.5 /ig/ml) which 
is almost 20 fold more toxic than the 4 step procedure described by Fulton 
et al. (1986) for the purification of ricin A chain.
Briefly, this method involves binding whole ricin to a sepharose 4B 
column, eluting any unbound material, and then reducing the bound ricin on 
the column with a buffer containing 2 -mercaptoethanol. After incubating 
with the reducing agent for 3 hours at 4°C, liberated A chain was eluted 
leaving most of the B chain still attached to the column. The collected A 
chain was separated into its A t and A a -chains by CM cellulose ion-exchange 
chromatography and then applied to an asialofetuin column. The final step 
was the removal of any residual B chain by passing the A chain preparation 
through an anti-ricin B chain monoclonal antibody column. The most 
effective step in this procedure was the asialofetuin column stage which 
Increased the IC60 from 0.61 /jg/ml to 16.7 /ig/ml - a 27 fold increase.
Such an increase was not observed after chromatofocused A chain (ICt0 - 
0.21 /ig/ml) had been passed down an asialofetuin column (ICt0 - 1.5 /ig/ml) . 
Anti-ricin B chain monoclonal antibodies (kindly supplied by E. Vitetta) 
were at one time used here to produce antibody affinity columns. However, 
the use of such columns did not significantly Improve the purity of the 
post-asialofetuln A chain and therefore this stage was not subsequently 
Included in the purification protocol. These findings are in contrast to 
those of Fulton et al. (1986) who achieved a 1.7 fold increase in IC,0 
after an identical step. The high efficiency of purification demonstrated 
by Fulton et al. (1986) could not be reproduced despite following their
methodology exactly. In particular, only a 7 fold Increase In the IC# 0 was 
achieved when chromatofocused rlcln A chain (IC60 - 0.21 /jg/ml) was treated 
with aslalofetuln, compared with the 27 fold Increase In the IC 5 0 of post- 
CM cellulose rlcln A chain (0.61 pg/ml) observed by Fulton et al. (1986) 
after an Identical step.
3; 3;2;3:3 Analyst? of rlcln A chstn In 9 M l k i a i i i u i -
The biological activity of rlcln A chain, with respect to Its ability 
to Inhibit protein synthesis, was fully retained in both purification 
regimes as Judged by cell free assay (see Section 2:10). Figure 3:12 shows 
the inhibition of protein synthesis caused by rlcln A chain, (purified by 
the methods described in the results section) in a rabbit reticulocyte 
cell-free system. The IC5 0 of 2.5 x 10 ’ 1 1  M  (0.8 ng/ml) is in close 
agreement with published data (Stirpe and Barbierl, 1986).
3; 3; 2; 3 - 4 Analysis of„xlcln B chain in a cytotoxicity »»y.
The purity of the chromatofocused ricin B chain was also analysed In 
cytotoxicity assays producing an IC, 0 value of 3.0 x 10*T M  (9.6 pg/ml).
This value is, however, 1.5 fold lower (i.e. 1.5 times more toxic) than 
that of B chain purified by the method of Fulton et al.. (1986). In their 
method, B chain was obtained by eluting it from the sepharose column after 
the reduction step and then employing two DEAE ion-exchange steps followed 
by a CM-cellulose ion exchange chromatography. Finally, an anti-rlcln A 
chain antibody affinity chromatography step was used. B chain purified by 
this method had an IC, 0 of 14.4 /ig/ml in cytotoxicity assays, which 
compares reasonably closely with the IC# 0 value of 9.6 pg/ml obtained with 
chromatofocused B chain.
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3:3;2:3;5 Analysis of ricin B chain in a cell-free assay.
A much larger discrepancy was noted between the IC60 value for 
chromatofocused B chain (0.27 /ig/ml) and that for B chain purified by 
Fulton et al. , 1986 (> 1 mg/ml) obtained from rabbit reticulocyte cell*free 
assay systems. This initially suggests that the chromatofocused B chain 
has considerable A chain contamination, but subsequent analysis of RNA 
extracted from rabbit reticulocyte lysate ribosomes treated with a range of 
chromatofocused B chain, concentrations indicated the presence of A chain 
only at concentrations above 1 x 10*T M (3.2 pg/ml) , (Figure 3:13, track 
5) . This result therefore -suggests that the toxicity observed with 
chromatofocused B chain concentrations 1 x 10** M  and 1 x 10*T M (Figure 
3:12) is not the result of contaminating ricin A chain, as no concomitant 
modification of the extracted RNA was detected at these concentrations 
(Figure 3:13, tracks 6 and 7). This data is in contrast with Fulton et al. 
(1986) who did not detect any significant inhibition of protein synthesis 
in their cell-free assays up to B chain concentrations of 1 x 10* 5 M. As 
an extension to these studies the extent of A chain contamination in the 
chromatofocused B chain preparation was determined as described in Section 
3:2:6. Thus after a single-step purification procedure from whole ricin, 
purified B chain containing only 0.003% ricin A chain contamination was 
obtained.
? ;3 ;2 ;3;$ <?»iacto»9-frlnjlng a c t iv ity  <?f p e r ille d  r l c l n  8 chain-
To establish that binding activity had not been reduced during the 
purification procedure, aliquots of purified B chain were applied to 
sepharose columns, and then eluted with 100 mM lactose. Ricin B chain 
which eluted at a pH - 4.8 from the chromatofocusing column bound with high 
efficiency to the sepharose which suggested this material represented non-
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denatured material. On occasions it was observed that some material 
remained bound to the chromatofocusing column after the pH had reached 4.0. 
This material was eluted with 1 M NaCl and was shown to be composed of 
ricin B chain by SDS-PAGE analysis. This material, thought to represent 
denatured B chain, was discarded.
3 ■ 3:2:3:7 Activity <?£ 19*??9<?l4ted
B chain purified by chromatofocusing was also tested directly in 
cytotoxicity assays after reassociation with purified ricin A chain as 
described in Section 2:9:2. Under these conditions a concentration of 
ricin B chain of 1 x 10~# M, which was non-toxic to cells (see Figure 3:9), 
was able to produce a significant cytotoxic effect when mixed with 
concentrations of ricin A chain which by themselves were non-toxic to cells 
(see Figure 3:10). This data was taken to indicate fully functional B 
chain in terms of its cell binding and putative translocation activity.
The reduced cytotoxic activity observed with these reassociated subunits, 
compared to the holotoxin, probably reflects incomplete or Incorrect 
association of the two subunits which is shown by SDS-PAGE analysis in 
Figure 3:11. This finding is in agreement with those of McIntosh et al. 
(1988), who also favour chromatofocusing as a method for purifying ricin B 
chain. Houston (1982) has also demonstrated cytotoxicity between 
reassociated ricin subunits, but his claim that reassociated subunits have 
a cytotoxicity almost equivalent to ricin holotoxin probably reflects the 
stringency of his subunit purification procedure which was based on the 
method of Olsnes and Plhl (1973), and therefore based on ion-exchange 
chromatography. In agreement with the findings of Fulton et al. (1986) 
these earlier procedures for subunit purification were found to be 
inadequate as means of obtaining highly purified material.
125
3:3:3 Conclusion.
The purity of subunits achieved by the methods described in this 
chapter is similar to that achieved using the more recent method of Fulton 
et al. (1986). In cytotoxicity studies, used for indirect analysis of 
subunit purity, subunits purified by either method give similar results, 
the slight discrepancies probably reflecting the use of different cells 
lines or assay conditions. The largest discrepancy between the two 
methods, comes in the analysis of purified B chain in the rabbit 
reticulocyte cell-free translation system. In their assay system, Fulton 
et al. (1986), observe no toxicity at concentrations of rlcln B chain up to 
1 x 10 5 H, whilst the chromatofocused B chain here produces 45% and 85% 
inhibition of protein synthesis at 1  x 1 0 ’# and 1  x 1 0 "T M concentrations 
respectively. The possibility that this observed inhibition is the result 
of ricin A chain contamination is unlikely, since no concomitant 
modification of the ribosomal RNA could be detected at these B chain 
concentrations. The observation of inhibition in cell-free systems caused 
by some effect of ricin B chain is in contrast with the observations of 
Fulton et al. (1986). By a further application of the RNA modification it 
has been possible to make an accurate estimation of A chain contamination 
by assaying directly for a specific A chain modification, which for the 
first time allows a clear distinction to be made between ricin A chain 
specific inhibition of protein synthesis and inhibition resulting from some 
other undefined action.
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itil Introduction of thiol linkers Into gelonln using heteroblfunctlonal
A number of workers have reported an enhancement of cell killing when 
A chain containing immunotoxins are provided with purified ricin B chain 
(see Discussion 4:9). In an attempt to examine this phenomenon and to 
assess the universality of the role of the B chain, ricin B chain was 
covalently linked via a reducible disulphide bond to the Type I ribosome 
inactivating protein, gelonin. The disulphide linkage between the two 
polypeptides was formed between the sulphydryl group at residue 4 
(cysteine) of the B chain (Funatsu et al., 1979) and thiol groups 
introduced into the gelonin molecule by heterobifunctional reagents. The 
methodology and chemistry relating to the introduction of thiol groups 
using the commercially available linkers N-succinimidyl 3(2-pyridyldithio) 
proprionate (SPDP) and 2-iminothiolane (2-IT) has been detailed in Section 
.2 :1 2 .
Before committing large amounts of purified protein to such 
conjugations, preliminary experiments were carried out to determine (a) the 
appropriate reaction conditions for optimal derivatisation (Ideally one 
introduced thiol group per protein molecule) and (b) the effect of 
derivatisation on the ribosome inactivating activity of gelonin. Section 
4:1:1 and 4:1:2 give experimental details relating to the derivatisation of 
gelonin with SPDP and 2-IT respectively.
4; 1; 1 P * r l v t l m l 9 n  of gtlenln v s Ip k  ?PPP.
(i) Cfllsul&tlen a l  SPDP laauijcad-
0.4 mg of gelonin in 200 /il of borate buffer was reacted with a 2.5 fold 
Molar excess of SPDP.
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X - X - 1.08 x 10" 2 mgs of SPDP required
29,000 314.2
where 0.4 mg - amount of gelonln
2.5 - molar excess of SPDP required
29,000 - molecular weight of gelonln
314.2 - molecular weight of SPDP
x - amount of SPDP required
0.3 mg of SPDP was carefully weighed and dissolved In 139 /il of dry 
dimethyl formamlde so that 5 /«I of this solution contained 1.08 x 10*2 mgs 
of SPDP. The SPDP and gelonln solutions were reacted at room temperature 
for 1 hour and then derivatlsed protein separated from free SPDP using a 
PD10 column as described In Section 2:12:1.
The extent of derlvatlsatlon was determined as follows:-
A 500 pi sample of derivatlsed protein taken from the PD10 column was 
placed into a quartz cuvette and the optical density determined at 450 nm 
(base line), 343 nm (the release of S-pyridyl groups) and at 280 nm 
(protein absorbance). 25 ¿<1 of 100 mM DTT was added, and the optical 
density at the three wavelengths redetermined.
To calculate the release of S-pyridyl groups the difference in 0DS4J 
before and after the addition of DTT was calculated.
Change in 0D,4S - 0.216 - 0.059 - 0.157
where 0.059 - 0Dl4J before DTT 
0.216 - 0D,4, after DTT
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To convert the change In 0D,4, into moles of S-pyridyl divide the 
change in 0 DS4, by the molar extinction coefficient for S-pyridyl groups at 
343 nn and correct for the volume change when the DTT was added.
(ii) Calculation of S-pvrldvl released.
Therefore 0.157 x 525 - 2.04 x 10 * moles of S-pyridyl released (A)
8.08 x 1 0 » 500
where 0.157 — change in 0D24S (after DTT added).
8.08 x 1 0 » - extinction coefficient for S-pyridyl groups at 343 nm.
525 - volume (/il) of sample + DTT.
500 - volume (/il) of sample.
To calculate the number of moles of protein, the observed OD2 i 0  was 
corrected to account for the effect of derivatising linker.
Therefore the actual OD2 , 0 - Observed OD2 , 0 - OD2go of attached SPDP 
groups.
OD2so of attached SPDP groups - moles of S-pyridyl x molar extinction
where
coefficient S-pyrldyl groups at 280 nm 
- 2.04 x 10*» x 5.1 x 10» - 1.04 x 10*»
2.04 x 10*• - moles of S-pyridyl groups released (from calculation)
5.1 x 10* - molar extinction coefficient S-pyrldyl groups at 280 nm.
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Thus the corrected 0Daso for the protein is
0.362 - 0.104 - 0.258
where 0.362 - OD2 8 0 (before DTT)
0.104 - ODj8o of S-pyridyl groups
(111) Calculation of moles of protein.
To calculate the moles of protein
0.258 _ 1.3 x 10 ' 8 moles of gelonln (B)
0.68 x 29,000
where 0.258 - corrected 0D3 S 0
0 . 6 8  - extinction coefficient at 280 run (- lg/1 )
29,000 - molecular weight of gelonln
(iv) Calculation of molar ratio.
Thus the molar ratio of derivatlsing residues to gelonln molecules was 
calculated by:-
A/B moles of S-pyridyl released 
moles of protein
2.04 x 10 ' 8 
1.3 x 10 ' 8
1.56 residue/gelonln molecule
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The conclusion from this experiment was that a 2.5 M excess of SPDP 
was appropriate.
* : 1 : 2  p r i v a t i s a t i o n  •?( g s l o n t n  u ? lh g  2 - I T .
In this example 3.0 mgs of gelonin was derivatised with a 10 fold 
molar excess of 2-iminothiolane. The gelonin was in borate buffer pH 9.0.
( i )  C g lc v la t l< ? n  o f  2.-IT X M v ir e t i .
3 x 10 - x
29,000 137.6
where 3.0 - amount of gelonin
10.0 - molar excess of 2-IT
29,000 — molecular weight of gelonin 
137.6 - molecular weight of 2-IT 
x — amount of 2-IT
x — 0.142 mgs of 2-IT to be added in a volume of 7.5 pi borate buffer. 
Therefore 10 mgs 2-IT was dissolved in 526.3 pi of borate buffer such 
that 7.5 pi contained 0.142 mgs of 2-IT. The gelonin and 2-IT were reacted 
together at room temperature for 1  hour then the reaction stopped by adding 
0.1 volume (31 pi) of 2.2 M glycine and reacting for a further hour.
To activate and protect the introduced thiol groups Ellman's reagent 
was added to a final concentration of 2 mM. In this example add 15 pi of a 
2 1  mg/ml solution (in dry dimethyl formamlde) was reacted for a further 
hour and the derivatised protein separated from free 2-IT by gel filtration 
using a PD10 column (see Figure 4:1).
Figure 4:1 Protein elution profile : Separation of derivatised «.Ionia
from unreacted 2 -iroinothlolane.
Figure 4:1 shows the protein elution profile for the separation of 
derivatised gelonin from unreacted 2 -iminothiolane by gel filtration using 
a PD10 G25F pre-packed column as described in Section 2:12:1.
The elution of the derivatised protein was monitored by measuring the 
absorbance of each fraction at 280 run.
Peak I represents the derivatised protein eluting as a tight peak from 
the column after the initial 2.5-3.0 ml void volume has passed throught the 
column.
Peak II represents the unreacted 2-iminothiolane derivatisation 
reagent which elutes as a wider peak.
132
Figure A: l Protein elution profile : Separation of derivatlsed 
gelonIn from unreacted 2-lBlnothlolane.
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As with the SPDP derivatised sample, the extent of derivatisation was 
determined spectroscopically.
A 500 pi sample was measured at ODaoo (base line), 412 nm (the release 
of 4 Ellman's reagent) and 280 nm (protein absorbance). Once a steady 
state was achieved 50 /il of 100 mM DTT was added and the optical densities 
at the three wavelengths redetermined.
Difference in 0D4ia - 0.230 - 0.016 - 0.214
where 0.016 — 0D4ia before addition of DTT 
0.230 - 0D4,a after addition of DTT
(ii) Calculation of 4 Ellman's released.
5 5 0  - 1.732 x 10" 8 moles (A)
500
0.124 x
1.359 x 10«
where
0.214 
1.359 x 104 
550 
500
change in OD at 412 nm
molar extinction coefficient for 4 Ellman's at 412 nm 
sample volume (/*1) after DTT addition 
sample volume (¿il)
(iii) Calculation of moles of eelonin.
0.336 1.703 x 10’ 8 moles (B)
0.68 x 29,000
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where 0.336 - OD 2 # 0 before addition of DTT
0 . 6 8  - extinction coefficient of gelonin at 280 nm (lg/1 )
29,000 — molecular weight of gelonin.
(iv) galfialatlfln pf aalâi rati?-
The ratio of derivatising residues to gelonin molecules was calculated 
by
A/B - 1.732 x 10’4/1.703 x 10 ' 6 - 1.01/1
Therefore a 10 fold molar excess of 2-IT was appropriate for an almost 
1 : 1  derivatisation of gelonin.
fill P$t9naln*ti<?n pf rlfrpipnp ln4Pttv*tlng activity 91 dcrivatiatd
Dilutions from 1 x 10* 1 1  M to 1 x 10"* M of free gelonin, gelonin 
derivatised using SPDP (gelonin-SPDP) and gelonin derivatised using 2-IT 
(gelonin 2-IT), were tested for their respective abilities to inhibit 
protein synthesis, as judged by the incorporation of radiolabelled amino 
acids, in a rabbit reticulocyte cell-free translation system (as described 
in Section 2:10).
The results, expressed as percentage inhibition of Incorporated counts 
(compared with a no-toxin control) are shown in Figure 4:2. The IC6 0 for 
non-derivatlsed gelonin was calculated at approximately 1  x 1 0  1 0 M, 
equivalent to a final concentration of approximately 2.9 ng/ml. 
Derivatisation of gelonin with 2-IT results in an increase in the ICS 0 to 
4.5 x 10'* M (130.5 ng/ml), i.e. a 45 fold reduction in biological 
activity. The activity of gelonin is reduced even further after
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Figure 4: 2 Cell-free assay : Inhibition of protein synthesis by 
gelonln. gelonln-SPDP and gelonln-2IT.
Toxin Concentration (M)
Figure « 8  show the inhibitory affect of gelonin. galonin-SPOP 
and gelonln-ZIT upon protein oyntheoio in e rabbit reticulocyte 
lyoote cell-free troneletion eyotae. oe judged by the incorporation 
of 3&-8 pothionine.
*— a  ropreeente the effect of native gelonln upon protein 
eyntheeio in the eyetee.
o— o ropreoente the effect of gelonin-aiT upon protein 
eyntheeio in the eyotoa
o— a roprooonto the effect of gelonin-aPDP upon protein 
eynthaeio in the oyeten.
All reeulte ore expreeeed oe > inhibition calculated froo no­
toxin control veluea end hove boon corrected for background counto.
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derivatisation with SPDP, which has an ICS 0 of 3.5 x 10** M (1.015 /ig/ml) . 
This represents a 350 fold reduction activity when compared to the activity 
of non-derivatised gelonin.
The observation of reduced inhibitory activity with gelonin-SPDP is in 
agreement with the findings of Lambert et al. (1985). They observed up to 
90% inactivation upon SPDP derivatisation. However these findings are in 
contrast to the findings of both Sivam et al. (1987) and McIntosh et al.
(1988) who have successfully derivatised gelonin with SPDP under standard 
conditions (l.e. as described in Section 2:12) with no significant 
reduction in activity. Also Lambert et al. (1985) experienced no reduction 
in gelonin activity after derivatisation with 2-IT, which is in contrast with 
the data described here. However, this may simply reflect differences in 
experimental conditions. These workers carried out the derivatisation 
reaction at 0°C under argon for 90 minutes, suggesting that these 
conditions may be required to maintain full protein synthesis inactivating 
activity of the gelonin.
From the results of the cell-free assay shown in Figure 4:2 it was 
concluded that 2 -iminothiolane should be the reagent of choice for the 
derivatisation of gelonin despite the reduction in activity associated with 
its use. This reduced activity has been accounted for in the analysis of 
results from later experiments.
hil RfiAi.g9gUtl9D-^zP9irlffl9nt; C<?mp»rl?<?n <?t rlcln P chslr./rlcln A ch*ln 
end.xlcln B sh»in/dcrlvtlt*d atlanln In « u m
The Inhibitory effect of derivatised gelonin upon protein synthesis in 
Vero cells, of a concentration range of 1 x 10* 1 1  - 1 x 10 • M is shown in 
Figure 4:3. Across this dilution range gelonin 2-IT exhibits no 
significant cytotoxicity, in contrast to the result observed when purified 
rlcln A chain was tested in an identical assay (Figure 3:8). Here
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Figure 4: 3 Cytotoxicity assay : Inhibition of protein synthesis by 
the type I RIP gelonln.
T o x in  C o n c e n t r a t i o n  (M)
Figure a: 3 «hows the effect of gelonln concentretlone upon 
protein synthesis In Vero cells, ee Judged by the incorporation of 
35-S Mthionino.
Across this concentration range, gelonln doss not exhibit any 
significant Inhibitory effect.
Results era expressed as X Inhibition calculated fro* no toxin
control values,
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Flour» 4: 4 Cytotoxicity w a y  : Inhibition of protein »vnthaals In 
Vero cells bv dilution» of oelonln 2IT Mixed with purified rlcln 
■  ch«ln UXlO-gM) .
Flour« «  4 «horn tha offset on protoin oynthoolo in Voro collo 
of tho addition of polonin 3ZT concentrations with IX10“Si purified 
rlcln ■ chain, so Judged by tho Incorporation of SB-d pothionino.
Acroao this ranpo of oalonin 8ZT concentrations no slpnlflcant 
cytotoxicity woo observed. At those concontrotlono both subunit 
cooponsnto are non-toxic to collo ahon too tod individually.
Moults ars oxpraoood as 8 inhibition calculatad froo no toxin 
controls.
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cytotoxicity was observed at ricin A chain concentrations of 1 x 10’T M and 
1 x 10'* M. At concentrations of 1 x 10’* M and below, ricin A  chain was 
completely non-toxic to cells.
Work by Houston (1982) and data presented in the previous chapter 
(Figure 3:10), have demonstrated that the presence of purified ricin B 
chain (at a non-toxic concentration) can produce a cytotoxic effect when 
reassociated with normally non-cytotoxic ricin A chain concentrations. In 
an attempt to reproduce this result, ricin A chain dilutions were replaced 
with dilutions of gelonin 2-IT from 1 x  10 1 1  M to 1 x 10 ‘ H and reacted 
with ricin B chain (at a final concentration of 1 x 10 • M) as described in 
Section 2:9:2. The cytotoxic effect of the reassociated B chain-gelonin 
dilutions is shown in Figure 4:4. No significant cytotoxic effect was 
detected over this range of gelonin concentrations which in contrast to the 
40% inhibition of protein synthesis observed at a concentration of 1 x 10** 
M A chain (see Figure 3:10). In conclusion therefore, despite increasing 
the gelonin concentration 100 fold over the highest ricin A chain 
concentration tested ( 1  x 1 0 ~* H) , no cytotoxic activity was observed.
This increase in the total gelonin concentration is, in reality, only a S3 
fold increase in terms of the concentration of biologically active gelonin, 
taking into account the loss of activity resulting from 2-IT 
derivatisation.
These results suggest that the cell killing activity of ricin A chain 
in the presence of ricin B chain is chain-specific, and that when ricin A 
chain is replaced with equivalent concentrations of the Type I RIP, gelonin 
there is no equivalent reconstitution of cytotoxicity.
AiA SPS-PACE 9t derlvtltcd gclenln/rlcln B chiln cpnWgato
As an extension to the ricin B chain/gelonln reassociation 
experiments, derivatised gelonin was reacted with freshly reduced purified
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ricln B chain at 4°C under nitrogen for 36-48 hours in order to manufacture 
and ultimately purify ricln B chain - gelonin conjugates in an active form 
for analysis in cytotoxicity assays.
Prior to reacting with gelonin-2-IT, highly purified ricin B chain was 
incubated at 4°C with a final concentration of 10 mM DTT for 45 minutes.
The freshly reduced polypeptide was then separated from the reducing agent 
by gel filtration using a PD10 column (as described in Section 2:12:1) and 
then added in a 1.5 molar excess to the derivatised gelonin and reacted as 
described above.
As a preliminary to any purification protocol, the reaction mix was 
analysed by SDS-PAGE, as shown in Figure 4:5. Under non-reducing 
conditions (track 2 ), a prominent band electrophoresing with a mobility 
equivalent to 60 Kd is apparent in the crude ricin B chain/gelonin reaction 
mix. This band is the expected size for a ricin B chain-gelonin conjugate. 
However, the situation is complicated by the possibility of both B chain 
and gelonin homodimers which, if formed, would electrophorese with almost 
the same mobility as the desired heterodimer. At a position approximately 
coinciding with the 31 Kd marker, a group of protein bands, probably 
representing unreacted B chain and gelonin monomers can be observed. 
Indicating that a significant proportion of the conjugate components do not 
form dimers of any sort.
In order to analyse the content of the 60 Kd protein band, without 
risking the loss of material in unproven purification procedures, the pre- 
purifled conjugate mix was electrophoresed under denaturing, non-reducing 
conditions and the band excised from the gel and electroaluted into 
electrophoresis buffer. Tracks 6 and 4 of Figure 4:5 show the excised 
protein electrophoresed under non-reducing and reducing conditions 
respectively. Tracks 3 and 5 show the mobility of reduced ricln B chain 
and reduced gelonin respectively. It can be seen that these proteins 
migrate with the same mobility as the upper and lower bands of the reduced
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Figure 4: 5 SDS-PAGE analysis of ricin B chaln-gelonln reaction 
■lxture
Sllvar-etalned aoe-PASE analysis of ricin B Choln-oolonln 
reaction alxturo.
froa tho oo 1 and roeovorad by alactroalutlon. Track S shows thla 
oxclaad band oloctrophoroaad under non-reduclna eondltlona. The 
sano band, electrophoreeed under re due ino condltlona la shown in 
track 4. Tracka s and B aha« rleln ■ chain and oalanln 
olactrophoroaad undor raduclno condltlono respectively.
Figttir* 4:6 western l»l9t analysis of. ths.slectrgslvted r U i n  g
chain-gelonln conjugate.
Figure 4:6, box I shows the SDS-PAGE analysis of ricin B chain-gelonin 
conjugate material and its components. Track 1 contains free derivatised 
gelonin electrophoresed under reducing conditions. Track 2 represents a 
sample of purified ricin B chain electrophoresed under reducing conditions. 
Track 3 represents the electroeluted ricin B chain-gelonin conjugate 
electrophoresed under reducing conditions and in track 4 the same conjugate 
sample electrophoresed under non-reducing conditions.
Box II shows the western blot analysis of this gel, probed with anti- 
gelonin antibodies. These antibodies react with the gelonin in track 1, 
the gelonin component of the reduced conjugate sample in track 3 and the 60 
Kd unreduced conjugate sample in track 4.
Arrows have been used to indicate the positions of the reactive bands.
Box III contains the SDS-PAGE analysis of the ricin B chain-gelonin 
conjugate and its components similar to that shown in box I. In this box, 
track 5 contains the unreduced conjugate sample, track 6 , the reduced 
conjugate sample, track 7 a sample of purified ricin B chain 
electrophoresed under reducing conditions, and track 8 a sample of 
derivatised gelonin electrophoresed under reducing conditions. Track 9 
contains molecular weight size markers.
Box IV contains the western blot analysis of the electrophoresed 
proteins of Box III and probed with anti-ricln B chain antibodies. These 
antibodies react strongly with the reduced B chain sample in track 7 and 
weakly with the B chain component of the reduced conjugate sample, (track 
6 ) and the non-reduced conjugate sample (track 5). Arrows have been used 
to indicate the position of these weakly reactive bands.
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Figure 4: 6 Western blot analysis of electroelutad ricin B chain 
géionin - conjugate. I.
2 3 A
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60 Kd protein (track 4). This indicates that the electroeluted 60 Kd 
protein consists of a molecule of gelonin and a molecule of ricin B chain. 
Also, although not an absolute indication, the components of the 60 Kd 
protein when electrophoresed under reducing conditions appear in 
approximately equimolar amounts.
As additional confirmation, samples of the 60 Kd protein were 
electrophoresed under reducing and non-reducing conditions, Western blotted 
and then separate samples probed with either antl-gelonin or anti-ricin B 
chain polyclonal antibodies. In the non-reduced form, both antibody types 
reacted with the 60 Kd unreduced protein (tracks 4 and 5, Figure 4:6). 
However, anti-gelonin antibodies only bound to the gelonin component of the 
reduced 60 Kd protein (track 3). Equally the antl-ricln B chain antibodies 
only bound to the B chain component of the reduced 60 Kd protein (track 6 ). 
Anti-ricin B chain antibodies did not cross react with a gelonin only 
control (track 8 ), and anti-gelonln antibodies demonstrated only a slight 
cross reactivity with ricin B chain (Crack 2).
It was concluded from this data that the 60 Kd protein observed in 
non-reduced, pre-purified gelonin-B chain conjugate reaction mixtures, was 
composed of ricin B chain and gelonin in a 1:1 ratio.
A i i  The vs9 at ¿ h E g H a fa fim ln E  In th s Bm lUfiA&lan 9 f . J i .c l o  Bsb g ln -gtlgn in  c<?n1
The standard recommended technique for the purification of 
immunotoxins from their unreacted components is gel filtration using a 
Sephacryl S-200 matrix (Thorpe and Ross, 1982; Cumber et a l . . 1985). 
However, because of problems unique to the construction and purification of 
the ricin B chain- gelonin conjugate, such as the formation of homodlmers 
(in particular B chain homodlmers) of the same molecular size as the 
desired product, gel filtration proved an unsuccessful method for obtaining 
purified B chain-gelonin.
As an alternative to gel filtration, the pre-purified conjugate 
reaction mixture was chromatofocused using a pH range 9-6. The basis of 
this technique was to exploit differences in the pi's of the components, 
ricin B chain (pi — 4.8) and gelonin (pi — 8.5). It was assumed therefore 
that a conjugate composed of a single B chain component and a single 
gelonin component would have a pi somewhere between 8.5 and 4.8. With the 
exception of using a pH range of 9-6, the conjugate sample was 
chromatofocused in a manner identical to the purification of the ricin 
subunits (see Section 2:2:3). Figure 4:7 shows the protein elution profile 
at 280 nm from the chromatofocusing column. Also shown is the development 
of the pH gradient down the column and the elution profile for the [1 3 SI] 
radiolabelled gelonin component. This trace of [1 3 *I] labelled gelonin was 
added to the main gelonin stock prior to derivatisation with 2-IT, for use 
both as a tracer in subsequent purification studies, and as a means of 
calculating the concentration of the conjugate formed, (for which there 
would be no extinction coefficients).
Figure 4:7 indicates that no protein emerged over the pH range 9-6, 
but eluted as three peaks from the final salt wash. Only the first peak 
contained any [ia*l] radioactive counts (and therefore gelonin). The other 
peaks were composed of unreacted ricin B chain as judged by SDS-PAGE (see 
Section 4:6). Two important observations may be made from this result. 
Firstly, no free gelonin (pi —  8.5) was detected, suggesting that all this 
material had reacted with the excess B chain added. Secondly, all the 
gelonin detected had eluted after the column had reached a pH of 6.0. This 
decrease in the apparent pi might be explained by the Influence of the 
ricin B chain component (pi —  4:8) of the conjugate, which, when conjugated 
to gelonin, results in a product with a pi less than 6.0. Apparently the 
pi of any conjugate species is not necessarily the average of the pis from 
the two components. Together these two observations indirectly suggest the 
formation of a B chaln-gelonin conjugate. Fractions 78 and 79,
Figvrg ? ?r<?t3in..tlvUgn profile ; Partial purification g£ ricin B
chaln-eelonln conjugate bv chrometofocusine.
Figure 4:7 shows the protein elution profile from the partial 
purification of ricin B chain-gelonin conjugate material using a 
chromatofocusing 9-6 pH range system.
Protein eluting from the column (solid line) was monitored by 
measuring the absorbance of the eluting material at 280 nm. Also indicated 
on the figure is the elution profile of ia8I cpm which indicates the 
position of the radiolabell ed gelonin component (evenly broken line). The 
unevenly broken line represents the formation of the pH gradient generated 
as the polybuffer 9-6 elution buffer enters the column matrix.
Note: All material remained bound to the column of pH 6.0 and eluted 
in the final salt wash. Peak I, which contains all the ia8I counts, 
represents the partially purified conjugate material, whilst peak II 
contains free, excess ricin B chain.
148
Figure 4:7 Protein elution profile : Partial purification of 
rlcln B chain - gelonln coniugate by chroaatofocusing.
!  M
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corresponding Co Che gelonln-concaining peak were dialysed inCo 50 mM 
sodium phosphace buffer pH 7.5 prior Co applicaClon onCo a blue sepharose 
column. All peak fracCions were analysed by SDS-PAGE (see Seccion 4:6).
4j_£ gpg-PAgE...analYst? pf chr<?im<?f<?<?used
Peak fracCions from Che chromacofocusing seep described in SecCion 4:5 
were analysed by SDS-PAGE under boCh reducing and non-reducing condiCions. 
Only fracCions 78 and 79 conCained gelonin (as judged by [126I] counCs).
The larger, second peak and smaller Chird peak appeared Co be composed of 
excess, unreacced ricin B chain which, wich a pi —  4.8, would have been 
expecCed Co eluce in Che sale wash.
Figure 4:8 shows a 15% SDS-PAGE gel of fraction 78 elecCrophoresed 
under reducing and non-reducing condiCions. Tracks 1-3 of Figure 4:8 
conCaln gelonin, fracCion 78 from Che chromacofocusing seep and ricin B 
chain elecCrophoresed under non-reducing condiCions raspecclvely. As 
considered earlier, Che analysis of such data is compllcaced by Che likely 
formation of homodimers which electrophorese wich the same mobility as the 
desired heterodimer. Figure 4:8, crack 1 of non-reduced gelonin-2-IT 
indicates Chat most of this material exists in a monomeric form (Mf 
approximately 30 Kd). However in this same track (track 1), material also 
exists with a mobility of 60 Kd which would correspond Co Che position of 
gelonin 2-IT homodimers. These putative homodimers are apparently in part, 
the result of a disulphide linkage as less 60 Kd band is apparent when 
gelonin 2-IT is electrophoresed under reducing conditions (crack 4).
Track 2, containing non-reduced fracCion 78, is composed of a sharp 
band at 60 Kd and a more diffuse band at around 30 Kd. This 30 Kd band 
electrophoreses with a mobility corresponding to that of ricin B chain 
(track 3 and 6), and is believed Co represent free B chain which has 
coeluCed wich Che gelonin-B chain conjugate fractions. Under reducing
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Figure A: B SDS-PA6E analysis of chrosatofocused rlcln B chain- 
gslonln conjugate Material.
Sllver-atained aoe-PASE analysis of partially pur if lad rlcln B 
ehaln-salonln conjugate fraction« froa chroaatofocuelng a tap.
Tradca 1-3 contain aaoploo of golonln. conjugate notarial, and 
rlcln B chain respectively. all alactrophoraaod under non-reducing 
conditions.
Tracks 4-6 contain tha oaaa eaaplea. In tha aana ardor, all 
alactropnoraoad under raducln« condition«.
Ni. The SQKd band apparent In tha non-reducing conjugate oaaple 
(track 2) dlsappaara upon reduction (track 8}. Tha looo of thla 
hand coincide« with tha appearance of a aaaller band with an 
oloctrophoratlc nobility coincident with that of reduced golonln 
S-XT (track 4).
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conditions, the non-reduced 60 Kd protein from fraction 78 disappears, 
whilst the Intensity of the 30 Kd band (corresponding to the position of 
rlcin B chain) Increases and a new band, coinciding with the mobility of 
free gelonln monomers, appears (track 5). The conclusion from this data is 
chat fraction 78 is composed of a ricin B chain-gelonln conjugate of 60 Kd 
which has some contamination with free monomeric rlcin B chain.
The possibility that the 60 Kd protein from fraction 78 is composed of 
gelonin and/or ricin B chain dimers may be discounted since no gelonin 
monomers can be detected when fraction 78 is electrophoresed under non­
reducing conditions (Figure 4:8, track 2). By comparison, when gelonln-2- 
IT is electrophoresed under identical conditions it comprises 
predominantly 30 Kd monomers with only a small proportion of dimers (Figure 
4:8, track 1). Therefore the only possible way that gelonln can form a 60 
Kd complex/without forming a homodlmer) is to form a conjugate with ricin B 
chain in a 1:1 ratio. Further evidence of this association comes from the 
observed increase in the Intensity of the ricin B chain monomer band when 
fraction 78 is electrophoresed under reducing conditions (Figure 4:8, track 
5).
fill Vs* 9f Plv* SMahtxaia. CL 6P »fflnlty <?hr9m§t9gr»phY pvrlfy rlcin P
chain-g«l9Dln
Aliquots of fractions 78 and 79 from the chromatofocusing step were 
applied to a column of blue sepharose CL 6B as described by Knowles & 
Thorpe (1986). Figure 4:9 shows the elution profile from this step, 
together with the corresponding [ia*I] cpm associated with the gelonln 
component. As expected, most [13*I] cpm became bound to the column and 
were eluted with 500 mM NaCl (fractions 50-53). A large proportion of 
materiel passed straight through the column. Both unbound and bound 
material was analysed by SDS-PACE (Figure 4:10). Unbound material from
I 5 i
Flgyrt »^:9 Protein elution profile : Partial purification of ricin B 
<?hajp-gci<?nin conjugate fry affinity chrsagmcaphY vsinR 
Biaa Scpharggc CL $B-
Figure 4:9 shows the protein elution profile from the partial 
purification of ricin B chain-gelonin by affinity chromatography using Blue 
Sepharose CL 6B.
Protein eluting from the column was monitored by measuring the 
absorbance at 280 run (broken line).
Peak 1 represents non-binding material which passed straight through 
the column and was shown to be predominantly excess ricin B chain (Figure 
4:10, track 4).
Peak II represents material binding to the blue sepharose, 
predominantly the partially purified ricin B chain-gelonin conjugate 
material. The elution of 1251 cpm represented by the solid line shows that 
the majority of radioactivity and therefore gelonin has bound to the column
matrix.
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Figure 4; 10 S0S-PA6E analysis of protein fractions frow Blue 
Sepharose CL 6B affinity chroaatography step.
1 2 3  4 5 6 7  8 9
Sllvor-etalned S09-PA0E analysis of partially purlflsd rlcln • 
chaln-gslonln conjugate fractions from blua aapharoaa CL M  
affinity chronatography stap.
Tracks 1-4 contain saaplss of pslonIn e-XT. conjugota fraction 
(bound aatarlal), rlcln B chain and notarial net binding to tha 
coluan raspectlvaly, all alactrophorsaad under non-reducing 
conditions.
Tracks S-S whom the sans saaplss. In tha saas order, eloctreph
Identical aabllltlos under bath reducing and non reducing 
conditions aa rlcln B chain.
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fraction 18, whan electrophoresed under non-reducing (Figure 4:10 track 4) 
or reducing (track 8 ) conditions, had a mobility which coincided with rlcln 
B chain under the same conditions. Material from fraction 51 which bound 
to the blue sepharose column was composed of enriched conjugate with some 
contaminating B chain (track 2). The same material when electrophoresed 
under reducing conditions appeared as two bands with positions 
corresponding to free B chain and free gelonln (track 6 ). Tracks 1 and 5 
of figure 4:10 show free gelonin-2-IT electrophoresed under non-reducing 
and reducing conditions respectively.
The use of the blue sepharose CL 4B affinity chromatography step aided 
the purification of conjugate by binding the gelonin component of the 
hybrid toxin. A large proportion of free B chain which contaminated the 
conjugate preparation after the chromatofocusing step passed straight 
through the column. Fractions 50 and 51, representing material which bound 
to the column, were dialysed into PBS containing 100 mM galactose at 4°C 
prior to analysis of their biological activities.
4i& Analxilt at the Maiatiai ittliitt a£ partially muJULad sanâagâiAtr i c in  P çh«lp-g?l9nln
At all stages during the purification procedures described in the 
previous sections, the protein samples were maintained at 4°C in buffers 
containing 100 mM lactose or galactose. This minimises the possibility of 
aggregation and biological inactivation. The biological activity of the 
partially purified conjugate was analysed in cell-free, RNA modification 
and cytotoxicity assays at the different stages of purification.
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4:8:1 T? dstonnliift. ths rlhosom* lnffctlv»tlns »ctlvity 9f
tht partially pvriflaA..S9n1wt9-
The concentration of the partially purified conjugate was determined 
by measuring the radioactivity associated with the gelonln component of 
each fraction, and then by comparing these values to the radioactivity 
produced by a gelonln standard of known concentration. Thus heterodimer 
concentrations were expressed as a function of their gelonln content. This 
made the assumption that all gelonln was In the form of a rlcln B chaln- 
gelonln complex, as Indicated by SDS-PAGE analysis.
Figure 4:11 shows the-results of a cell-free assay In which dilutions 
of gelonln-2-IT, fraction 79 from the chromatofocusIng step and fraction 51 
from the blue sepharose step were tested for their ability to Inhibit 
protein synthesis. All three of these samples had almo st Identical 
inhibitory activity, i.e. IC4 0 values around 2.7 x 10* 1 0 M ( 8  ng/ml). This 
result demonstrates that neither the association with ricin B chain, or the 
subsequent purification procedure has reduced the biological activity of 
the derivatised gelonin. A non-derivatised gelonln control with an IC, 0 
value of 0 . 8  ng/ml has been included, Indicating that the reduction in 
activity is a result of the initial derivatisatlon and not the result of 
storage or subsequent manipulations.
6;8;2 Rt*A aadlflfiatlgn-aiaixi. To dataralna • rlcln A chaln-typg
modification with a rlcln B chaln-gelonln conjugate.
The development of techniquea to Identify a RIP — specific 
modification of 28S rRNA from eukaryotic ribosomes has enabled the toxicity 
observed In the various assay systems to be associated with a specific 
ribosome modification event (Endo et al.. 1987).
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Figure 4:11 Call-free assay ; Inhibition of protein ayntheala by 
»— pies froa the different stages of purification of the rlcln B 
chain - gelonln conjugate.
Toxin Concentration (ng/«l)
Fleur* «  11 thorn tho inhibitory *ff*ct of eolonln. e*lonln-2IT 
ond purlflod rlcln B chain conjupata concontratlono upon protoIn 
aynthoala in a rabbit rotlculocyto lysato coll-froo tranolatlon 
■yataa, aa Judea* by tha Incorporation of 3B-S aathlanlna.
------  rapraaanta tha Inhibitory offact of native ealonln.
•-----rapraaanta tha Inhibitory affect of palonln-8TT.
------ rapraaanta tha Inhibitory affoct of rlcln B chaln-ealonln
conjueata natarlal (fraction 78) froa tho chroaatofocualne atop, 
aoa flour* 4:7.
----  rapraaanta tho Inhibitory affect of rlcln ■ chaln-palonln
eenjupat* aatarlal (fraction Bl) ahlch bound to tha blue aapharaaa
caluan. aaa flour* 4c 0.
Figura 4:12 HNA aodlflcatlon bossy ; Analyals of purlfled rlcln B 
chaln-gelonln coniugato fractlona for RNA aodlflcatlon actlvlty.
saaplee extracted free rabbit reticulocyte
Tracks 1 ani t M a  rieftn A chain treated ANA incubated with 
and withaut aniline respectively. Traete a and 4 shows felon in 
treated IMA inofteted with and without oniline raspactivsly. Tracks 
■ and • ahewo felon in 8-IT treated ANA with ond without aniline 
respectively, doaanotrotlnp the ANA aodification activity of the 
folonin has boon retained after dori vet lest ion.
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The method (described in Section 2:11) has been employed to 
demonstrate that concentrations of conjugates shown to be toxic in the 
cell*free assay (Section 4:8:1) can produce the diagnostic RNA modification 
associated with gelonin activity (Figure 4:12). Tracks 1 and 3 from Figure 
4:12 demonstrate the production of the diagnostic fragment (indicated by 
the arrow) when ribosomes are treated with ricin A chain and gelonin 
respectively followed by treatment with aniline. Without the subsequent 
aniline treatment, RNA from ribosome treated with either rlcln A chain 
(track 2) or gelonin (track 4) does not show the characteristic breakdown 
fragment. This result strongly indicates that ricin A chain and gelonin 
exhibit identical RNA modification activity, and that the cleavage of the 
fragment from the modified RNA is dependent upon subsequent incubation with 
aniline.
Gelonin after derivatisation with 2-IT also exhibits an Identical RNA 
modification activity (track 5) which is not apparent without aniline 
treatment (track 6 ). Conjugate material at a concentration equivalent to 
the 1CS 0 (determined in Section 4:8:1) from fraction 51 of the blue 
sepharose step (track 7), and from fraction 79 of the chromatofocusing step 
(track 8 ), also produced the diagnostic RNA fragment after aniline 
treatment of toxin exposed ribosomes. This data shows that the inhibition 
of protein synthesis observed with these fractions is concomitant with 
specific modification of 28S rRNA which in turn, is associated with RIP 
activity.
* ;8 ;3  A nalYfl» of  f l u  a l i s t a u  binding a c t i v i t y  at rifiln . B - « lo n ln
The binding activity of the various conjugate preparations were 
analysed in a modification of the standard aslalofetuln radioimmunoassay 
(Vltetta, 1986). Briefly, 96 well mlcrotltre plates were coated with 2
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Mg/well of asialofetuln and Chen blocked vlch a 1% "marvel" solution in PBS 
Co prevent non-specific binding. The wells were extensively washed with 
PBS and the conjugates or ricln B chain then applied to defined wells.
After 2 hours at 25°C the wells were washed with PBS and then probed with 
anti-ricin B chain antibodies which were detected with [ia*IJ radlolabelled 
protein A. The extent of binding was determined by comparing bound [,a#IJ 
cpm from a standard curve created using defined quantities of ricln B chain 
(Vitetta, 1986).
Since the major contaminant in the conjugate preparations was 
unreacted B chain, the lectin activity of the conjugate could not be 
analysed using anti-ricin B chain antibodies. Instead, bound samples were 
probed with anti-gelonln antibodies which were shown to have insignificant 
cross reactivity with rlcin B chain. Thus the binding assay was modified 
to probe specifically for conjugate (B chain-gelonln) as it was assumed 
that gelonin would only be able to remain bound to the wells if coupled 
with ricin B chain. Prior to binding, lactose was removed from the samples 
by dialysis. Each sample was assayed in triplicate and counted three times 
using a Mini Instruments type 6-20 7  counter to obtain a steady state 
reading. The results are shown in Table 4:1.
Rlcin B chain (control 1) probed with anti-gelonin antibodies and the 
protein A shows that these antibodies do not react with ricin B chain. 
Therefore any counts detected when these antibodies are used to probe any 
conjugate fraction must be the result of binding to the gelonin component. 
The use of anti-gelonin antibodies is therefore a valid means of detecting 
bound conjugate, as it has been assumed that the gelonin component can only 
bind to the asialofetuln coated wells when conjugated to rlcin B chain.
The second control comprises ricln B chain in which the sample has 
been probed with antl-B chain antibodies, but without the subsequent 
protein A step. This reveals the level of background counts detected. As 
the gelonin-2-IT itself was radiolabelled with ,a,I it was necessary to
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correct for these counts. This was achieved by omitting the antibody step 
(either a ricin B chain or a gelonin) and then determining bound counts. 
With all three fractions, when the antibody step was omitted a background 
count of about 8S0 cpm was detected.
When an anti-gelonin antibody step followed by [>9*I] protein A was 
included, significant counts above background were detected in all three 
samples tested, indicating that some gelonin (and therefore conjugate) was 
bound to the wells. When anti-ricin B chain antibodies were used as the 
probe, the counts detected in chromatofocused fractions 78 and 79 were 
approximately 1 0  fold higher than the counts obtained when using anti- 
gelonin antibodies. This reflects ricin B chain contamination apparent 
upon SDS - PAGE analysis of the chromatofocused conjugate (Figure 4:8).
After affinity chromatography using blue sepharose CL 6B the counts 
detected when material from fraction 51 is probed with anti-ricin B chain 
antibodies is significantly reduced compared to the chromatofocused 
fractions. This may indicate an increased conjugate purity after this step 
(not apparent by SDS-PAGE analysis. Figure 4:10).
Analysis of this data has to be confined to a qualitative analysis of 
conjugate binding. This is because it proved Impossible to produce a 
quantitative curve of galactose binding activity directly since no 
absolutely pure ricin B chain-gelonin conjugate was available. Points that 
can be made from this data are:-
1. In this assay system, anti-gelonin antibodies did not significantly 
cross-react with ricin B chain and are therefore a valid probe for 
detecting conjugate (i.e. gelonin S-S linked to B chain which in turn 
is bound to asialofetuin).
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Trtl« *;1 Analysis gf galactose. binding activity gf risin g gfrain-galgnln
conjugate.
SAMPLE a B Chain a Gelonin ia#I Prot. A cpra
Control 1 ricin B chaln j j 702
Control 2 ricin B chain J X 633
2 0 ng fraction 78 j 880
2 0 ng fraction 78 J j 2538
2 0 ng fraction 78 J j 24660
2 0 ng fraction 79 J 837
2 0 ng fraction 79 j j 1439
2 0 ng fraction 79 J j 21624
60 ng fraction SI j 845
60 ng fraction 51 j J 1326
60 ng fraction 51 J j 1237
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2. When any of the three samples were probed with antl-gelonin 
antibodies, counts were detected above background Indicating the 
presence of gelonin and therefore of bound conjugate.
3. When probed with antl-ricin B chain antibodies, fractions 78 and 79 
demonstrated significantly increased binding which reflects the extent 
of ricin B chain contamination, also observed upon SDS-PAGE analysis 
of these fractions (see Figure 4:8).
4. Fraction 51, when probed with anti-ricin B chain antibodies, did not 
demonstrate the increased binding activity observed in fractions 78 
and 79 which may reflect a purification enhancement after the blue 
sepharose step.
5. Because it was impossible to characterise a number of important 
parameters related to the binding assay, it was impossible to draw 
firm conclusions from this data. At best it suggests that at least 
some conjugate material is capable of binding to aslalofetuln and that 
any free B chain contaminating the conjugate preparations, has 
retained its galactose activity despite undergoing various 
manipulations during both purification procedures and assays of 
activity.
fr; 9; 4 Cytotoxicity g»*v; Aaalul* of the tctlvltv of pgrtltlly auJliad 
ricin P chgln-golonln conlwtt prcpirttlont-
Lactose-free dilutions of partially purified conjugate fractions were 
analysed for their ability to inhibit protein synthesis in standard 
cytotoxicity assays as described in Section 2:9:1. Protein concentrations 
ware determined from the 1 ***1 ) content of each sample and Indexed to an
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Flflure 4:13 Cytotoxicity aaeay. Inhibition of partially purified 
rlcln B chain - gelonln conjugate.
Toxin Concentration (H)
Flpur-o « 1 1  shoos tho inhibitory offset of the purified ricin •
Across this panes of conjugate dilutions no oisnificont 
inhibitory offset moo observed.
A Mholo ricin control heo boon included so o coop orison.
ilts hove
[>**IJ labelled gelonin standard as described in Section 4:8:1.
Figure 4:13 describes the results froa the analysis of fraction 51 
from the blue sepharose purified material. Even at the highest 
concentration, which contains 1 x 10*T M gelonin, no cytotoxic activity was 
observed. Indeed a slight but consistent stimulation of radlolabelled 
amino acid incorporation was observed, although no substantiated 
explanation can be offered for this observation. No inhibitory activity 
was demonstrated when fractions 78 and 79 from the chromatofocusing step 
were applied to cells (data not shown), but because of the extensive 
contamination with free ricln B chain any toxic activity would have been 
difficult to Interpret.
4:9 Discussion.
The series of experiments detailed in this chapter were designed to 
assess the feasibility of using rlcin B chain as a vehicle for the binding 
and internalization of heterologous molecules, in this case gelonin, into 
eukaryotic cells. The observation of an increased cytotoxic activity of 
rlcin A  chain containing immunotoxins in the presence of free ricin B chain 
(Youle and Neville, 1982; McIntosh et al. . 1983), or ricln B chain 
containing immunotoxins (Vitetta et al. . 1983), has led to speculation that 
ricin B chain has some other role, in addition to its cell-binding role, 
that can aid or promote the entry of ricln A chain into the cell cytoplasm. 
This role of the B chain remains undefined both at the cellular and 
molecular level. It may, for instance merely aid toxicity upon 
internalization by directing or stimulating endocytosis to the correct 
environment from which the A chain can "escape” into the cell cytoplasm.
Or, it may afford protection against proteases encountered en route. It is 
known for instance that whole ricln is much more resistant to proteases 
than individual subunits (Olsnes et al. . 1975). Another possible role of
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ricin B chain during internalization is some direct involvement in 
physically aiding the crucial membrane translocation step, which must occur 
to afford ricin A chain entry into the cell cytoplasm. It is not known 
whether the B chain gains access to the cytosol itself during this step, 
though the general feeling is that it does not.
Although work by Vitetta (1986) has suggested that the sugar binding 
activity of ricin B chain is operationally separated from its ability to 
enhance some Intracellular aspect of toxicity, there has been no formal 
characterisation of this. Thus, the observed enhancement of activity may 
not nessarily be a function unique to ricin B chain, but possibly the 
result of co-operation between the two subunits. This is a particularly 
attractive hypothesis, because ricin B chain does not appear to have an 
obvious membrane translocation domain of the type characterised in other 
toxins e.g. diphtheria toxin (Sandvig and Olsnes, 1981; Greenfield et al.. 
1987) and pseudomonas exotoxin A (Allured et al. . 1986).
The Type I RIP, gelonin, because of its similar molecular weight (29 
Kd) and its apparently identical mode of action to ricin A chain was 
considered a suitable molecule to study the putative translocation activity 
of ricin B chain. In addition, gelonin alone was shown to be virtually 
non-toxic to cells (Figure 4:3).
In order to achieve the formation of a disulphide bond between ricin B 
chain and gelonin it was necessary to introduce thiol groups into the 
gelonin component. Preliminary experiments established that a 10 molar 
excess of 2 -imlnothiolane over the protein concentration gave optimal 
derivatisation, l.e. one chemically Introduced thiol group per protein 
molecule. The introduction of, on average, one thiol group per gelonin 
molecule using 2 -imlnothiolane did, however, result in a ten-fold loss of 
activity when the derivatlsed gelonin was tested for its ability to inhibit 
protein synthesis in cell-free assay systems. A considerably greater 
reduction in gelonin activity was observed when the heterobifunctlonal
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linker SPDP was used to Introduce the reactive thiol group (see Section 
4:2). Therefore 2-IT became the choice of linker reagent in these 
experiments. The inactivation of gelonln observed after derivatlsation 
with SPDP is in agreement with the findings of Lambert et al. (1985), but 
in contrast with the work of McIntosh et al. (1988) and Sivam et al. (1987) 
who detected no reduction in gelonin activity after SPDP derlvatisatlon.
It is possible that 2-IT and SPDP each react preferentially with different 
amino groups on the gelonln molecule which may influence resulting 
toxicity. Also the positive charge on amino groups is preserved upon 
reduction after treatment with 2-IT, and this may also account for the 
difference in observed activity between gelonin-2-IT and gelonin-SPDP 
(Lambert et a l .. 1985).
Having successfully introduced reactive thiol group into the gelonin 
molecules and characterised the activity of the derlvatlsed protein in 
cell-free assays, these molecules were reacted with purified rlcin B chain 
as described in Section 2:9:2. As a control, ricin A chain dilutions, 
normally non-toxic to cells alone, were reacted with a non-toxic 
concentration of rlcin B chain and tested alongside the gelonin-2-IT/ricin 
B chain reaction mix in standard cytotoxicity assays (described in Section 
2:9:2). Figure 3:10 from the previous chapter demonstrate the cytotoxic 
activity when dilutions of ricin A chain (upto 1 x 10*' M) were reacted 
with 1 x 10*' M  ricin B chain. Individually, these concentrations of 
purified subunits are non-toxic in cytotoxicity assays, but when reacted 
together demonstrate a 40% inhibition compared to no toxin controls. No 
toxicity was observed when the gelonin-2-IT/ricin B chain reaction mixture 
was tested in an identical assay, despite increasing the concentration of 
active gelonln molecules by 55-fold (Figure 4:4). SDS-PAGE analysis of the 
reassociated rlcin A chaln/rlcin B chain (Figure 3:11) and the gelonln-2- 
IT/rlcln B chain mixtures (Figure 4:5) Indicates that only a small 
proportion of the reactive components form disulphide-linked proteins with
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electrophoretic mobilities corresponding to those expected for the 
reassociated or hybrid toxins. Despite this apparently poor reassociation 
between rlcin B chain and either ricin A chain or gelonin-2-IT, the native 
ricin subunits are able to combine to produce a significant cytotoxic 
effect, whilst a gelonin-2-IT - ricin B chain conjugate is non-toxic under 
identical conditions.
A consistent problem encountered during the analysis of hybrid toxin 
formation between ricin B chain and derivatised gelonin was the formation 
of homodimers. Samples of both free ricin A chain (Figure 3:11 tracks 2-4) 
and free ricin B chain (tracks 5 and 6 ) indicate the formation of 
homodimers in the absence of reducing agent. This observation of homodimer 
formation is in agreement with Cushley et al. . 1984, but in contrast with 
similar studies in which no homodlmer formation was reported (Olsnes et 
a l ., 1974), or where their possible formation has not been considered 
(Coldmacher et al.. 1987; Foxwell et al.. 1987; Ovadia et al.. 1988).
Since the electrophoretic mobilities of both gelonin-2-IT/ricin B chain 
heterodimers and homodimer species made them Indistinguishable by SDS-PAGE 
analysis, it was impossible to accurately estimate the percentage of hybrid 
toxin formed by simple visual means, as described by Olsnes et al. (1974) 
in their study of rlcin/abrin hybrid toxins, and Sundan et al. (1982) in 
their study of diphtheria/ricin hybrid toxins. Instead, gelonln-2-IT and 
ricin B chain were reacted together as described in Section 4:4 and then 
applied to a purification procedure with the aim of obtaining pure 
heterodimers free from both monomeric and dimeric forms of the constituent 
polypeptide components.
The first purification steps was to apply the conjugate reaction 
mixture to a chromatofocuslng column with a pH range 9-6. Over this pH 
range it was hypothesised that monomers and dimers of gelonin would elute 
according to their pi of about 8.5, whilst ricin B chain monomers and 
dimers would remain bound to the chromatofocuslng column until the final
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sale wash. Any genuine hybrid molecules composed of one ricln B chain and 
one gelonln-2-IT molecule should therefore elute with a net pi somewhere 
between the pis of the components. Gelonln has a pi — 8.5 and rlcln B 
chain has a pi - 4.8. The actual elution profile of the chromatofocused 
conjugate mixture Is shown in Figure 4:7 and described In Section 4:5. 
Briefly, this technique achieved a partial purification of the conjugate 
material, although it remained contaminated with free ricin B chain which 
had been added in excess to ensure all free thiol groups on the gelonin 
molecules were reacted. In retrospect it might have been advantageous from 
the point of view of purification, to have reacted an excess of gelonin-2 - 
IT with ricin B chain (as described by Goldmacher et al., 1987). In theory 
such a reaction mixture would not contain any free B chain, as it would all 
react with the excess gelonin 2 -IT. It would therefore have been easier to 
separate conjugate gelonin 2-IT - ricin B chain from free gelonin by using 
a sepharose 4B affinity chromatography column. However, this method would 
not separate any ricin B chain homodimers from the gelonin-B chain hybrid 
if they formed.
In an attempt to Improve the purity of the chromatofocused conjugate 
material, aliquots were applied to a blue sepharose CL 6B column, the aim 
being to bind any conjugate formed via its gelonin moiety and to wash any 
unbound material (i.e. free B chain) from the column. Material eluting 
from the column with a 500 mM NaCl buffer (see Figure 4:9) contained the 
[1 2 »I] labelled gelonin component conjugated to rlcln B chain (see Figure 
4:10 track 2) but still carried contaminating B chain. Because of the 
limiting amount of starting material for these purification procedures, and 
the losses encountered when material was applied to each respective column, 
it was only possible to attempt small scale purification. At each stage 
material was retained for analysis of biological activity, and throughout 
all procedures of coupling to ricin B chain, purification and storage, no 
reduction in the activity of the derivatlsed gelonin was detected, (see
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Section 4:8:1, Figure 4:11). This inhibitory activity observed in cell- 
free assay systems was found to be concomitant with a modification of the 
28S rRNA from eukaryotic ribosomes. This has been judged as specific to 
ricin A chain and other RIPs (see Section 4:8:2, Figure 4:12).
Analysis of the galactose-binding activity of the purified conjugate 
was carried out using a standard asialofetuin radioimmunoassay (Vitetta, 
1986), modified so as to probe the material bound to the asialofetuin- 
coated wells with anti-gelonin antibodies. Antl-gelonin antibodies which 
did not cross react with ricin B chain were used as a probe specific for 
the conjugate and demonstrated that some conjugate material had bound to 
the coated wells. This bound conjugate material could not however, be 
accurately quantified as the required binding curve control, specific for 
conjugate could not be produced (see Section 4:8:3 for a more detailed 
analysis of this data).
The final product obtained after the chromatographic procedures was an 
apparently enriched gelonin-ricin B chain conjugate linked via a disulphide 
linkage. Because this material was contaminated with unreacted ricin B 
chain a complete analysis of the galactose binding activity could not be 
achieved, but the protein synthesis inhibiting activity of the gelonin 
moiety was found to be no different from the activity of free derlvatised 
gelonin. This conjugate however, failed to exhibit any cytotoxic activity 
when tested on Vero cells (see Figure 4:13). It was therefore concluded 
that from both this analysis of partially purified gelonin-ricin B chain 
and the reassocletion experiments described in Section 4:3, that rlcin B 
chain does not mediate the entry of gelonin into cells so that it can act 
to inhibit protein synthesis.
The conclusion from the data described in this chapter, that ricin B 
chain does not mediate the internalisation and/or translocation of gelonin, 
are in agreement with the findings of McIntosh et al. (1988). In their 
experiments they found that pre-treatment of cells with elthar ricin B
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chain or abrin B chain, sensitized those cells to treatment with either 
free abrin or ricin A chains and to immunotoxins containing either abrin or 
ricln A chain. Furthermore, they observed the greatest potentiation with 
either B chain species when the interacting species contained the 
homologous A chain. In particular the weakest potentiation was observed 
with ricin B chain and either abrin A or abrin A chain containing 
immunotoxins. They were however, unable to sensitize cells with any B 
chain pre-treatment to either free gelonin or gelonln-containing 
immunotoxins.
Further evidence of the limited ability of ricin B chain to 
reassoclate with heterologous A chains comes from the observations of 
Olsnes et al. (1974) who noted that only between 10 and 30% of abrin 
A/ricin B subunits reacted together to form a hybrid toxin, in contrast to 
the reaction between abrin B/ricin A which was almost complete after 24 
hours. Further to this, Sundan et al. (1982) were able to produce a toxic 
hybrid molecule from diphtheria fragment B and ricin A  chain, but a hybrid 
protein between ricin B chain and diphtheria fragment A was shown to be 
non-toxic despite being able to bind to cells. Thus, a body of evidence 
exists in the literature which suggests that ricin B chain is unable to 
potentiate the entry of all but what are speculated to be the most closely 
related heterologous A chains (e.g. abrin A chain). The best results in 
terms of cytotoxicity are with reassociated ricin A chain, although this to 
is reduced as compared to whole ricin. In contrast Foxwell et al. (1987), 
claim to have reassociated 70% intact toxin from deglycosylated ricin A and 
B chains, as judged by SDS-PAGE analysis. They have not however, in their 
analysis, made any attempt toe account for the formation of ricin B chain 
homodimers which would be indistinguishable from reassociated ricin A and B 
chains upon SDS-PAGE under non-reducing conditions.
The poor interaction between ricin B chain and heterologous A  chains, 
including in this case the Type I RIP gelonln, makes the purification of
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such hybrid toxins difficult as only a snail amount of product can be 
obtained from an already U n ited amount of starting material. To avoid the 
problems associated with purifying such small amounts of material Olsnes et 
al. (1974) and Sundan et al. (1982) estimated the extent of reassoclatlon 
from SDS-PAGE analysis and corrected their results accordingly. In these 
earlier reassoclatlon experiments however. It Is unlikely that the 
constituent toxin subunits were purified to the high stringency now 
possible using more recent technology. Therefore It Is possible that the 
complete toxicity observed In the Olsnes et al. (1974) abrin/rlcin 
reassociation experiments reflects the incomplete purification of the 
constituent subunits. In contrast McIntosh et al. (1988), who describe a 
more stringent subunit purification methodology, found a reduced 
cytotoxicity from reassociated abrin/ricin subunits compared to the 
respective holotoxins.
It is apparent from the experiments described In this chapter, and 
from the work of others described earlier, that the reassociation of rlcin 
B chain either to ricin A chain, or some other RIP requires more than Just 
the simple formation of a disulphide bond between polypeptides. With 
respect to the association of the rlcin subunits, a body of evidence in the 
literature suggests that the two rlcln subunits are held together by non­
polar forces (Lewis and Youle, 1986; Houston, 1980). Further to this,
Lewis and Youle (1986) have suggested that the disulphide linkage between 
the two subunits is not critical for toxicity, and only functions to 
maintain protein-protein interactions at low ricin concentrations. These 
findings are in contrast with those of Lapp! et al. (1978) and Wright and 
Robertus (1987) whose results implicate the interchain disulphide bond in 
the transport of the A chain into the cytoplasm. Analysis of the three- 
dimensional structure of ricin has indicated a close interaction between a 
carboxyl-terminal region of the A  chain and the amino terminal region of 
the B chain (Montfort et al. . 1987). The interaction between the two rlcln
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subunits will be considered in more detail in the following chapter, but 
such observations fuel speculation as to a more complex interaction between 
the two subunits than just the formation of a disulphide bond. Indeed a 
more complex subunit interaction, and the possibility of conformation 
changes in the subunits associated with reduction of the disulphide bond 
(Montfort et al., 1987) may go some way to explaining (a) the poor 
reassociation of rlcin B chain with heterologous A chains and related RIPs 
and (b) the reduced cytotoxic activity of reassociated ricin subunits.
In contrast to these previous observations and the overall conclusion 
from the data presented in this chapter, Goldmacher et al. (1987) has 
described the preparation df a ricin B chain-gelonln conjugate with 
cytotoxic activity against the human B-cell line, Namalwa. In their 
experiments this conjugate together with ricin, diphtheria toxin, and a 
series of ricin A chain, or gelonin based immunotoxins (reactive towards 
Namalwa cells) were tested for their cytotoxicity against wild type, or 
toxin resistant Namalwa cell lines. A  direct comparison of the cytotoxic 
activities of the various conjugates upon each cell line is not possible as 
the assaying technique varied for the constructs tested. However, a direct 
comparison can be made between the cytotoxic activity of the ricin B chaln- 
gelonin conjugate and ricin, upon wild type Namalwa cells. These 
experiments show the IDS0 for the ricin B chain-gelonin conjugate to be 
1000-fold higher than that for whole ricin i.e. the conjugate is 1000-fold 
less toxic than ricin. Further to this Goldmacher and co-workers do not 
disclose the source, or purification procedure for obtaining ricin B chain 
used in these experiments, nor do they describe any analysis of the 
toxicity of this component alone to the target cells. Without this 
essential control therefore, it is impossible to associate the toxicity 
observed with this conjugate to a genuine ricin B chain-mediated entry of 
entry of gelonin into Namalwa cells.
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In a similar study by Ovadia et a l . (1988), barley RIP was crosslinked 
to ricin B chain, purified by gel filtration and affinity chromatography 
and then assayed for cytotoxic activity against a K562 cell line derived 
from a patient with chronic myelogenous leukemia. In these assays the ID#0 
for the conjugate was calculated between 0.15*0.25 /ig/ml (2.3 nM-3.9 nM) 
which is some 2000 fold less toxic than the published ID60 for whole ricin 
on HeLa cells (Stirpe and Barbleri, 1986). No data for the cytotoxic 
activity of whole ricin against K562 cells has been presented. Despite 
this reduced cytotoxicity compared to whole ricin, this barley RlP-rlcln B 
chain conjugate does apparently exhibit some ricin B chain mediated 
activity, which can be blocked by the addition of 50 mM lactose.
In all these hybrid toxin studies, the absolute test of genuine RIP- 
mediated inhibition of protein synthesis would involve the analysis of 
ribosomal RNA extracted from intoxicated cells. Because no cytotoxic ricin 
B chain-gelonln conjugate was produced by the procedures described earlier, 
this method could not be employed appropriately. It would however, enable 
a distinction to be made between any possible non-specific cytotoxicity and 
that caused by the successful translocation of a ribosome inactivating 
protein into the cell cytoplasm and ultimately to its target, the 
ribosomes.
As more Information has become available regarding the biochemistry 
and mode of action of these ribosome inactivating proteins it now seems 
likely that these proteins, which are widespread throughout the Plant 
Kingdom, have originated from some common ancestor. A more detailed 
consideration of the evolution of plant toxins has been made in the 
introduction to this thesis and therefore only an outline of these 
perspectives, as they relate to the material in this chapter, are discussed 
below.
The B chains of Type II RIPs may have originated from a common 
ancestor (Ready et al. , 1984) as has been proposed for the A chains of Type
I and Type II RIPs (see introduction). The body of evidence supporting 
this makes the cytotoxicity observed with some hybrid toxins less 
surprising. However, to fully understand the interrelationships of the 
various hybrid toxins it would be necessary to perform detailed sequence 
and structure comparisons. Unfortunately because only the sequence and 
structure of ricin B chain has been analysed in any detail no comparison 
between the B chains of Type II heterodimeric plant toxins has been made.
Studies on the structure of ricin have shown 1c to be composed of two 
sugar-binding domains (Villafranca and Robertus, 1981) which exhibit 
considerable homology, each binding a galactose residue in a non- 
cooperative fashion (Zentz et al. . 1978; Houston and Dooley, 1982).
Although two putative galactose binding sites have been identified from the 
X-ray structure (Montfort et al. . 1987), no other functional domains have 
been correlated with the three dimensional structure of B chain. Supposing 
that the B chain does have a role in membrane translocation, then a 
translocating domain (usually a region of significant hydrophobiclty) 
should be apparent in the amino acid sequence. However, detailed sequence 
and structural analysis of ricin B chain have not identified, or even 
implicated, a domain likely to become embedded within a lipid bllayer 
during the membrane translocation of ricin A chain. For this reason it is 
perhaps important not to consider the membrane translocation of ricin A 
chain as a function solely confined to ricin B chain, but possibly the 
result of some synergistic interaction between the two subunits.
Additionally, some workers now feel that the potentiation of toxicity 
observed during the Intracellular phase of intoxication in the presence of 
ricin B chain is the result of a specific interaction between the two 
subunits rather than some generalised non-specific effect of the B chain 
upon the cellular membranes. McIntosh et al. (1988) have described 
experiments which indirectly support such a theory. They argue that 
because abrin and ricin B chain enhance the cytotoxicity of their own, or
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each others A chains when reassociated, but do not enhance the cytotoxicity 
of gelonin under the same conditions, this potentiation is the result of 
specific interactions between closely related subunits (Funatsu et al., 
1988) and not some generalised effect on the membranes caused by the B 
chain. Work carried out by Houston (1982) and McIntosh et al. (1988) 
suggests that this interaction occurs prior to endocytosis.
Perhaps the strongest evidence suggesting that the cytoplasmic entry 
of ricin A  chain is not a function confined to ricin B chain comes from the 
observation that various ricin A chain (or Type I RIP) conjugates with cell 
surface specific antibodies or other ligands are capable of considerable 
cytotoxic activity, against appropriate target cells. Oeltmann and Heath 
(1979) have prepared a specifically cytotoxic hybrid molecule from purified 
ricin A chain and the subunit of human chorionic gonadotrophin and in 
more recent studies, Cawley et al. (1980) produced an epidermal growth 
factor-ricin A chain conjugate with specific cytotoxic activity towards its 
target cells. Although many other examples of ricin A chain immunotoxlns 
with specific and potent cytotoxic activity may be quoted the possibility 
of contaminating ricin B chain enhancing their activity could never be 
ruled out. However potent, specific cytotoxins constructed from 
recombinant ricin A chain and antibodies raised against murine transferrin 
receptor had similar activities to immunotoxins constructed from 
biochemically purified ricin A chain (Fitzgerald et al. , 1987).
Furthermore, immunotoxins prepared using gelonin (a Type I RIP) have also 
demonstrated considerable cytotoxic activity (Lambert et al. . 1985; Thorpe 
et al. . 1981). This raises two questions. Firstly do the A chains (or 
Type I RIPs) used in these conjugates possess some - Inherent ability by 
which they promote their own translocation into the cell cytoplasm upon 
endocytosis? And secondly, can they in any way Influence the route to 
their Intracellular destination, or is this directed by the ligand to which 
the A chains are bound? The diversity of ligands might suggest that the A
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chains can promote their own translocation, and at least In these examples 
cited are not adversely Influenced by the ligand to which they are 
conjugated. However, no direct evidence for such a mechanism exists.
A review of the current literature discussed here strongly suggests 
that the presence of ricin B chain somehow promotes the entry of rlcln A 
chain into the cell cytoplasm (McIntosh et al. , 1988; Youle and Neville, 
1982; Houston, 1982). Whilst some authors, e.g. Vitetta (1986), have 
suggested that rlcln B chain possesses some translocation activity distinct 
from its galactose binding activity, no direct evidence for such a function 
has been forthcoming. Indeed more recent studies of the structure of ricin 
B chain (Montfort et al. , 1987) have failed to identify or even imply any 
putative translocation domain on the B chain. Indirectly in agreement with 
these findings, the results presented in this chapter suggest chat the 
potentiation of ricin A chain when reacted with ricin B chain Is a specific 
interaction, and does not extend to the potentiation of the Type I RIP 
gelonln. The agreement in favour of a specific interaction between rlcln 
subunits has been further strengthened by the observations of poor or non­
existent associations with either abrin A chain (Oslnes et a l ., 1984) or 
diphtheria fragment A (Sundan et al., 1982) respectively. In contrast to 
the results described in this chapter, Goldmacher et al. (1987) and Ovadla 
et al. (1985) both describe hybrid toxins constructed from purified ricin B 
chain and Type I RIPs which exhibit cytotoxicity. In both cases the 
activity of the hybrid toxins is more than 1000 fold less than that for 
whole ricin which would give these hybrid toxins IC,0 values comparable to 
the same RIP coupled to a cell specific antibody. Furthermore the 
observations of McIntosh et al. (1988) that neither abrin or ricin B chain 
could potentiate the activity of either free gelonln or more significantly 
gelonln immunotoxins strongly suggests that the nature of the subunits is 
vital in the reconstitution of potent cytotoxins. This possibility is 
considered in much greater detail in the following chapter.
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chain cDNA bv oligonucleotide site-directed mutagenesis.
The introduction of a translation stop codon at nucleotides +712-714 
of the published rlcln cDNA sequence (Lamb et al., 1985) was achieved by 
the application of oligonucleotide site-directed mutagenesis as described 
in Section 2:23. The aim of this mutagenesis procedure was to ultimately 
produce a truncated form of ricin A chain devoid of the final 30 amino 
acids. This C-terminal region forms a significantly hydrophobic domain 
(see Figure 5:1) which is believed to interact with regions of rlcln B 
chain and may therefore be important in ricin subunit interactions 
(Montfort et al.. 1987). Furthermore this C-termlnal hydrophobic domain 
has been shown to have an affinity for lipids, which may indicate some 
membrane penetration function associated with this region (Uchlda et a l . , 
1980). By successfully deleting this C-termlnal region it was hoped to 
establish its importance, if any, during the translocation of ricin A chain 
into the cell cytoplasm.
i l l  c p I opy h Y V n i lm io n  using t l w ..« w « n l s  <?Ug9nv><;lgp*l<»g as » prpb$.
Details of the mutagenesis of the ricin A chain-encoding sequence, 
prior to the colony screening step, have been considered in Sections 
2:23:1-2:23:5. After the transformation of competent E. colt 71.18 nut L 
cells with the oligonucleotide primed extension reaction, plaques 
(representing areas of retarded bacterial growth due to M13 'phage 
infection) were picked onto duplicate L-agar plates in a predetermined grid 
formation as described in Section 2:23:6. After incubation, one of the 
duplicate plates was stored at 4°C, whilst the other was used for the 
colony hybridization. The colonies were transferred onto nitrocellulose, 
lysed, neutralized, fixed and baked and then probed with the mutagenic
ill Introduction of a premature translation termination codon Into rlcln A
Figure 5:1 Hvdrophoblcltv plot of che C -terminus of rlcln A chain.
Figure 5:1 shows a dlagramatic representation of the hydrophobicity of 
the C-terminal region of ricln A  chain.
Indicated on the figure are che 30 C-terminal amino acids deleted as a 
consequence of che introduced translation termination signal introduced 
into the DNA sequence.
As a result of this deletion, the cysteine residue at position 259 
which is normally involved In che interchain disulphide linkage has been 
removed. Also this deletion has disrupted che N-glycosylation site at 
residues 236-238 in the A chain, as indicated on the figure.
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Flpurt a  1 Hydrophob le lty plot of the C-tenlnu» of ricin A chain
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F ig u re  8: 2 Colony h y b r id iz a t io n  screen of «utaoenlsed clones 
probed w ith  the r a d lo ls b e lle d  Mutagenic o lig o n u c le o tid e .
z n
••••at* • e
t J r f r t s m :
• * • •• • • •
• ••••••#•••#• • •#••••••••#• • %• •#«••*•••••• •• • • • %e««a«« • • .• i
Z. NltrocalluloM flltar probad with
I"P ] radlolaballad autaganlc ollponuclaotlda
waahad with ex esc at rooa taaparatura.
XZ. Nltracalluloaa flltap waahad with 
ex sec at Td-e c (as c j .
•  XXX. Nltpocallulaaa fllta r waahad with
BX M C  at Td (B4 O  .
182
oligonucleotide which had been end-labelled using [7 *aP], as described in 
Section 2:23:6.
By applying the Wallace rules (Wallace et al., 1980) the dissociation 
temperature of the mutagenic oligonucleotide from the mutated ricln A chain 
sequence was calculated at 54°C. Figure 5:2 shows a series of 
autoradiographs representing 6 x SSC washings of the nitrocellulose filters 
at room temperature, the dissociation temperature -5°C and the dissociation 
temperature for mutagenic oligonucleotide from the mutated ricin A chain 
DNA sequence. At room temperature, as expected, the [7 *aP] labelled 
oligonucleotide probe binds to every colony. When the temperature of the 
wash was increased to 49°C a significant reduction in bound probe was 
observed on all but six colonies. Finally the filter was washed at 54°C, 
the dissociation temperature. The autoradiograph of the filter after this 
wash shows that the probe has remained bound to these six colonies at the 
higher temperature.
From this colony hybridization step, six putative positive colonies 
were identified on the master plate and plaque purified as described in 
Section 2:23:7. Single-stranded M13mpl9 template containing the BamHI 
fragment encoding ricin A chain was prepared from the plaque purfied 
material as described in Section 2:18:1 and its sequence analysed by 
dideoxy-chaln termination DNA sequencing, see Sections 2:24:1 to 2:24:5.
5_l2 Analysis of mutated DNA sequence encoding for ricin A chain-
Of the six putative positive colonies identified from the plaque 
purification step only one, colony 26, possessed the mutated sequence. 
Figure 5:3 shows the sequence analysis of single-stranded template obtained 
from colony 26 on standard buffer gradient polyacrylamide gels (Biggin *£ 
al.. 1983), compared to unmutated ricin A chain template. On all gels the 
order of nucleotide tracks is CATC from left to right. As can be seen from
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Figure 5:3 DNA sequence analysls of mutagenlsed rlcin A Chain 
clones on standard buffer gradient gels.
I. Non-autstsd ricin A chain aaquance analysed on a standard 
buffer gradient ONA sequencing gal (Biggin at el.. 1883) .Sequence 
coaplleantary to baeea 711-719 of the publlehed ricin ONA sequence 
CLaab et al.. 1986) hae been indicated. The asterisks indicate the 
positions of the oligonucleotide directed two base alaaatch in the 
nutated ricin A chain sequence.
ZI. Nutated rlcin A chain sequence analysed on standard buffer 
gradient ONA sequencing gals. The two base changes at positions 718 
and 714 in the ricin A chain sequence resulted in secondary 
structure foraatlon around the nutated region. To verify that this 
secondary structure foraatlon was the result of the directed 
autogenesis, the nutated sequence was analysed under sore 
denaturing codltlone (see figure Be 4).
184
Figure S: 4 Analyst» of Mutated rlcln * chain DNA »«quence on 
25> (V/V) foreaeldfl buffer gradient gels.
Z. Non-eutatad rlcln A chain aaquanca analysed on a standard 
buffer gradient sequencing gel . aa described In figure ft 3.
ZZ. Nutated rlcln A chain aequance analyaed on a 201 (v/v) 
foreaelda buffer gradient gal. The nucleotide eequonce 
coapllaentary to baaoo 711-719 froa the published rlcln sequence 
(Lash at al.. 1 9 «  la sheen.The tso baas changes have bean
indicated by asterlake.
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this figure the sequence becomes unreadable around the position of the 
mismatch in the colony 26 single-stranded template, although it can still 
be clearly read over the same region in the unmutated template sequence.
To overcome this problem, template from colony 26 was analysed on 25% 
formamide buffer gradient gels (see Section 2:24:4). Using this type of 
gel creates a more denaturing environment in which to electrophorese the 
DNA fragments and in this example was successful in eliminating any 
secondary structure, see Figure 5:4. Unfortunately in using these 25% 
formamide gels the resolution of the individual bands is reduced compared 
to the standard buffer gels. However, it was possible in this example to 
establish the existence of the mutated sequence, as shown in Figure 5:4.
At certain positions, notably in the C track, the bands are extremely faint 
and because of this the position of some bands has been estimated from the 
relative positions of adjacent bands. What can be clearly observed in 
Figure 5:4 however, is the existence of the modified bases at positions 
713-714 in the ricin A chain nucleotide sequence (Lamb et al.. 1985).
These two base changes have created a codon, TGA, which is a translation 
termination signal (stop codon). The existence of a functional stop codon 
at this position in the ricin A  chain sequence was later verified by In 
vitro transcription/translatlon analysis, discussed in Section 5:6.
Z iA Analyst» <?f puc.6M.gt9p by lialtad regtpictlgn an d a m i s l a m  tapping-
During the sequence analysis of the modified ricin A chain sequence in 
M13mpl9 it was observed that sequence upstream of the £¿111 site at 
position 589 no longer encoded for ricin A chain. In order to reconstitute 
the complete ricin A chain sequence and include the introduced stop codon, 
a Bylll/EcoRI fragment isolated from double-stranded RF M13mpl9RA stop was 
ligated into the large fragment isolated from a Belll/EcoRI digest of 
pUC8RA, as described in Section 2:25:1 and shown in Figure 2:2. The new
186
Figure 5:5 Restriction endonuclease mapping of pUC 8 RA "atop"
pUC 8 RA 'atop* was digested with the following restriction 
endonuclassas.
Track 1 jam I / ££fl HI 
Track 2 JÇh£ I / 51« I 
Track 3 J2ia I / MIL I 
Track 4 XHo I / Bgl II 
Track S Xho 1/ Cia I 
Track 6 Baa HI / Bol II 
Track 7 Baa HI / Cia I 
Track B Eco RI / Bol II 
Track 9 M a  RI / £lâ I
Track 10 pBR322 Hln fl alza Barkers
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?;1 Limited restriction endonuclease mapping of PUC8RA stop.
TRACK NO. RESTRICTION ENDONUCLEASES FRAGMENT SIZES
1 pUC8RA stop XhoI/EcoRI 949, 2678
2 pUC8RA stop Xhol/Smal 944, 2683
3 pUC8RA stop Xhol/Kpnl 901, 2726
4 pUC8RA stop Xhol/Bylll 705, 2922
5 pUC8RA stop Xhol/Clal 455, 3172
6 pUC8RA stop BamHI/Belll 630, 263, 2734
7 pUC8RA stop BamHI/Clal 380, 513, 2734
8 pUC8RA stop EcoRI/Bylll 285, 3342
9 pUC8RA stop EcoRI/Clal 535, 3092
10 pBR322 Hlnfl 1631, 517, 506, 396,
344, 298, 221, 220,
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plasmid, pUC8RA stop contains the complete ricin A chain encoding sequence 
composed of the 5' end of the clone to the BplII site at position +589 from 
pUC8RA and the remaining 3' end from M13mpl9 A stop. The reconstituted 
ricin A chain clone was analysed by limited restriction endonuclease 
mapping as shown in Figure 5:5. Table 5:1 shows the expected fragment 
sizes from each digest, including the Hinfl digested pBR322 marker track. 
The actual sizes of the digested fragments from pUC8RA stop corresponds 
with the expected sizes shown in Table 5:1.
Evidence that the modified ricin A chain sequence has been introduced 
into the pUC8 ricin A chain encoding plasmid is shown in track 2. In this 
track, the plasmid has been digested with Xhol and Sroal ■ to give a 944 base 
pair fragment. This Smal site has been derived from the M13mpl9 polylinker 
region and as no Smal site exists in pUC8RA its presence in the plasmid 
pUC8RA stop confirms the introduction of the mutated A chain sequence.
Also by replacing the Belll/EcoRI fragment from the 3' end of the ricin A 
chain sequence in pUC8RA with the mutated ricin A chain sequence from the 
&gllI/EfifiRI fragment from M13mpl9RA stop a Sail and a PstI site are lost. 
Thus when pUC8RA stop was incubated with either of these enzymes no 
cleavage of the DNA occurred (data not shown).
The creation of pUC8RA stop as described in Section 2:25:1, provided a 
working stock of modified ricin A chain sequence with which to carry out 
further manipulations. The next stage in the analysis of ricin A stop was 
to establish the effectiveness of the Introduced stop codon in an in vitro 
transcriptlon/translation system. To achieve this the modified ricin A 
chain clone was ligated into a suitable in vitro transcription vector as 
described in Section 2:25:1.
h i  Aaalxtii -fll pSr$4APam A step by lim ite d  m t i i f i t i a n  napping-
pSP64ABam A stop was created by ligating the 893 base pair BamHI
Figure 5:6 Restriction endonuclease aapplng of pSP64 Baa A "stop1
pSP64a  B—  A ’•top" m  dip«*tad with th« following r««trlotion
endonuclaaaea
Track 1 Hind III / Cl» I
Track 2 Hind III / Bgl II
Track 3 Hind III / ton I
Track 4 Bae HI / ton I
Track B Baw HI / Bgl II
Track 6 Bm  HI / Cla I
Track 7 pBR322 Hin fI aiza Barkers
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fragment, encoding the complete, modified rlcln A  chain, from pUC8RA stop 
Into BamHI restricted, phosphatased pSP64ABam (Figure 2:3). Figure 5:6 
shows the limited restriction endonuclease mapping of this clone. Table 
5:2 shows the expected fragment sizes from each digest including the pBR322 
HlnfI markers (track 7). All fragments corresponded to the expected sizes 
as shown in Table 5:2. Track 3, the Hlndlll/Konl digest of pSP64ABam A 
stop, demonstrates that the BamHI fragment derived from pUC8RA stop has 
ligated into the SP6 vector in the correct orientation.
In vitro transcription of the modified ricin A  chain sequence in 
pSP64ABam A stop was carried out as described in Section 2:25:2.
Table ?;2 Limited restriction.eadanuclease mapping <?f pSF$4ûBam A step-
TRACK NO. RESTRICTION ENDONUCLEASES FRAGMENT SIZES
1 Hindlll/Clal pSP64ABam A stop 423, 3477
2 Hlndlll/Bglll pSP64ABam A stop 673, 3227
3 Hlndlll/Konl pSP64ABam A stop 910, 2990
4 BamHI/Kpnl pSP64ABam A stop 867, 26, 3007
5 BamHI/BelII pSP64ABam A stop 630, 263, 3007
6 BamHI/Clal pSP64ABam A stop 380, 513, 3007
1631, 517, 506, 396 
344, 298, 221, 220
Hinfl pBR322
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LiA Analyst? <?f pgr^^ AB^ m A scpp trangcrlpts in *Jdm£i>a lv?t»te system-
Newly transcribed RNA from the transcription of pSP64ABam A stop (see 
Section 2:25:2) was translated in a wheatgerm lysate system as described in 
Section 2:25:3. The products of this wheatgerm translation were separated 
by SDS-PAGE under reducing conditions, and visualised by fluorography and 
autoradiography (see Figure 5:7). Track 1 of this figure shows the 
translation product from non-modified ricln A chain mRNA, which 
electrophoreses with an apparent molecular mass of 30 Kd. The 
transcription product of the ricin A stop transcripts, shown in track 2, 
clearly has an Increased mobility, which corresponds to the expected 
decrease in molecular mass resulting from the Introduced stop codon into 
the ricin A chain sequence. Track 3 is the translation product of a non- 
related ricin A chain deletion not directly relevant to the work discussed 
in this chapter. As a control to demonstrate that the wheatgerm 
translation system was functioning, and as a molecular weight marker, 
prepro-alpha factor mRNA was also translated (track 4). This protein 
electrophoreses with a mobility corresponding to a molecular mass of 18.6 
Kd.
From the result shown in Figure 5:7 it is apparent that the premature 
stop codon introduced into the ricin A chain encoding DNA sequence, is 
functioning to produce a truncated product. The removal of 30 amino acids 
from the C-terminus of ricin A chain would be expected to reduce the 
molecular mass of ricin A chain by approximately 3.3 K ds. The observed 
electrophoretic mobility of the truncated A chain product agrees with this 
predicted size reduction, see Figure 5:7 tracks 1 and 2. Having 
established that the Introduced stop codon was functioning to direct the 
production of a truncated A chain, the next stage was to establish the 
effect, if any, of the modification upon the ribosome-inactivating activity 
of the translated products. Because the ribosomes in a wheatgerm system
Figure &  7 Analysis of rlcln A chain transcripts In a 
wheatgera In vitro translation system.
1 2  1 4
Mhaatgora In vitro translation ayatoa and analyaad on 18* S08-PA8E 
under reducing conditions.
Track 1 contains a aaapla of the translation product froe the 
addition of coaplata rlcln A chain aflNA.
Track 2 contains the translation product froa the addition of 
tha truncated rlcln A chain aflNA. with the introduced translation 
stop codon at aalno acid residua 236.
Track 3 contalna an A chain translation product not related to 
this work.
Track 4 contains tha translation product froa tha addition of
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are not significantly inactivated by ricin A chain, the ricin A chain 
transcripts were translated in a rabbit reticulocyte lysate system as 
described in Section 2:25:4. The toxicity of each product was established 
by assessing the ability of the reticulocyte lysate to translate a second 
mRNA subsequent to the Initial ricin A chain mRNA as described in Section
i l l  A n a lyst? <?i the to x is ls v  <?( A  chain tran scrip ts in  » rabbit
reticulocyte lysate translation system.
Transcripts of ricin A stop, and unmodified ricin A chain (see Section 
2:25:2) were translated for 30 minutes in a rabbit reticulocyte lysate 
translation system as described in Section 2:25:4. A second transcript, 
for prepro-alpha factor, was then added to each translation reaction and 
incubated for a further 30 minutes. The products from each translation 
reaction were separated by SDS-PAGE under reducing conditions and then 
visualised by fluorography and autoradiography as shown in Figure 5:8.
Track 2 of Figure 5:8 shows the translation products from the addition 
of the truncated ricin A chain (A stop) transcripts, followed by a prepro­
alpha factor transcripts. In this reaction, the reticulocyte lysate was 
able to support the translation of a limited amount of truncated ricin A 
stop product, but could not translate any of the second, prepro-alpha 
factor message. This result is identical to that shown in track 3 in which 
the reticulocyte lysate system supports the translation of a limited amount 
of the full length ricin A chain mRNA, but does not translate any of the 
second prepro-alpha factor mRNA. In contrast to these results, when 
chicken lysozyme mRNA is used first, the reticulocyte lysate system readily 
supports the translation of the second prepro-alpha factor mRNA (track 1). 
Track 4 shows the background detected with no first mRNA but followed by 
addition of prepro-alpha factor mRNA.
194
Figure 5: 8 Analysis of rlcln A chain transcripts In a rabbit 
reticulocyte in vitro translation systsa.
i a a 4
Autoradiograph of rabbit reticulocyte lyeate in vitro 
tranoletlon products analysed on IBS SOS-PASE under reducing 
conditions.
The riboeoae lnactlvetlng actlvlty of thè translatsd rlcln A 
Chain producta waa analyaed by thè ablllty of thè tranalatlon 
ayetea to eupport thè tranelatlon of e second preproalpha factor
Track l contarne thè tranelatlon producta froa thè sddltlon of 
chlcken lyeozyae aflNA followed by preproalpha factor eflNA.
Track2 containe thè tranelatlon producta froa thè addltlon of 
thè truncated rlcln A Chain aeeaage. followed by preproalpha factor 
aflNA.
Track 9 contaIna thè producta froa thè tranalatlon of coapleto 
rlcln A chaln aaasage. followed by preproalpha factor aRNA.
Track 4 conta Ina only preproalpha factor aRNA aa background.
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The results shown In Figure 5:8 clearly shows that the translation of 
A "stop” transcripts and unmodified rlcin A chain transcripts results in 
the inactivation of the translation system, as judged by its inability to 
support the translation of a second mRNA. This effect was not observed 
when chicken lysozyme was used as the first mRNA (track 1). It may be 
assumed therefore, that the loss of translational activity observed in 
tracks 2 and 3 is the result of the translation of active rlcln A chain 
products. Thus from these types of assay it may be concluded that the 
truncated ricln A chain product, devoid of 30 terminal amino acid residues 
has retained it ribosome Inactivating activity. In contrast ribosome 
inactivating activity is abolished in ricln A chain after the removal of 
only a few amino acid residues from the N-termlnus of ricin A chain (M.
Hay, personal communication).
The data described so far in this chapter has demonstrated that by the 
use of site-directed mutagenesis it is possible to modify the ricin A chain 
encoding DNA sequence to produce a truncated protein which has retained its 
ribosome-inactivating activity. In order to study the effect, if any, of 
removing the 30 C-terminal amino acids on the ability of ricin A  chain to 
enter mammalian cells, it was necessary to obtain reasonably large amounts 
of material. For this purpose the truncated ricln A chain clone was 
ligated into the E. coll expression vector pDS5/3.
ill Analysis of pDS5/3 A stop by limited restriction endonuclease mapping.
pDS5/3 A stop was created by ligating the 893 base pair BaroHI fragment 
from pUC8RA stop into BamHI restricted pDS5/3 as described in Section 
2:26:1. The new vector, pDS5/3 A stop (Figure 2:5) was analysed by limited 
restriction endonuclease mapping, as shown in Figure 5:9. Table 5:3 shows 
the expected fragment sizes from each digest.
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Figure 5:9 Restriction endonuclease mapping of pDS5/3 A "stop"
pOSS/3 A ’•top* m  dlgaatad with tha following raotrlction 
anzyaaa.
Track I Xhol /Bgl II 
Track 2 Xho I / Cla I 
Track 3 Aflft HI 
Track 4 Baa HI /Bgl II 
Track B Baa HI / Cla I
Track 6 laada DNA . Eco RI / Hind III
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Iafalfi.5:3
TRACK NO. RESTRICTION ENZYMES FRAGMENT SIZES
1 Xhol Bglll 709
2 Xhol Clal 459
3 BamHI 893
4 BamHI Belli 630, 263
5 BamHI Clal 380, 513
6 X EcoRI HindiII Markers 3530, 2027,
1530, 983, 831, 564
Figure 5:9, Crack 1, Xhol/Bglll digest demonstraces chat Che BamHI 
fragment derived from pUC8RA stop has been ligated Into pDS5/3 In the 
correct orientation. Tracks 3-5 shows the fragment sizes from the various 
digests coincides with the expected sizes.
The vector containing the correctly orientated fragment (pDS5/3 A 
stop) was transformed into BMH 71.18 E. coli cells as described in Section 
2:15:1.
5:81 Western blot analysis of transformed E. coll cells upon induction-
BMH 71.18 E. coli cells were transformed with either pDS5/3 A stop or 
pDS5/3 A  chain (O'Hare et al., 1987) and induced with 1 mM IPTG, as 
described in Section 2:26:2. Whole cell extracts from these cultures were 
analysed by SDS-PAGE under reducing conditions and Western blotting as 
shown in Figure 5:10. Track 3 of this figure contains a whole rlcin 
control, which indicates the mobility of the native glycosylated rlcln
Figure 5:10 Expression of rlcln A "atop11 In E.coll. : Analysis of 
whole cell products by western blotting.
Mhola cell extract! fros Induced cultural of E.coll cal la 
tranaforad with either poas/3 A chain or pOSB/S A ’atop* woro 
analyoad by woatorn blottlnp. Flltors w o n  probod with polyclonal 
antl-rlcln A chain antlbodloa.
Track 1 contain! wholo coll extract fros p080/a A 'atop' 
tranoforaod and Induced E.coll cal la. A band of tho cornet 
nobility for the truncated rlcln A chain and waakly reactive with 
the antibody probe la Indicated on tho flpun.
traneforaad and Induced E.cell cello. A M M  band, reactive with 
the antibody probe haa boon Indicated on tho flfun.
Track S contain a purified native rlcln control.
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subunits. Track 2 of this figure reveals a protein band, reactive with 
anti-rlcin A chain antibodies, and with an electrophoretic mobility 
slightly faster than native ricin A chain obtained from a whole cell 
extract of pDSS/3 A-transformed E. coll. This protein band is known to be 
full length recombinant ricin A chain. Track 1 of this figure contains a 
whole cell extract from pDS5/3 A stop-transformed E. coll cells. In this 
track, two bands which react with anti-ricin A chain antibodies are 
observed. Both protein bands have an Increased electrophoretic mobility 
compared to either native or recombinant ricin A chain, the upper band 
coinciding closely with the electrophoretic mobility of the truncated 
product observed in the in vitro transcriptlon/translation analysis (see 
Figure 5:8). The nature of the lower band in track 1 is unclear. Possibly 
this band represents some breakdown product of the truncated ricin A chain, 
or premature translation termination or downstream translation initiation, 
or some irrelevant E. coll protein which cross reacts with the anti-rlcin A 
chain antibodies. In this particular example the first possibility is more 
likely since pDS5/3 vector alone produces no reactive bands corresponding 
to the positions of the bands in either track 1 or 2 (data not shown). No 
early initiation or termination of translation has ever been observed when 
expressing full length recombinant ricin A chain and it would seem unlikely 
here, discounting the other possibilities.
In both tracks 1 and 2 approximately equal protein loadings were 
applied, however it was consistently observed that the unmodified 
recombinant ricin A chain produced a much stronger reaction with the antl- 
rlcln A chain antibodies than did the truncated form of the ricin A chain. 
It is possible that this reduced reactivity is the result of a reduced 
level of expression with pDS5/3 A stop compared to pDS5/3 A chain.
However, for this reasoning to hold true, both expressed forms of the ricin 
A chain would have to appear equally reactive with the anti-ricin A chain 
antibodies. Another possible explanation for this observation could be
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that the truncated form of ricin A chain is less antigenic than the full 
length polypeptide. The 30 amino acid region deleted from the C-terminus 
of the ricin A chain represents a significant hydrophobic domain which has 
been implicated in possible subunit interactions, (Montfort et al.. 1987). 
Furthermore, if as has been suggested by Montfort et al. (1987), that this 
"hydrophobic disc-like structure" interacts by inserting between the two 
sugar-binding domains of ricin B chain, then it is likely to be exposed to 
the media in the isolated ricin A chain. These predictions therefore, go 
some way to reinforcing the suggestion that this region may possess 
important antigenic determinants, and thus explain, at least in part, the 
reduced reactivity observed in track 1, Figure 5:10, which shows the C- 
terminal truncation of ricin A chain known as A stop. Neither of the 
possibilities mentioned above have been vigorously examined. Another 
possibility, again not explored, is that the shorter A chain may be less 
stable than full length ricin A chain and be turned over more rapidly. The 
kinetics of turnover were not investigated.
ill purification ° f  ricin A ?*9P by chropgtgfpcysing.
In view of the success of chromatofocusing for the purification of 
recombinant ricin A chain from E. coli (O'Hare et al.. 1987), this 
technique was employed here with the aim of obtaining milligram amounts of 
pure, enzymatically active, truncated ricin A chain.
Samples from the scaled-up expression system were prepared as 
described in Section 2:26:3 and applied to a chromatofocusing system with a 
pH range 9-6 as described in Section 2:26:4. The protein elution profile 
from this purification step is shown in Figure 5:11. As is shown in this 
figure, a significant proportion of the protein applied to this column 
either passed straight through without binding, (pi >9.6) or eluted in the 
final salt wash (pi <6.0). Samples across the elution profile were
lo\
Figure £ :11 Protein elution profile : Partial purification of recombinant
trvncgte«? ricin A ch?in. fry chrgnfftgfpausing-
Figure 5:11 shows the protein elution profile from the partial 
purification of recombinant truncated ricin A chain by chromatofocusing 
using a 9-6 pH range system.
Protein eluting from the column was monitored by measuring the 
absorbance at 280 ran.
Peak I represents material passing straight through the column 
i.e. E. coli proteins with pis greater than 9.6.
Peak II represents material eluting with a pi close to 7.5, and 
including the recombinant truncated ricin A chain.
Peak III represent material eluting in the final salt wash 
i.e. E. coli proteins with pis less then 6.0.
°°
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analysed by Western blotting, as shown in Figures 5:12 and 5:13. In Figure 
5:12, tracks 1 and 12 contain native ricin controls electrophoresed under 
reducing conditions, as are all the other fractions. Tracks 2 and 3 
represent material from fractions 5 and 7 which did not bind to the column. 
None of the proteins in either of these two fractions reacted with the 
anti-ricin A chain antibodies. Tracks 4-11 of this figure represent 
fractions 12-19 from the chromatofocusing protein elution profile 
inclusively. Across these fractions the pH falls from approximately 8.0 to 
7.5. In fractions 18 and 19 (tracks 10 and 11) a protein band which both 
cross-reacts with anti-ricin A chain antibodies and has an electrophoretic 
mobility corresponding to the truncated ricin A chain (A stop) is apparent. 
In tracks 8 and 9 some material, with an electrophoretic mobility 
corresponding to native glycoslyated ricin A chain, and cross-reacting with 
anti-ricin A chain antibodies, can be observed. It is thought to be 
unlikely however, that this material represents full length ricin A chain 
which may have been the result of some read through of the introduced stop 
codon. The electrophoretic mobility of this product on SDS-PAGE does not 
show the slight but characteristic increase associated with non- 
glycosylated recombinant A chain (O'Hare et al. , 1987) and as seen in 
Figure 5:10, track 2).
Figure 5:13 shows Western blot analysis of the remaining fractions 
from the chromatofocusing profile (Figure 5:11). Tracks 2-8 of Figure 5:13 
:ontains samples from fractions 20-26 inclusively. Fraction 20 (track 2), 
like fraction 19 (Figure 5:12, track 11) contain a protein band which 
reacts with the anti-ricin A chain antibodies and electrophoreses with the 
appropriate mobility for ricin A stop. No significant reactivity with 
antibodies can be detected in the other tracks, including material from the 
final salt wash i.e. fractions 68, 69 and 70 (tracks 9-11). The failure to 
detect any truncated ricin A chain material in the salt wash possibly 
Indicates that none of this material (A stop) has been denatured during the
204
Figure a  12 Purification of recoablnant A "stop* I.: Western blot 
analysis of chroaatofocuaed frectlons.
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Flgurt 8:12 Purification of reconblnant A "stop" I.: Western blot 
analysis of chronatofocused fractions.
Z. S0B-PA8E analysis of soluble E.coll proto In froctlono of fear 
chronatofocuelng. eloctrophoraeed under reducing condlfelono.
Tracks 1 and 12 contain saaplss ofwholo rlcln olacferophorosad 
under reducing condlfelono. Tracks * and S contain notarial froo 
fractions B and 7 respectively, uhlcn did not bind to tlto chroaato- 
focuslng coluan. Tracks 4-11 contain aanplaa froa fractions 18-19 
Inclusively.
ZZ. Neotom blot analysis.
All the above fractions uaro tranoblottad onto nltrocollulosa 
filters and probed with antl-rlcln A chain antlbodlaa. Track 11 
(fraction 1« contains a protein band reactive with the antibody 
probe and with a corriapondlng electrophoretic nobility to that 
expected for the truncated A chain. Zt*a position haa boon 
indicated by an arrow on the figure, notorial free track 10 
(fraction 18 waa aloe weakly reactive with the antibody probe . 
although this band la net apparent after photography).
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Figure 5; 13 Purification of recoebinent A "etop* II. : Western blot 
analysis of chroeatofocueed saeplea.
Z. 808-PASE analysis of chroaatofocueed fractions of soluble 
E.coll protslns under reducing conditions.
Tracks 2-e contain saaplss froa fractions 20-28 inclusive.
Fractions »-11 contain fractions 8* 89, and 70 froa the final aalt- 
Maah. Track 1 la a whole rlcin control electrophoresed under 
reducing conditions.
ZZ. Msstern blot analysis.
As with figure ft 12. track 11 . aprotaln band reactive with 
the antibody probe . and with an electrophoretic aobillty corriopo- 
ndlng to that expected for rlcin A 'stop* la evident in track 2 
(fraction 20). No other reactive banda, of appropriate nobility can 
be detected in any other track. Boas proteins, with aobilltlss 
quits different froa that of ricln A ‘stop*, can bo detected in the 
final salt-wash. Indicating that soaa cross-reactivity occurs 
between the anti-rieln A chain antibodies and soaa E.celi proteins.
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preparative and purification steps. It is interesting to note that some 
proteins, with mobilities quite different from either complete or truncated 
A chain cross-react with the polyclonal antl-rlcin A chain antibodies, 
which may help explain the cross-reacting material observed with fractions 
16 and 17 (Figure 5:12, tracks 8 and 9).
These results indicate that the truncated ricin A chain (A stop) has 
been partially purified to 7 or 8 other proteins by a single chromatofocusing 
step and that this material elutes with a pi of approximately 7.5 
(fractions 19 and 20). The polyclonal antl-ricln A chain antibodies used as 
the probe in the Western blot analysis do show some limited cross­
reactivity with a number of E. coll proteins, the most significant being 
fractions 16 and 17. The cross-reacting material in these tracks 
electrophoreses with a mobility close to, but slightly higher than that 
expected for recombinant whole ricin A chain. The partially purified 
truncated ricin A chain has apparently not become denatured during sample 
preparation or subsequent purification steps.
A particular problem encountered during this type of analysis was the 
apparently low level expression, high turnover, or low antigenicity of 
ricin A stop which required subsequently higher protein loadings onto gels. 
The effect of this was to raise the background levels of co-purlfying 
proteins thereby hampering the interpretation of results. In an attempt to 
avoid the use of an antibody-based detection system for the validation of 
subsequent purification procedures, the RNA modification analysis described 
in Section 2:11 was employed.
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iilfl Petcrffllnstibn <?£ ricin A chain-specific activity. In-shroiMtcfccvscd
fractions.
Aliquots from fractions 19 and 20 were analysed for their ability to 
catalyze a rlcin A chain specific modification of ribosomal RNA in rabbit 
reticulocyte lysate ribosomes (after Endo et al., 1987).
Figure 5:14 is a 1.2% (w/v) agarose, formamide gel showing the results 
from the application of aliquots of fraction 19 and 20 directly onto rabbit 
reticulocyte ribosomes. Tracks 1*4 are controls, demonstrating that the 
diagnostic fragment indicated by the lower arrow is produced only after 
appropriate incubation with rlcln A chain and aniline. In tracks 5 and 6, 
20 pi of fraction 19 have been incubated with rabbit reticulocyte lysate 
plus and minus aniline treatment respectively. In track 5 the fragment, 
diagnostic of ricin A chain specific activity can be clearly seen (lower 
arrow). Equally when either 20 pi or 30 pi of fraction 20 (tracks 9 and 11 
respectively) are incubated with reticulocyte lysate followed by aniline 
treatment the characteristic fragment is apparent.
This result clearly indicates the presence of an enzymically active 
fora of ricin A chain present in these two fractions (i.e. fractions 19 and 
20). This finding is in agreement with the result described in Section 5:7 
where the in vitro translation product of pSP64ABam A stop was shown to be 
biologically active, as judged by the inability of the rabbit reticulocyte 
system to support the translation of a second prepro-alpha factor 
transcript. Assuming that all the ribosomal RNA modifying protein purified 
by chromatofocusing in fractions 19 and 20 is the truncated fora of ricin A 
chain, then this result demonstrates the expression and purification of 
soluble, non-denatured ricin A chain which exhibits ribosomal RNA 
modification activity despite the absence of 30 amino acids from the C-
terminus.
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F ig u re  5: 14 RNA m o d if ic a tio n  assay : A nalys is  of p a r t ia l l y  p u r if ie d  
recom binant r i c i n  A 'sto p *.
Foraaalde gel of RNA aaaplee extracted froa reticulocyte lysate 
Incubations with fractions of chroaatofocussd recoablnant ricin 
A ’stop*.
Tracks 1 and 2 shows ricin A chain treated ANA Incubated with and 
without aniline respectively.
Tracks 3 and 4 shows buffer only treated RNA Incubated with and 
without aniline resectlvely.
Tracks 8 and 6 shows RNA extracted fros lysate saaplea Incubated 
with 20ul of fraction 19 froa the chroaatofocuslng step . treated 
with and without aniline respectively.
Tracks 7 and B are Invalid as no RNA was recovered In track 7.
Tracks 9 and 10 show RNA extracted froa lysate Incubated with 
20ul of fraction 20 froa the chroaatofocuslng step with and without 
aniline respectively.
Tracks 11 and 12 show RNA extracted froa lysate Incubated with 
30ul of fraction 20 Incubated with and without aniline.
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S;ll Evaluation of affinity chromatography using Blue Seph»r<?$e « 
method for the purification of rlcin A stop.
An aliquot (4-5 mis) of fraction 20 from the chromatofocusing step 
(see Section 5:9) was dialysed against 50 mM sodium phosphate buffer pH 7.5 
at 4°C and then applied to a blue sepharose column as described in Section 
2:26:6. Figure 5:15 shows the elution profile from this step. In theory 
the truncated ricin A chain should bind to the column matrix while the 
other proteins co-purified by the chromatofocusing procedure pass straight 
through the column.
At this stage, the use of Western blotting as an analytical technique 
was prohibited by the small amount of material obtained from the column.
The validity of this chromatographic technique was analysed therefore by 
the much more sensitive RNA modification assay. Figure 5:16 shows the 
result of such an assay. As described before in Section 5:10, tracks 1-4 
are controls which demonstrate that the production of the diagnostic rRNA 
fragment is a consequence of both appropriate ricin A chain and aniline 
incubations. In tracks 5 and 6 unbound material from fraction 8 was 
incubated with the reticulocyte lysate and subsequently with and without 
aniline respectively. The material from fraction 8 failed to produce the 
diagnostic rRNA fragment, a finding which is in contrast to the result when 
material from fraction 10, which also did not bind to the blue sepharose 
was tested. Without the subsequent aniline treatment (track 8) no fragment 
was produced. However with aniline treatment the diagnostic fragment is 
clearly visible indicating that ricin A chain specific activity is present 
in the material present in this fraction.
As expected all bound material, (eluting with 500 mM NaCl wash), 
fractions 28, 29 and 30 produced the diagnostic fragment when incubated 
with aniline (tracks 9, 11 and 14). No fragment was observed when the 
aniline incubation was not included (tracks 10, 12 and 13).
Figure 5:15 Protein elution profile : Partial purification of recombinant 
truncated rlcin A chain bv affinity chromatography-
Figure 5:15 shows the protein elution profile of the partial 
purification of recombinant, truncated ricin A chain by affinity 
chromatography using blue sepharose CL 6B.
Protein eluting from the column was monitored by measuring the 
absorbance at 280 nm.
Peak I represents material not binding to the column.
Peak II represents material which bound the column and was eluted 
with 0.5 M NaCl.
Material from each peak was evaluated for its RNA modification
activity, see Figure 5:16.
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F ig u re  5: IS Retain e lu t io n  p r o f i l e  ; P a r t ia l  p u r i f ic a t io n  of 
recoablnan t t runcated r i c l n  A chain  by a f f i n i t y  chroaato graphy 
using Blue Sepharose CL 6B.
O P 3 8 0 ™ .
214
Figure ft 16 RNA Modification assay; Evaluation of blue sepharoae 
affinity chronatography In the purification of recoablnant 
truncated rlcln A chain.
1 2 3 4 5 a 7 I 0 10 11 12 13 14
Formal«)« 90I of RNA staples extracted free rabbit reticulocyte 
lysate incubations with fractions free the blue sepharose affinity
chroaatography atop attaaptlng to purify the recoablnant truncated 
rlcln A chain.
Tracks 1 and 2 ar« rlcln A chain treated HNA saaplas incubated 
with and without aniline respectively.
Tracks 3 and 4 are buffer only treated RNA saaplas with and 
without anlllns traataant respectively.
Tracks 8 and 8 show RNA extracted from lysate treated with 
fraction 8 (unbound eatarlal) with and without aniline traataant 
respectively.
Tracks 7 and a show RNA extracted free lysate saaplss lncubatad 
with fraction 10 (also unbound notarial) with and without aniline 
treataant respectively.
HNA extracted froa lysate Incubations with notarial bound to the 
blue sapharoea coluan. fractions 28.28 and SO. plus aniline 
traataant are shown in tracks 8.11 and 14 reapectlvaly.
Tracks 10.12 and 13 ahow RNA saaplas extracted froa lysates 
treated with fractions 2 * 2 8 and 30 without anlllns traataant.
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This result whilst demonstrating perhaps the unsuitability of blue 
sepharose for purification of A stop has demonstrated an application of the 
most recent method for detecting ricin A chain specific activity in a 
practical protein purification situation. This technique is particularly 
useful in these circumstances, as the small amounts of material available 
from this procedure cannot be analysed by Western blot analysis.
¿¿12 Ptscysslen-
The means by which the A chain subunit of ricin gains entry into the 
cell cytoplasm during intoxication is poorly understood at both cellular 
and molecular levels. A body of evidence exists in the literature which 
suggests that the presence of ricin B chain may facilitate the entry of 
ricin A chain into cells (Youle and Neville, 1981; Houston, 1982; McIntosh 
et al.. 1983; McIntosh et al.. 1988). With the exception of Vitetta 
(1986), who was able to abolish the sugar-binding activity of ricin B chain 
by chemical means whilst retaining its putative A chain translocating 
activity, there is little direct evidence that ricin B chain is actively 
and solely involved in the translocation of ricin A  chain into the cytosol. 
Furthermore, an analysis of the three dimensional structure of ricin 
(Montfort et al., 1987) has neither identified or even Implicated any 
region of ricin B chain likely to have any potential for membrane 
interaction and translocation. Indeed the most likely candidate as a 
membrane translocating domain is found at the C-terminus of the A chain 
subunit. Montfort et al., (1987) have indicated that final 57 residues of 
the carboxyl-terminal of the ricin A chain forms a compact disc-like domain 
which protrudes so as to slide between the cleft formed between the two 
sugar-binding domains of ricin B chain. The final 27 amino acids of this 
region have been shown to be significantly hydrophobic, which may account 
for the relatively high association of ricin A chain with lipid vesicles
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(Uchida et al.. 1980). It is possible therefore, that this region of the 
ricin A chain subunit is involved in membrane interactions which may be 
important during the translocation process. This C-terminal domain of 
ricin A chain has also been implicated in strong interactions with domains 
within the ricin B chain. It is possible to speculate therefore, that the 
potentiation of the cytotoxicity, associated with ricin A chain containing 
immunotoxins, in the presence of B chain may be a result of this A chain C- 
terminal domain being protected (by the B chain), until it encounters the 
appropriate environment. Within this environment the C-terminal domain of 
the A chain becomes dissociated from the protective B chain and is able to 
perform its membrane interactions leading to translocation into the cell 
cytosol. Unfortunately there is no direct evidence to support the 
existence of such a mechanism, but as an approach to studying the possible 
role of the hydrophobic C-terminus of ricin A chain during translocation 
into the cytosol, a truncated form of the ricin A  chain devoid of the 30 
terminal amino acids was engineered. This was achieved by the introduction 
of a translation termination codon by site directed mutagenesis into the 
ricin A chain DNA sequence as described in Section 2:23.
Once the existence of the mutated ricin A chain sequence had been 
established by DNA sequence analysis (see Figure 5:4) the mutated clone was 
ligated into an in vitro transcription/translation vector (see Figure 5:6). 
The RNA transcripts of the mutated ricin A chain, catalysed by the activity 
of the bacteriophage SP6 RNA polymerase, were translated in both wheatgerm 
and rabbit reticulocyte lysate In vitro translation systems (see Figures 
5:7 and 5:8 respectively). The first observation that can be made from the 
analysis of these in vitro translation results is that the introduced stop 
codon functions to produce a truncated protein whose mobility on SDS-PAGE 
under reducing conditions coincides with the expected mobility for ricin A 
chain after the removal of 30 amino acids (see Figure 5:7, track 2). The 
second observation, regarding the ability of the truncated ricin A chain to
inhibit protein synthesis can be made by considering the results of the in 
vitro translation of the protein in a rabbit reticulocyte lysate system.
Because the ribosomes from this system are susceptible to inactivation by 
ricin A chain, the translation of an active form of ricin A chain will only 
be supported for a limited period, after which the level of translated 
product is sufficient to inactivate the translation system. Thus, a 
reticulocyte lysate system which translates an active form of ricin A chain 
will not support the translation of a second mRNA encoding a control 
protein. In Figure 5:8 track 2, the truncated form of the ricin A  chain 
can be clearly visualized; electrophoresing on SDS-PAGE with an increased 
mobility compared with the non-mutated ricin A chain product visualized in 
track 3. In neither of these tracks is there any evidence of the protein 
product of the second prepro-alpha factor RNA transcript subsequently added 
to each reaction. In the positive control translation (Figure 5:8, track 
1) the translation of an RNA transcript encoding for chicken lysozyme does 
not inhibit the translation of the second prepro-alpha factor transcript.
It is apparent from these results, that the removal of 30 amino acids 
has not affected the ribosome inhibiting activity of the A chain. In 
contrast the removal of just 12 amino acids from the N-terminus of the 
ricin A chain abolishes all ribosome inactivating activity. However no 
loss of activity was observed when only 9 amino acids were deleted 
(Mike May, personal communication). It has not been shown whether the loss 
of activity resulting from this 12 amino acid deletion of the N-terminus is 
a consequence of the loss of residues involved specifically with ribosome 
inactivation or, as seems more likely, the result of some other effect on 
protein structure, leading to mlsfoldlng and loss of enzymatic activity.
Having established the fidelity of the Introduced stop codon, and the 
retained ribosome inactivating activity of the truncated ricin A chain, the 
next stage was to obtain enough of the purified protein in a soluble and 
active form to examine the effect, if any, of the 30 amino acid deletion
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upon che ability of ricin A chain Co become internalized into cells. The 
first step towards achieving this aim was to express, in a soluble and 
active form, the truncated ricin A chain in an E. coli expression system. 
The expression of the truncated ricin A chain, (A stop) in E. coli was 
carried out by following as closely as possible the methodology described 
by O'Hare et al. (1987) during the expression and purification of whole 
recombinant ricin A chain. An important feature of this expression system 
was the growth of the transformed and IPTG-induced E. coli at 30°C, which 
was essential for the production of biologically active expressed product 
(O'Hare et a l . , 1987). If grown at 37 C recombinant ricin A chain was 
found to form soluble aggregates which demonstrated greatly reduced 
biological activity. O'Hare et al. (1987) were able to estimate the 
expression level of recombinant A chain at between 2-3 mg/litre of culture 
under optimal conditions. The expression level of the truncated ricin A 
chain can not be so readily determined, as it is unclear as to whether the 
removal of the C-terminus has resulted in reduced antigenicity (see Section 
5:8). If no difference in the antigenicity between whole and truncated 
ricin A chain is assumed, then the Western blot analysis of equal loadings 
of lysed whole cell cultures (see Figure 5:10) suggests that the expression 
level of the truncated form is reduced, possibly by as much as 75% compared 
to whole recombinant A chain. Because of this doubt as to the feasibility 
of the use of antibody detection as a measure of expression levels, a more 
suitable analysis might have been to determine the ribosome inactivating 
activity of the expressed products. Possibly the best method for achieving 
a measure of this activity would be to dilute the recombinant ricin A 
chains until the concentration which no longer produces the characteristic 
RNA cleavage product is reached, similar to the analysis described in 
Section 3:2:6. By assuming that the specific activities of native, whole 
recombinant and truncated recombinant ricin A chain are the same it would 
then be possible to estimate the concentration of the expressed products by
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comparing the activities of dilutions of E. colt preparations to the known 
concentrations of native ricin A chain standards. Figure 3:14 shows that 
30 pg is the smallest amount of native ricin A chain which produces the 
diagnostic rRNA fragment under the experimental conditions defined in 
Section 3:2:6. A further attraction of this type of analysis is that 
because such an assay detects a specfic ricin A chain modification it is 
not necessary to purify the recombinant proteins to homogeneity. Analysis 
of impure fractions in non-specific assay systems such as the cell-free 
assay described in Section 2:10 would not be able to differentiate between 
ricin A chain specific-inactivation or some non-specific inactivation of 
the rabbit reticulocyte translation system. A major drawback of this ricin 
A chain-specific RNA modification approach for the analysis of recombinant 
proteins is the susceptibility of the rRNA to enzymic cleavage of RNAases. 
If this problem can be overcome however, it represents a means of making a 
reasonably accurate assessment of expression levels, providing that RNA 
modifying activity of the recombinant protein is the same as the native 
ricin A chain standards. In this analysis of recombinant truncated ricin A 
chain this technique has only been successfully employed to determine that 
the expressed product had retained its biological activity after partial 
purification by chromatofocusing (see Figure 5:14). The ability of the 
recombinant protein to modify rRNA in a ricin A chain specific manner has 
been taken to indicate that the product has been expressed in a soluble 
form, however a rigorous evaluation of solubility has not been undertaken.
The expression of a eukaryotic gene in E. coll, yielding a soluble, 
active product is not a trivial event. Indeed, although expressed gene 
products can represent up to as much as 25% of the total cell protein, in 
the majority of cases these proteins are expressed in an insoluble fora 
(Harris, 1983). The appearance of inclusion bodies concomitant with the 
accumulation of pro-insulin, Insulin A chain or insulin B chain by Williams 
et al. (1982) was the first indication that the insoluble proteins might
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accumulate in a discrete form. By isolating the inclusion bodies from 
cells expressing prochymosin, Marston et al. (1984) demonstrated that these 
inclusions were composed predominantly of the expressed product. In order 
to recover active, soluble protein from aggregated recombinant polypeptides 
it is necessary to first isolate the Inclusion bodies. Then dénaturants 
are used to unfold the proteins and finally appropriate conditions for the 
correct refolding of the polypeptides are Introduced. The fact that many 
of these aggregated recombinant products form Inclusion bodies is useful 
for purification, which is normally achieved by sedimentation using low 
speed centrifugation. Co-purifying E. coll proteins which sediment with 
these inclusion bodies can -be preferentially solubilised using detergent 
solutions (Marston et al., 1984) which leave the recombinant material 
between 30% and 90% pure (Marston, 1982). Solubilization of the protein 
requires the disruption of non covalent, hydrogen bonds, ionic and/or 
hydrophobic Interactions and unfolding of the polypeptides. A number of 
solubilization agents can be used for this procedure e.g. 8M guanidinium 
chloride, 6-8 M Urea, detergents and organic solvents. The choice of 
solubilization reagent will depend upon the nature of the protein, and on a 
number of other variables such as pH, temperature, time and ionic 
environment.
Having disrupted the aggregated polypeptides, conditions must be 
adjusted for refolding. In some cases removal of the dénaturant has been 
achieved by dialysis, successfully generating a soluble and active protein 
e.g. with bovine growth hormone (George et al.. 1985) and urokinase 
(Winkler ct al.. 1985). Correct refolding can also be achieved by 
appropriately altering the pH of the environment, a variable which may be 
critical for correct disulphide bond formation, since thiol-disulphide 
exchange proceeds more rapidly at alkaline pH (Freedman and Hlllson, 1980). 
In some cases, the correct formation of disulphide bonds may be critical 
during refolding, although this would not be necessary with ricin A chain
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as no intra-chain disulphide bonds are formed.
In view of the apparent consistency with which recombinant proteins 
are expressed in an insoluble or aggregated form it is perhaps fortunate 
that a soluble truncated ricin A chain can be produced de novo without 
recourse to the denaturation or refolding procedures described earlier.
Besides growing the transformed E. coli cells at 30°C and fortuitously 
having a low level expression system, the method by which the cell lysate 
was obtained may well have contributed to the extraction of a soluble, 
active product. The use of chromatofocusing to purify the truncated ricin 
A chain has indicated that this polypeptide has a pi of around 7.5-8.0, 
similar to the value for native ricin A  chain. Furthermore, as no evidence 
of the truncated protein was apparent in any other fractions from the 
chromatofocus ing column, including the final salt wash, it is probable that 
only non-denatured material was applied to the column from the cell lysate 
preparation. This is assuming that the pi of any denatured material will 
differ from non-denatured material, as experienced with the purification of 
native ricin B chain (see Section 3:3:2:3:6).
The data presented in the chapter has demonstrated that it is 
possible, by the use of site directed mutagenesis, to introduce a premature 
stop codon into the DNA sequence encoding for ricin A chain and 
successfully produce a truncated form of the A chain devoid of 30 amino 
acid residues from its C-terminus. Furthermore it has been demonstrated 
that both the in vitro translation product and the recombinant protein 
expressed in E. coll, have retained their ability to inactivate eukaryotic 
ribosomes (Figure 5:8 and 5:14 respectively). The deleted region is a 
hydrophobic stretch of amino acids which forms part of a disc-like domain 
that is believed to insert between the two sugar-binding domains of the B 
chain when the holotoxin is formed (Montfort et al.. 1987). It has been 
hypothesised that this region interacts with lipid membranes and may be 
important during the events leading to the translocation of the A chain
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into the cytosol (Uchida et al. , 1980) .
It is interesting to note that when the amino acid sequences of ricin 
A chain (Yoshitake et al. , 1978) and the toxic plant protein trlchosanthln 
(Gu Ziwei et al. , 1984; Vang Yu et al., 1985) are compared, not only do 
they show a striking homology along much of their length, but trichosanthin 
terminates some 29 amino acid residues before rlcln A chain and therefore 
lacks the ricin*llke C-termlnal hydrophobic domain. Thus trichosanthin is 
very similar to the truncated version of ricin A chain (A stop), created by 
the introduction of a premature stop codon into the ricin A chain DNA 
sequence. Possibly a more detailed analysis of the toxic nature of 
trichosanthin, which is extracted from the root tuber of Trlchosanthes 
kirllowll maxim, may give some indication as to the significance of the C- 
terminal domain in ricin A chain. The proposed analysis of the function of 
this C-terminal region following on from the results described in this 
chapter, and possible improvements to the experimental strategy are 
considered later in the general discussion in Section 6:1.
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¿ll general Pt?9ussloQ.
Despite the considerable interest generated by the potential of plant 
toxins for development as specifically targeted anticancer drugs, much of 
their basic biochemistry and mode of action remains poorly understood. The 
process of cellular intoxication by ricin and other type II RIPs may be 
considered in three stages, binding, internalization and ribosome 
inactivation.
I. Binding of the toxin to the cell surface.
With ricin, cell-surface binding is mediated through interactions 
between sugar-binding domains of the ricin B chain and galactosyl residues 
on the cell surface, probably in the form of terminal galactosyl residues 
on glycoprotein and glycolipid oligosaccharide side chains (Rosen and 
Hughes, 1977). Ricin may also bind to cells by a different mechanism; 
through its mannose rich oligosaccharide side chains. Cells of Che 
reticuloendothelial system which bear mannose receptors on their cell 
surface can mediate the uptake of both whole ricin and ricin A chain 
(Simmons et al. . 1986). It is likely therefore, that ricin may become 
internalized into cells via a number of different routes, which may be 
determined by the particular receptor(s) or ligand that the toxin binds or 
is bound to.
II. intern»lls»yion-
It is apparent that at least some cell surface bound ricin molecules 
are Internalized via the coated pit-endosomal pathway (Van Deurs et al., 
1985). This pathway however, may not necessarily represent the route taken 
by those ricin molecules whose A chains ultimately become translocated into
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Che cell cytosol, where they bring abouc Che cessacion of proceln 
synthesis. A more derailed consideraCion of inCernalizacion is given in 
ChapCer 1.
III. inhifeltlvn Qi eretEln tvnthcsi?-
The inhibicion of proCein synthesis in Che intoxicated cell is Che 
resulc of Che enzymic inactivation of 60S subunits of Che ribosomes by Che 
A chain polypeptide. Again a more detailed analysis of this activity is 
described earlier in Chapter 1. However, before the ricin A chain is able 
to inactivate the ribosomes, it must first gain entry to the cytosol. Very 
little is known about the nature of this translocation event or the 
respective roles, if any, of the ricin subunits in this process. The 
overall aim of the experiments detailed in this thesis has been to (a) 
examine the possible role of ricin B chain during this translocation 
process and (b) to examine the significance of deleting a hydrophobic C- 
terminal domain from the ricin A chain which has been implicated in both 
ricin subunit interactions (Montfort et al., 1987) and Interactions with 
lipid vesicles (Utsumi et al. . 1984).
As a prerequisite to studying the role of ricin B chain during the 
intoxication process it was necessary to obtain a source of ricin B chain 
available in milligram amounts, in a non-denatured form and free from 
contaminating ricin A chain. These requirements were met by purifying the 
reduced ricin subunits by the procedure outlined in Sections 2:2:3 to 2:2:4 
and then assessing the purity of the subunits by increasingly stringent 
assay procedures. This analysis ranged from straightforward visual 
examination of silver stained SDS-PACE for evidence of any contaminating 
subunit (see Section 3:2:1) through to the analysis of rlbosomal RNA for a 
ricin A chain specific modification. The use of this RNA modification 
assay, developed from the work of Endo et al. (1987), represents the most
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stringent analysis of ricin B chain purity possible at present (see Section 
3:2:5). The application of this type of assay has not only indicated that 
some contaminating ricin A chain is present in the highly purified ricin B 
chain preparations at higher concentrations (see Figure 3:13), but has been 
extended to quantify the extent of contamination, see Section 3:2:6. In 
the example quoted in Sections 3:2:5 and 3:2:6, which represents purified 
ricin B chain used in later experiments, the contaminating ricin A chain 
represented only 0.003% of the total protein. This high degree of purity 
of ricin B chain was obtained after a single chromatofocusing step, which 
helped to minimise the loss of material experienced when subsequent 
purification steps were included.
A further consequence of applying the RNA modification assay to 
analyse the purity of ricin B chain was that it enabled a distinction to be 
made between ricin A chain-specific ribosome inactivation and inactivation 
of rabbit reticulocyte lysate translation systems caused by some other 
factor(s) resulting from incubation with purified ricin B chain. Prior to 
publication of the work Endo et al. (1987) it was not possible to make such 
a distinction and some authors assumed that inhibition of cell free 
translation systems with ricin B chain preparations was the result of 
contaminating ricin A chain (Fulton et al. . 1986).
A body of evidence exists in the literature indicating that the 
addition of free ricin B chain can lead to an enhancement of ricin A chain 
immuno toxin-mediated cytotoxicity (McIntosh et al. , 1983) and that a 
similar "potentiation" of cytotoxicity can be observed if the ricin B chain 
is applied in the form of a suitably targeted immunotoxin (Vltetta et al. . 
1983). To examine the apparent "potentiation" of ricin A  chain mediated 
cytotoxicity by ricin B chain, the potential of the latter as a carrier of 
polypeptides other than ricin A  chain into cells was analysed. It was felt 
that if ricin B chain was solely responsible for directly or Indirectly 
facilitating the cytoplasmic entry of ricin A chain, then it might be
226
expected that the B chain would act in the same manner when coupled with a 
similar A chain polypeptide. If successful, then the ability of B chain to 
help transport less related polypeptides into the cytoplasm could then be 
explored. In these experiments, native ricin A chain was replaced with the 
type I ribosome inactivating protein (RIP) gelonin. Gelonin was selected 
as the ricin A chain analogue for a number of reasons; firstly it is a 
glycoprotein of similar molecular weight to ricin A chain and secondly it s 
ribosome inactivating activity is similar to that of ricin A chain in a 
cell-free assay (Stirpe and Barbieri, 1986). In addition, it has 
subsequently been shown to modify rRNA in an identical manner to ricin A 
chain (Endo et al. , 1988) and finally, it was relatively easy to obtain.
In order to link ricin B chain to gelonin via a reducible linkage, it 
was necessary to introduce a thiol group into the gelonin molecule. This 
was achieved by reacting the protein with 2-imlnothiolane as described in 
Section 2:12:3. However, despite demonstrating that some conjugate, 
composed of one ricin B chain molecule disulphide bond linked to one 
gelonin molecule, had been synthesised (Figure 4:5), no cytotoxicity was 
associated with this construct. This result is perhaps surprising as 
cytotoxic activity has been associated with gelonin immunotoxins (Lambert 
et al. . 1985; Thorpe et al. . 1981). At the very least the association with 
ricin B chain would provide the gelonin with a cell binding moiety. It is 
perhaps interesting to note at this point that free gelonin was less 
cytotoxic than purified ricin A chain. It is unclear as to whether this 
higher cytotoxicity, associated with ricin A chain, is a result of slight B 
chain contamination or a consequence of some innate ability for promoting 
its own entry into the cytosol (Figure 4:3 and Figure 3:9). In contrast to 
the findings here, Coldmacher et al. (1987) have produced a cytotoxic 
gelonin-ricin B chain conjugate. However, it is interesting to note that 
in studies by McIntosh et al. (1988) neither the addition of ricin- or 
abrln B chains could potentiate the cytotoxic activity of a gelonin
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containing immunotoxin.
Whilst considering the data presented in this thesis relating to the 
construction of a ricin B chain-gelonin hybrid toxin, it is worth recalling 
the experiences of other workers who observed that ricin B chain achieved 
poor association with abrin A chain (Olsnes et al., 1974) and diphtheria A 
fragment (Sundan et al.. 1982). These results would suggest that any form 
of subunit reassociation, let alone correct reassociation, may require more 
than the formation of a single disulphide bond between the two subunits.
The poor reassociation of ricin B chain with heterologous "A chains" 
observed both in this study and by other authors (see above) suggest that 
ricin B chain is perhaps unsuitable for use as a carrier molecule. A more 
suitable choice of carrier molecule might, in retrospect, be abrin B chain 
which, as well as possessing identical functions to ricin B chain (i.e. 
sugar-binding and A chain potentiation activities), more readily 
reassociates with alternative A chains (Olsnes et al.. 1974). It should be 
added however that McIntosh et al. (1988) were unable to potentiate the 
cytotoxic activity of a gelonin containing immunotoxin with abrin B chain, 
as well as failing with ricin B chain.
Despite reports of cytotoxic activity associated with ricin B chain 
conjugates containing gelonin (Goldmacher et al.. 1987), barley RIP (Ovadla 
et al. (1988) and abrin A chain (Olsnes et al.. 1974), a true potentiation 
effect has only been demonstrated when ricin B chain has been added to 
systems containing either abrin A chain or ricin A chain containing 
immunotoxins (McIntosh et al., 1988). Recent amino-acid sequence analysis 
of abrin A chain has shown it to have considerable homology with the amino 
acid sequence of ricin A chain (Funatsu et al.. 1988), including the C- 
terminal region which is absent from the sequence of the toxic plant 
protein trichosanthln (Xuejun and Jlahuai, 1986). It is possible to 
speculate therefore that ricin B chain may only associate correctly with 
closely related proteins and, in particular, may require an equivalent C-
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terminal disc-like domain, as is present on ricin A chain, to form such an 
association. Following this argument through it would seem that correct 
subunit association is somehow necessary for cytotoxicity. Until more 
sequences of type 1 RIPS are published, it is only possible to speculate as 
to the significance of hypothetical domains within type I RIPs such as 
gelonin, in hybrid toxin formation and translocation events.
It may be concluded from the data presented in Chapter 4 that ricin B 
chain does not act to promote the entry of gelonin into cells. However, 
ricin B chain can apparently promote ricin A chain cytotoxicity (McIntosh 
et al. . 1983, Vitetta et al. . 1983) which might suggest a specific 
interaction between the two ricin subunits. In an attempt to analyse this 
possibility and to analyse the possibility that ricin A chain itself might 
have a role to play in promoting its own membrane translocation, a 
hydrophobic region of 30 amino acids was deleted from the C-terminus of 
ricin A chain.
The successful introduction of a functional stop codon into the DNA 
sequence encoding for ricin A chain has been shown by in vitro translation 
analysis of transcripts from the mutated sequence (see Figure 5:7). That 
toxicity had been retained in the truncated form of the A chain was also 
shown by in vitro analysis as described in Section 5:7. Following on from 
these observations, the truncated ricin A chain has been expressed in L. 
coll and partially purified in a soluble, active form (see Sections 5:8,
5:9 and 5:10). A further purification step involving the use of blue 
sepharose, see Section 5:11, was unsuccessful in isolating the truncated 
ricin A chain. However, the evaluation of this method demonstrates a 
further application of the RNA modification assay (see Section 2:11), by 
which the presence of the biologically active ricin A chain product can be 
detected at concentrations beyond the resolution of more conventional 
methods such as Western blotting.
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The effect of removing 30 amino acids from the C-terminus of ricin A 
chain, on the ability of this truncated A chain to gain entry into the cell 
cytosol might be analysed by a number of ways. One such way would be to 
directly reassociate the truncated ricin A chain via a disulphide linkage 
to purified native B chain thereby reconstituting a modified ricin 
holotoxin. Such a procedure would require both relatively large amounts of 
completely purified truncated ricin A chain and the introduction of a thiol 
group into the truncated protein by chemical reagents, (see Section 2:12). 
The introduction of the thiol group is necessary to replace the thiol group 
normally provided by the cysteine residue at amino acid residue 259 in the 
ricin A chain sequence (Lamb et al. . 1985). This residue is one of the 30 
deleted from the A chain C-terminus as a result of the introduced stop 
codon. The large amount of starting material required to counter the 
anticipated losses during both the purification and derivatisation 
procedures would involve large-scale cultures of expressing E. coli. and 
possibly the use of a small chemostat. These proposals become less 
practical when the stringent safety regulations associated with Category 
III laboratory containment conditions are taken into account. Furthermore, 
the optimisation of growth conditions in chemostat cultures and 
considerations of plasmid stability upon continuous culture are also of 
paramount importance. The impractlcalities of such a major endeavour under 
Catergory III containment therefore precluded attempts to scale up the 
production of truncated A chain.
One strategy to reduce the amount of material required would be to 
introduce a cysteine residue into the amino acid sequence of the truncated 
A chain. The introduction of a naturally occurring thiol group into this 
protein would, in theory, eliminate the requirement for a chemically 
introduced group and therefore the relatively large amount of purified 
material required for this procedure. Ideally the Introduced residue 
should be as close to the C-terminus of the truncated A chain as possible.
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Suitable residues for modification might be the glycine residue at position 
237 or the arginine residue at position 235. A single base change in 
either of these codons, to read TGT instead of CGT (for arginine) and GGT 
(for glycine), would encode for a cysteine residue at these positions. The 
sulphydryl groups of either of these cysteine residues would, in theory, be 
able to pair with the sulphydryl group of the cysteine at residue 4 of the 
ricin B chain amino acid sequence to create a disulphide bond between the 
two subunits.
There is however some uncertainty as to the importance of the 
disulphide bond for subunit association and toxicity of ricin. Vhilst some 
authors suggest it is of little significance, other than to hold the two 
subunits together at low concentrations (Lewis and Youle, 1986); other 
authors believe that the interchain disulphide linkage is essential for 
toxicity (Wright and Robertus, 1987). Whatever its significance, to carry 
out experiments with the recombinant truncated A chain would still require 
that the product be purified from other E. coli proteins, before attempting 
reassociation with purified native ricin B chain. Furthermore even if such 
a reassociation between the truncated ricin A chain and purified native B 
chain were possible, such a "forced" reassociation may result in the 
formation of a non-cytotoxic molecule.
One approach, which may avoid the possibility of an incorrectly 
manufactured subunit association would be to make a truncated ricin A chain 
containing immunotoxin. Such an immunotoxin if linked to an appropriate 
antibody could be directed to the cell surface of the target cell and its 
cytotoxic activity analysed both with and without the addition of free 
ricin B chain. The addition of ricin B chain to this system would allow 
reassociation, if it was to occur, in a non-forced manner. The problem 
with creating such an lmmunotoxin, even with the introduction of a cysteine 
residue into the truncated A chain, would be obtaining an adequate amount 
of purified material to couple with the antibody. For this particular
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reason a method, by which partially purified truncated rlcln A chain could 
be coupled to antibodies targeted to cell surface determinants, Is 
particularly attractive.
Such an approach might be possible by the use of bi-specific 
antibodies. Bi-specific antibodies, as their name implies have dual 
specificities, each associated with one arm of the antibody structure. In 
this example, the specificities would be against a determinant unique to 
the truncated rlcin A  chain and against some determinant on the cell 
surface of the target cells. In theory therefore, such a bi-specific 
antibody could be reacted with a partially pure truncated rlcln A  chain 
preparation and then be applied to the target cells. This, again in 
theory, would result in only the truncated rlcln A chain being directed to 
the cell surface where, as suggested above, its cytotoxicity both with and 
without the addition of purified native ricin B chain could be assessed. 
Predictably the best analysis would be to compare the results from 
experiments with truncated ricin A chain with those using whole recombinant 
rlcin A chain under identical conditions. This approach to immunotoxin 
production has been successful in producing a cytotoxic product using a bi­
specific antibody raised against both a cell surface determinant of guinea 
pig lymphoblastic leukemia L3C cells and against a determinant of the type 
I ribosome inactivating protein, saporin (M. J. Glennie, abstract from the 
International Symposium on Immunotoxins, Durham, North Carolina, 1988).
The apparent ease with which these bi-specific antibodies can be produced, 
together with the advantage of using only partially purified products, 
which are not required to carry their own thiol linkage group, makes this 
approach the most attractive considered so far.
An alternative to these in vitro studies, in which the deletion at the 
C-terminus of the A chain is analysed in terms of its overall effect on 
cytotoxicity, would be to examine the interaction of the expressed 
truncated protein with lipid vesicles. In similar studies carried out by
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Utsumi et al. (1984) ricin, rlcln A chain and ricin B chain were tested for 
their association with dipalmitoylphosphatidylcholine (DPPC) vesicles.
From these experiments they were able to make a number of interesting 
observations. The first of these was that intact ricin demonstrated no 
association with the vesicles, although both free ricin A chain and free 
ricin B chain could evidently associate with the lipid bilayer. These 
results suggests that in the intact ricin molecule no hydrophobic domains 
are accessible for lipid interaction. Once reduced however, hydrophobic 
domains on both ricin A and B chains are exposed, and can interact with the 
lipid membrane. This observation in which hydrophobic domains are not 
exposed in the holotoxin until dissociation of the subunits agrees with the 
hypothetical model proposed earlier, whereby the B chain subunit acts to 
protect the hydrophobic C-terminus of the A chain. However, Utsumi et al.
(1984) observed that both subunits interacted with the lipid vesicles and 
indeed that the B chain had a greater affinity for the DPPC vesicles than 
did the A chain, with respective Ka values of 14.5 x 10s M 1 and 2.30 x 
10"6 M"1. This result would at first suggest that ricin B chain 
interaction with the lipid membranes has a greater possible significance in 
membrane translocation than ricin A chain interactions. However, in an 
extension to these studies it was observed that ricin A chain was able to 
induce the complete release of a carboxyfluorescein dye from the vesicles. 
Neither B chain or intact ricin could induce this release, even at 
concentration five times greater than those required for the complete 
release by ricin A chain. The overall conclusion from these findings is 
that although both ricin A chain and ricin B chain can associate with the 
lipid vesicles, only the A chain (as judged by dye release experiments) can 
penetrate the lipid bilayer and cause perturbation of both leaflets. The 
strong interaction of ricin B chain with the lipid vesicles without the 
concomitant release of dye suggests that this polypeptide does not achieve 
complete penetration and therefore does not disrupt the bilayer.
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Clearly this type of analysis would be appropriate to determine the 
extent of membrane interaction with the truncated form of the ricin A 
chain. Ideally in this type of study, a comparison with whole recombinant 
ricin A chain should be carried out in parallel with the recombinant 
truncated material. This type of approach, coupled perhaps, with the bi- 
speciflc antibody-immunotoxin approach, (which examines both the 
interaction to the truncated A chain with whole cells and the interaction 
with ricin B chain), represents perhaps the best way forward in analysing 
the overall activity of truncated ricin A chain.
It is Impossible, without attempting such experiments, to predict the 
effect that the removal of this 30 amino acid region from the C-terminus of 
the A chain will have on the events contributing to the entry of this 
polypeptide into the cytosol of cells, or on its interaction with ricin B 
chain. What this work has shown however, is that the ribosome-inactivating 
activity of the A chain is not affected by this deletion. Furthermore, the 
fact that this truncated protein can be expressed and purified in a 
soluble, active form may offer a hitherto unexplored approach in helping to 
understand the apparently intricate and subtle mechanisms of toxin 
internalization and membrane translocation.
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